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Abstract 
 
 
Cutaneous wound healing is orchestrated by a number of physiological pathways 
which ultimately lead to re-formation of skin integrity and the production of 
functional scar tissue. Matrix metalloproteinases (MMPs) act to control the 
remodelling of the extracellular matrix (ECM). Regulation of MMPs is imperative 
for wound healing as excessive levels of MMPs can lead to disproportionate 
destruction of the wound ECM compared to ECM deposition. In addition to human 
MMPs, bacterial proteases have been found to be influential in tissue breakdown and 
as such have a role to play in the healing of infected wounds. Of particular interest in 
this thesis is Pseudomonas aeruginosa elastase, which has been reported in previous 
studies to induce degradation of host proteins including proteoglycans in chronic 
wounds and has also been shown to degrade host immune cell mediators. This 
evidence, along with recent data demonstrating the presence of P. aeruginosa 
biofilms in equine wounds, led to the hypothesis that P. aeruginosa proteases play a 
role in the non-healing of equine wounds and that the wound environment has an 
influence on the pathogenicity of P. aeruginosa in terms of protease expression. 
 
In this thesis I identify that isolates of P. aeruginosa obtained from equine wounds 
display a highly variable protease expression and biofilm forming potential (BFP). 
Furthermore, environmental changes made to P. aeruginosa cultures including 
changes to the initial culture pH (i.e. changes to the initial pH of the media in a non-
buffered system) and depletion of oxygen in vitro were shown to alter protease 
expression. Further experimentation has shown that the biofilm mode of growth 
causes changes in the proteolytic profiles of these isolates.  
 
A further study was conducted to investigate the effects of exoproducts derived from 
P.  aeruginosa in addition to purified P. aeruginosa elastase on the viability, growth 
and MMP/TIMP mRNA expression of equine dermal fibroblasts in vitro. 
Preliminary findings demonstrated that P. aeruginosa exoproducts, including 
purified elastase exert deleterious effects on both normal skin fibroblasts and 
granulation tissue fibroblasts in a concentration-dependent manner.  
 II 
 
Immunohistochemistry analysis of wound tissue revealed the presence of bacterial 
clusters disseminated throughout the wound bed and this bacterial staining occurred 
in conjunction with moderate staining of MMPs -2, -3 and -13 throughout the tissue. 
Furthermore, whilst data is preliminary, QRT-PCR analysis showed that mRNA of 
each of the MMPs and TIMPs of interest were expressed in normal skin fibroblasts 
and granulation tissue fibroblasts to a higher level than GapDH, with cells from 
different equine donors responding differently in terms of MMP/TIMP mRNA 
expression when treated with P. aeruginosa conditioned media and P. aeruginosa 
elastase. 
 
My results also identified the potential MMP modulating capacity of a novel foam 
dressing which incorporates polyphosphate. The dressing was effectively able to 
reduce the levels of MMP-2 and MMP-9 in both their active and latent forms and the 
dressing demonstrated its potential in the regulation of P. aeruginosa derived 
proteases.  
 
In light of the results from these investigations, it is proposed that in future work the 
proteolytic phenotype and BFP of infecting bacteria should be considered when 
investigating the clinical nature of chronically infected wounds. 
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1.1 Abstract 
 
Cutaneous wound healing is orchestrated by a number of physiological pathways 
which ultimately lead to re-formation of skin integrity and the production of 
functional scar tissue. The remodelling of a wound is significantly affected by matrix 
metalloproteinases (MMPs) which act to control the degradation of the extracellular 
matrix (ECM). Regulation of MMPs is imperative for wound healing as excessive 
levels of MMPs can lead to disproportionate destruction of the wound ECM 
compared to ECM deposition. In addition to human MMPs bacterial proteases have 
been found to be influential in tissue breakdown and as such have a role to play in 
the healing of infected wounds. For example the zinc-metalloproteinase, elastase, 
produced by Pseudomonas aeruginosa has been shown to induce the degradation of 
fibroblast proteins including extracellular matrix component fibronectin and the 
proteoglycan decorin, and has also been shown to degrade host immune cell 
mediators, including complement components. 
 
Microbial extracellular enzymes have also been shown to degrade proteins in human 
wound fluid and inhibit fibroblast cell growth. It is now being acknowledged that 
host and bacterial MMPs may act synergistically to cause tissue breakdown within 
the wound bed. Several studies have suggested that bacterial derived secreted 
proteases may act to up-regulate the levels of MMPs produced by the host cells. 
Together, these findings indicate that bacterial phenotype in terms of protease 
producing potential of bacteria should be taken into consideration during diagnostic 
and clinical intervention of infected wound management. Furthermore, both host 
MMPs and those derived from infecting bacteria need to be targeted in order to 
increase the healing capacity of the injured tissue.  
 
The aim of this review is to investigate the evidence suggestive of a relationship 
between unregulated levels of both host and bacterial proteases and delayed wound 
healing.  
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1.2 Introduction 
 
Cutaneous wound healing is the result of a complex process of physiological 
pathways, including many cell-cell and cell-matrix signalling pathways as well as 
communication between a number of cell lineages via soluble mediators, specifically 
between the epidermal and dermal layers (Werner & Grose, 2003; Martin, 1997; 
Singer & Clark, 1999). This is achieved through the careful balance between 
stimulating and inhibitory mediators during each stage of healing. When the wound 
does not heal in an orderly set of stages and in a short period of time they become 
chronic: chronic wounds are generally classified as those which fail to heal within 
three months of initial injury (Mustoe, 2005). It is those wounds which remain in one 
particular phase of healing, usually the inflammatory stage which is thought to 
synchronise the wound healing process (Harding, Morris & Patel, 2002), without a 
normal balance between deposition and degradation of extracellular matrix (ECM) 
components (most notably collagens) that become increasingly problematic 
(Diegelmann & Evans, 2004). 
 
In normal physiology the connective tissue ECM is constantly being remodelled for 
growth and regeneration given its non-static nature (Bosman & Stamenkovic, 2003). 
In terms of the cellular interactions which occur in normal wound healing, dynamic 
signalling pathways trigger comparatively latent cell lineages at the wound margin to 
proliferate, invade the wound area and lay down new matrix proteins in order to 
replace the wound area with new tissue (granulation tissue and scar tissue) which 
ultimately leads to the healing of the wound (Martin, 1997). The process begins with 
the formation of a fibrin clot followed by a local inflammatory response with the 
infiltration of neutrophils and monocytes as a means to prevent infection from 
contaminating bacteria (Singer & Clark, 1999). Not only are these effector cells able 
to resist invading pathogens but they are also involved in tissue degradation and re-
formation and in turn aid in the control of cell migration, proliferation and 
differentiation (Eming, Krieg & Davidson, 2007). Indeed, it has long been known 
that the inflammatory process following cutaneous injury is involved in the initiation 
of fibrosis, as well as its protective role (Simpson & Ross, 1972). Neutrophils are 
also involved in the debridement of necrotic tissue and phagocytosis of infectious 
agents, as they release a number of antimicrobial agents such as reactive oxygen 
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species (ROS), cationic peptides, and proteases (Eming, Krieg & Davidson, 2007) 
including neutrophil elastase (Yager & Nwomeh, 1999). Other important 
inflammatory cells involved in wound healing are mast cells which are ubiquitous 
effector cells involved in angiogenesis and the release of proinflammatory mediators 
(Nishikori, Shiota and Okunishi, 2014; Weller et al, 2006) and T lymphocytes which 
play a pivotal role in cell-mediated immunity. The inflammatory phase of healing 
begins shortly after injury and continues over the next 2-3 days in normally healing 
wounds (Falanga, 2005).The proliferation stage of healing follows the inflammatory 
stage, which involves the formation of granulation tissue (consisting of endothelial 
cells, macrophages and fibroblasts). Finally, the re-epithelisation of the wounded 
area along with angiogenesis and remodelling of the skin achieves tissue integrity 
and homeostasis (Martin, 1997; Singer & Clark, 1999). Keratinocytes detach from 
the basement membrane and migrate to cover exposed connective tissue with a 
gradual degradation of the wound clot and replacement by epithelial cells and 
granulation tissue. A selective release of signalling molecules produced by immune 
mediators acts to attract fibroblasts and keratinocytes to the wound bed, including 
interleukin-8 (Garner et al, 1994). 
 
Given the primary function of skin to serve as a protective barrier against 
environmental pathogens and thus infection, the loss of integrity of this important 
organ may ultimately lead to massive disability or even mortality in extreme cases 
(Singer & Clark, 1999). It is reported that there are approximately 250,000 burn 
victims per year in the UK (Hettiaratchy & Dziewulski, 2004) and over 15% of 
general hospital in-patients develop a pressure ulcer (Courtney, Ruppman & Cooper, 
2006). These wounds in particular can have serious implications for the patient, on 
both a physiological level causing pain, discomfort and immobility and also on the 
psychological and psychosocial level. Furthermore, given that chronic wounds 
mostly affect individuals later on in life (Mustoe, 2004), as the population ages the 
incidence of chronic wounds is set to rise (Supp & Boyce, 2005). In addition, not 
only can these wounds have significant implications on the health of the patient, they 
can have a huge financial impact on both the individual patient and the health care 
system as a whole. Cumulatively, this highlights the ever pressing need for 
improvements in clinical intervention strategies directed at efficient wound healing, 
with the primary goal of treatment being the rapid closure of the wound with a 
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resulting functional and aesthetically acceptable scar (Singer & Clark, 1999). 
Furthermore, continued progress in the comprehension of the diverse stages of 
wound repair and tissue regeneration will help to provide systems to manipulate and 
modulate other diseases with similar aetiology involving impaired tissue remodelling 
such as cancer. 
 
The three main chronic wounds include pressure ulcers, diabetic ulcers and venous 
ulcers. With this in mind, it has been proposed that chronic wound pathogenesis is 
based primarily on three major pathological stages: the cellular and systemic changes 
of ageing, repeated ischemia-reperfusion injury and bacterial colonisation with an 
ensuing inflammatory host response (Mustoe, 2004). 
 
The ECM is important for normal morphogenesis and structural support. It is 
composed of collagens, laminins, fibronectin, vitronectin, and proteoglycans among 
other structural proteins (Raghow, 1994). This structure supports cellular growth and 
proliferation and is important for normal skin regeneration and effective wound 
repair (Kleinman, Philp & Hoffman, 2003). The ECM is composed of two distinct 
regions: the basement membrane and the interstitial matrix (dermis) (Bosman & 
Stamenkovic, 2003). It is a complex mix of structural and functional proteins, 
glycoproteins and proteoglycans arranged in a tissue-specific ultrastructure 
(Badylak, 2002). During the healing of a wound, a provisional matrix is synthesised 
primarily of fibrin and fibronectin, acting as a scaffold for epithelial cell migration 
during repair (Clark et al, 1982; Greiling & Clark, 1997). An imbalance between 
ECM formation and destruction may have local and potentially systemic effects. The 
ECM is essentially a framework with signalling peptide sequences used to direct 
cells into the wound space and then activates these cells once bound to the matrix 
and is an ideal environment to support cellular proliferation and growth (Raghow, 
1994). In chronic wounds the balance in ECM maintenance is disrupted partly due to 
an imbalance between proteinases and their inhibitors (Harding, Morris & Patel, 
2002). 
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The normal end result of wound restoration is the formation of scar tissue which 
although provides a stable new barrier is subject to structural and aesthetically 
displeasing abnormalities. However, it is believed that in mammals, the 'normal' 
wound repair process has been evolutionarily optimised through a rapid 
inflammatory response for efficient healing to avoid complications such as infection 
(Bayat, McGrouther & Ferguson, 2003) and it is this level of skin restoration which 
is clinically important following the healing of a chronic wound. 
 
Equine wounds have a characteristic elevated level of exuberant granulation tissue 
(EGT) which can lead to the formation of sarcoids (Cochrane, Freeman & 
Knottenbelt, 1996) and in some instances may resemble the human keloid scar, a 
benign fibroproliferative dermal lesion (Jacobs et al, 1984). In particular, it is the 
lower limb which encounters wounds which do not heal with efficiency in 
comparison to those wounds inflicted upon the head and trunk (Jacobs et al, 1984). It 
has been suggested that a limited local blood supply in the distal regions in both 
humans and horses due to limited tissue coverage over underlying bone and a poor 
vascular bed correlates to the poor wound healing observed in lower extremity 
wounds (Knottenbelt, 1997; Theoret & Wilmink, 2013). Exuberant and indolent 
equine wounds have distinct similarities with human leg ulcers, with these wound 
types more common in elderly patients in both humans and horses (Knottenbelt, 
1997). Research has also revealed that wounds in ponies have been shown to heal 
more rapidly than those wounds observed in larger horses (Wilmink et al, 1999; 
Wilmink et al, 1999b; Stashak & Theoret, 2008; Theoret & Wilmink, 2013). The 
more rapid wound healing seen in wounds in ponies has been attributed in part to a 
greater contribution of wound contraction during wound healing, more effective 
myofibroblast organisation and a more efficient acute inflammatory response 
(Wilmink et al, 1999(a); Wilmink et al, 1999(b); Van Den Boom et al, 2002). In 
equine limb wounds, it has been shown that the wound retracts to nearly twice its 
original size within 2 weeks of the initial injury and the wound can take more than 3 
months to completely heal (Wilmink et al, 1999). However, although 
epithelialisation begins a few hours after the initial injury, this is a slow process in 
equine limb wounds with epithelialisation occurring at a rate of 0.2mm per day in 
flank region equine wounds, compared with a rate as low as 0.09mm per day in 
lower limb wounds (Wilmink & Van Weeren, 2005; Stashak & Theoret, 2008). 
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Research into the pathology of these wounds may help to find clinically important 
targets against both functional and aesthetic problems associated with poor wound 
healing in horses and may lead to similar targets in human wound restoration. 
However, cell culture studies incur a number of limitations in generating data that 
can be related directly to the in vivo biological and genetic events occurring in the 
wound, given the variation in these environments (Brown & Bayat, 2009). 
Difficulties in studying genetic and molecular alterations in wound healing may also 
be hampered by the multifaceted and intricate pathological alterations involved in 
this complex process of events. 
 
It is the aim of this review to analyse the current data within the literature which 
demonstrates either a positive or negative effect of MMPs or other relevant host 
proteases in the transformation from acute to chronic wound healing. Furthermore, 
considerations will be made into the possible detrimental effects of those proteases 
secreted from invading wound pathogens and the net effects on wound protease 
levels. 
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1.3 Proteases and wound remodelling 
 
Cellular stimuli caused by injury causes the expression of several MMPs at the 
wound site (Toriseva et al, 2012). MMPs are believed to have a role in all phases of 
wound healing, contributing to the removal of cellular debris and detachment of 
keratinocytes from the basement membrane shortly after injury then remodelling of 
the provisional matrix (Gill & Parks, 2008; Torriseva & Kähäri, 2009; 
Mirastschijski, Schnabel & Tomasek, 2010). Proteolytic degradation of the ECM is 
vital for the efficient healing of cutaneous wounds (Werb, 1997) and the unregulated 
activity of such proteases is a major pathological mechanism underlying non-healing 
wounds (Palolhati et al, 1993; Barrick, Campbell & Owen, 1999). It is known that 
various activated cell types including activated keratinocytes at the wound edge, 
fibroblasts, and endothelial cells all share a common characteristic of protease 
expression, however it is the invading neutrophils and macrophages which are 
considered to be the major source of proteases at the wound site (Eming, Krieg & 
Davidson, 2007). While fibroblasts are a major source of matrix metalloproteinases 
(MMPs) in the healing wound, secreting proteases capable of degrading collagens, 
elastin and proteoglycans, neutrophils and macrophages recruited during the 
inflammatory phase release elastase and collagenase which degrade damaged 
extracellular matrix components (Tarnuzzer & Schultz, 1996). Furthermore, 
proteinases with broad specificity including elastase, cathepsin G and urokinase may 
have detrimental effects on growth factor function (Yager et al, 1997; Wlaschek et 
al, 1997).  Neutrophil elastase has also been shown to have antimicrobial activity in 
the wound environment (Cole et al, 2001).  
 
There are a number of proteolytic enzymes present at the wound site including the 
serine proteases, such as plasmin and various matrix metalloproteinases (MMPs). 
These proteases have an important role in the migration of keratinocytes to the 
wound bed. Immature keratinocytes produce MMPs and plasmin, allowing the 
keratinocytes to dissociate from the basement membrane thus facilitating migration 
(Simonetti et al, 2013). MMP-9 has been shown to be upregulated in wounded skin 
compared with unwounded skin in parallel with an increase in CD44 molecules 
which are involved in cell-cell and cell-matrix interactions (Simonetti et al, 2013). 
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MMP-1 is able to bind to α2β1 integrin within the wound bed, resulting in the 
migration of keratinocytes which ultimately contact interstitial collagens during 
epidermal wound healing (Sternlicht & Werb, 2001; Dumin et al, 2001). As studied 
by Kubo et al (2001), wound edge keratinocytes do not express the receptors 
required for fibrin/fibrinogen adhesion which is thought to be a mechanism for the 
removal of fibrin during tissue remodelling (Kubo et al, 2001). MMPs may play a 
role in this fibrinolytic pathway, allowing the epidermal cells to migrate across the 
wound bed. Plasminogen also plays a role in keratinocyte migration with one study 
utilising mice with an impaired plasminogen gene to demonstrate this function 
(Rømer et al, 1996). The study concluded that there was a reduced migration rate of 
keratinocytes from the wound margin during re-epithelialisation (Rømer et al, 1996). 
It is believed that this may be due to the decreased ability of these cells to navigate 
their way proteolytically through the fibrin-rich ECM in the deep wound tissue 
(Lund et al, 1999). Lund and colleagues (Lund et al, 1999) have also demonstrated 
the importance of plasmin and MMPs in wound healing with the residual wound 
healing capacity observed in the plasminogen-deficient mice possibly being a result 
of the ability of MMPs to perform alone the functions which they would perform 
together with plasmin in wild-type mice. However, a direct functional overlap 
between plasmin and MMPs was not demonstrated. 
 
There is a generally high level of proteolytic activity in chronic wound fluid. 
Treatment aimed at the re-establishment of the natural balance of proteases as well 
as cytokines and growth factors and their inhibitors within the wound site, such as 
the application of combinations of selective inhibitors of metalloproteinases and 
growth factors may be beneficial (Tarnuzzer & Schultz, 1996). Conversely, it may 
be that combinations of certain growth factors applied to the wound at precisely 
timed intervals may be more effective in the promotion of healing (Singer & Clark, 
1999). 
 
Protease expression at the periphery of the wound aids leading edge keratinocytes to 
dissolve the fibrin (in the wound clot) through the fibrinolytic enzyme plasmin 
(Martin, 1997). This enzyme is derived from plasminogen and is activated by tissue-
type plasminogen activator (tPA) or urokinase-type plasminogen activator (uPA) 
(Lijnen & Collen, 1987). The role of plasminogen in wound repair has been 
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demonstrated in transgenic mice where the plasminogen gene is knocked out and the 
re-epithelialisation of the wound is almost abolished (Rømer et al, 1996). 
Furthermore, key regulators of plasminogen activation are expressed by migrating 
keratinocytes (Rømer et al, 1996; Morioka et al, 1987; Rømer et al, 1994). Various 
classes of MMPs are also up-regulated by wound-edge keratinocytes and are 
involved in cell migration. MMP-9 (gelatinase), for example, has been shown to 
cleave basal lamina collagen type IV and anchoring fibril collagen type VII, which 
then releases keratinocytes to the basal lamina (Martin, 1997; Salo et al, 1994). On 
the contrary, the many experimental studies which have identified MMPs 2 and 9 as 
type IV collagenases should be interpreted with caution (Rowe & Weiss, 2008).  In 
terms of basement membrane remodelling, the role of MMP2 and MMP9 is 
questionable given that the triple helical structure of collagen type IV under in vivo 
temperature is resistant to proteolytic breakdown (Rowe & Weiss, 2008). However, 
evidence has continued to suggest an elevated presence of these MMPs within the 
basement membrane during tissue repair (Gschwandtner et al, 2008; Matsubara, 
Zieske & Fini, 1991). In comparison, MMP-1 (interstitial collagenase) is only up-
regulated in basal keratinocytes which have already migrated beyond the free edge of 
the basal lamina, suggesting that cell-matrix interactions control the expression of 
this MMP (Martin, 1997; Saarialho-Kere et al, 1992). MMP-1 is involved in the 
migration of keratinocytes on collagen and so is important in the initiation of re-
epithelialisation (Pilcher et al, 1997; Toriseva et al, 2012). MMP-10 is also up-
regulated by keratinocytes at the margin of the wound and is specifically increased 
during impaired/prolonged healing (Martin, 1997; Saarialho-Kere et al, 1994). 
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1.4 Structure and Function of MMPs 
 
MMPs are a Zinc-dependent group of endopeptidases (proteolytic peptidases that 
break peptide bonds of non-terminal amino acids- i.e. within the molecule) and are 
part of a larger family of proteases called the metzincin superfamily (Ravanti & 
Kähäri, 2000; Parks, Wilson & López-Boado, 2004). Proteolysis aids in degradation 
of specific ECM proteins and can process bioactive molecules (Werb, 1997). The 
cleavage of cell surface receptors, release of apoptotic ligands (e.g. FAS ligand), 
chemokine/cytokine in/activation are all pathways initiated by MMPs which can 
regulate the wound healing process (Roeb, 2008). Importantly, they are involved in 
cell proliferation, migration (adhesion/dispersion), differentiation, angiogenesis, 
apoptosis and host defence (Roeb, 2008). These enzymes are dependent on metal 
ions and other co-factors (i.e. non-protein chemical compounds bound to a protein 
required for the protein‟s biological activity, usually other enzymes). This 
distinguishes MMPs from other endopeptidases. They have a common domain 
structure: Prop-peptide, catalytic domain, and a haemopexin-like c-terminal domain 
(linked to catalytic domain by flexible hinge region) (Murphy & Knäuper, 1997; Van 
Wart & Birkedal-Hansen, 1990). Figure 1 illustrates the structure of the gelatinases, 
MMPs -2 and -9, which have the addition of fibronectin type II modules which bind 
to gelatin, collagens and laminin (Visse and Nagase, 2003). 
  
1
2 
 
 
 
 
 
 
 
 
 
 
Figure 1: Structure of gelatinases (MMP-2/MMP-9). The three common domains are described as the pro-peptide, catalytic 
domain, and the hemopexin-like c-terminal domain (connected to the catalytic domain via a flexible hinge region). As MMPs are 
synthesized as inactive zymogens, the pro-peptide (part of the cysteine switch) must be cleaved to activate the protease. The 
cysteine switch contains a conserved cysteine residue which interacts with the zinc in the catalytic domain, preventing activation of 
the enzyme. The b-propeller structures in the c-terminal domain provide a substrate/TIMP recognition site. 
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MMPs are initially synthesised as inactive zymogens. For activation, the pro-peptide 
is removed. The pro-peptide domain is part of a “cysteine switch” which contains 
conserved cysteine residues and interacts with zinc in the active site, preventing 
binding/cleavage of the substrate (Van Wart & Birkedal-Hansen, 1990). This 
mechanism keeps the enzyme in an inactive state so as to control MMP expression 
during different healing demands of the skin. Additionally, some MMPs have a 
prohormone convertase cleavage site (Furin-like) in this pro-peptide domain which, 
when cleaved, activates the enzyme, particularly the membrane-type 
metalloproteinases (Stawowy et al, 2005). The catalytic domain is an active site 
running across catalytic domain with catalytically important Zn
2+
 ion, bound by 3 
histidine residues (zinc-binding motif). The hinge region connects the catalytic 
domain to c-terminal domain and contains up to 75 amino acids, but with no 
determinable structure (Murphy & Knäuper, 1997). The haemopexin-like c-terminal 
domain is absent in MMPs 7, 23 and 26 (Parks, Wilson & López-Boado, 2004). It is 
composed of a four bladed β-propeller structure which provides a large flat surface 
ideal for protein-protein interactions. This part of the MMP structure determines 
substrate specificity and is also the site for interaction with TIMPs. 
 
The classification of MMPs remains a subject of much debate, particularly in the 
identification of the MMP-2 and MMP-9 substrates (Rowe & Weiss, 2008). 
However, there are 4 classes of MMPs which have consistently been grouped 
according to substrate specificity: collagenases, which are thought to degrade triple-
helical fibrillar collagens into shorter fragments and include MMP 1, 8, 13 and 18 
(Nelson et al, 2000); gelatinases, which degrade ECM components including type IV 
collagen, gelatin and elastin (MMPs 2 and 9) (Steffensen, Hakkinen & Larjava, 
2001; Bauvois, 2012); the stromelysins including MMP 3, 10 and 11 which have a 
broad substrate specificity being able to degrade several ECM components such as 
collagens, gelatin, laminin, elastin and proteoglycans (Steffensen, Hakkinen & 
Larjava, 2001; Chandler et al, 1997; Kerkelä et al, 2001; Rechardt et al, 2000) and 
the Membrane-type MMPs (MT-MMPs) comprising MMPs 14-17, 24 and 25 which 
also have a role in the degradation of ECM components (Marco, Fortin and Fulop, 
2013). 
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1.5 Implications for MMPs in delayed wound healing 
 
MMPs have a significantly profound effect on wound healing. In addition to the role 
of these enzymes in tissue remodelling, with a particular effect on the deposition and 
degradation of collagens and other ECM components, MMPs have a role in 
keratinocyte migration to the wound site and degradation of growth factors and their 
receptors (Stamenkovic, 2003). In normal response to injury, epithelial cells migrate 
across the wounded tissue to close the wound area and restore the barrier to infection 
(preventing the entry of environmental pathogens and leakage of fluids). Cell-matrix 
(intracellular and extracellular) interactions control migration. MMPs can facilitate 
and also suppress cell movement by affecting the state of these cell-matrix 
interactions and proliferation. At present, there are 26 MMPs known to exist. 
 
Both MMPs and their inhibitors, tissue inhibitor of metalloproteinases (TIMPs) exist 
in a state of dynamic equilibrium, with a slight excess of one or the other depending 
on the need for either ECM breakdown or synthesis. Pathological consequences stem 
from prolonged disruption to this balance in MMPs and their inhibitors (along with 
other mediators involved in wound healing such as growth factors and cytokines). 
Specific examples include laminitis in horses and cattle caused by the destruction of 
ECM in the lamellar basement membrane (Kyaw Tanner & Pollitt, 2004), and 
osteoarthritis in which the articular cartilage is progressively destroyed (Naito et al, 
1999). However, a significant decrease in MMP activity can potentially lead to 
impeded wound healing by preventing fibrinolysis in fibrotic conditions (such as in 
the case of hypertrophic scarring and keloid formation) (Soo et al, 2000) and the 
resulting decrease in the removal of scar tissue in wounds.  
 
It has been shown that the expression of various MMPs are upregulated during 
wound repair and regeneration with mRNAs encoding respective MMPs including 
gelatinase A (MMP-2), gelatinase B (MMP-9), collagenase-3 (MMP-13), 
stromelysin-1 (MMP-3), stromelysin-3 (MMP-11), MT-1 MMP (MMP-14) and 
macrophage metalloelastase (MMP-12) being upregulated (Lund et al, 1999). These 
have been detectable by in situ hybridization with probes specific for these MMPs. 
There is no detectable mRNA for any of these MMPs in normal skin compared to a 
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vast expression in wounded skin (Lund et al, 1999; Saarialho-Kere, 1998; Norgauer 
et al, 2002). Pro-inflammatory cytokines are considered as potent inducers of MMP 
expression in chronic wounds and it has been shown that they down regulate the 
expression of tissue inhibitor of metalloproteinases (TIMPs) which in turn creates an 
over-expression of MMPs (Eming, Krieg & Davidson, 2007). In particular, TNF-α 
and IL-1β are capable of increasing the levels of MMPs in wounds (Barrientos et al, 
2008). Furthermore, important factors in healing such as platelet-derived growth 
factor (PDGF) and vascular endothelial growth factor (VEGF) are targeted by these 
proteases and are inactivated via proteolytic cleavage (Lauer et al, 2000; Roth et al, 
2006). 
 
It is also recognised that neoplastic progression is a realistic consequence of chronic 
wounding, with the risk of squamous cell carcinoma (SCC) significantly increased in 
chronic leg ulcers (Impola et al, 2005). Since MMPs are implicated in the 
pathogenesis of wound healing and are known to be involved in all stages of 
tumourigenesis it may be that epithelial MMP expression can influence hyperplasia 
in chronic wounds (Impola et al, 2005) and may be involved in tumour invasion and 
metastasis (Chin et al, 2005).  The up-regulation of MMPs in most human cancers 
has been shown to be a reaction to the presence of tumour cells and is produced 
mainly by the stromal cells and inflammatory cells which infiltrate the tumour 
(Ramnath & Creaven, 2004). Indeed, Sternlicht et al (1999) and D‟Armiento et al 
(1995) found MMP-1 and 3 alleles to be associated with an increased risk of cancer. 
MMP expression is also regulated by SNPs in the MMP gene promoter regions 
which create/abolish transcription factor binding sites (Overall & López-Otín, 2002).  
 
The expression of MMPs in the various anatomical layers of wounded skin 
Salo and colleagues (1994) demonstrated the localisation of various MMPs 
throughout wound repair. They found that the expression of MMP-2 was localised in 
connective tissue fibroblasts and endothelial cells during each of the phases of 
wound healing whereas MMP-9 mRNA was found to be located in the mucosal 
epithelium in the first few days of healing, yet the mucosal epithelium was mostly 
negative for MMP-2 expression.  Comparatively, the non-wounded area of the skin 
expressed a high level of MMP-9 which was localised in the basal and suprabasal 
cell layers, with only the basal cell layer being MMP-9 positive in the migrating 
 16 
 
epithelial sheet. In the later stages of healing, MMP-9 mRNA expression was 
significantly increased, specifically within the granulation tissue. Wound fluid also 
contained increased levels of MMP-9 (evident in the earlier stages) as compared to 
those levels of MMP-2. It was also discovered that a number of cytokines and 
growth factors are able to preferentially regulate the expression of MMP-9, in 
particular through keratinocyte production. Specifically, it was IL-1β, TGFβ-1 and 
tumour necrosis factor (TNF)-α which were able to enhance this production of 
MMP-9. In contrast, MMP-2 expression in cultured wound fibroblasts was not at all 
effected by the presence of any of these molecular mediators (Salo et al, 1994). 
Other important signalling pathways have a role in MMP expression within wounds, 
such as the mitogen-activated protein kinases (MAPKs) pathway and are possible 
therapeutic targets for wound healing disorders (Ravanti & Kähäri, 2000). Excessive 
collagenolytic activity in chronic wounds is also heightened due to reduced levels of 
tissue inhibitor metalloproteinase 1 (TIMP-1) (Armstrong & Jude, 2002). 
 
The study by Ladwig et al (2002) was aimed at analysing pro and activated MMP-2 
and MMP-9 in wound fluids and tissue biopsies from patients with chronic pressure 
ulcers. Patients were treated conventionally or with exogenous cytokine therapies 
over a period of 36 days. Quantitative assays were used to correlate the levels of 
these MMPs with the level of healing present in each wound. It was noted that the 
average ratio of MMP-9/TIMP-1 in fluids from chronic ulcers was significantly 
decreased as the ulcers healed. Additionally, in those wounds which ultimately 
healed well, fluids collected on day 0 of the wound had a significantly lower ratio of 
MMP-9/TIMP-1 compared with fluids from day 0 of wounds that healed poorly. 
Therefore, this study showed that the MMP-9/TIMP-1 ratio is a predictor of healing 
efficiency in pressure ulcers and shows that high levels of MMP activity along with 
comparatively low levels of TIMP activity, impairs wound healing in chronic 
pressure ulcers and is comparative to similar studies investigating other types of 
chronic abnormal cutaneous healing.
 17 
 
 
1.6 Biofilms- their role in chronic wound healing 
 
Biofilms are communities of microbial aggregates which form as a survival 
mechanism due to diverse adverse environmental conditions. They form through a 
structured process of adherence and matrix forming mechanisms to create an intra 
and intercellular communication network for rapid adaptation to their changing 
environment. Biofilms are able to adhere to both biological and non-biological 
surfaces, mainly colonizing the solid-liquid interfaces (Costerton, Stewart & 
Greenberg, 1999; Donlan, 2002). As the bacterial bio-mass begins to proliferate on 
the surface a self-produced extracellular polymeric matrix is formed which offers 
protection from both mechanical and shear forces and, if formed on a living tissue, 
from host immune defences and antimicrobial agents. The ability of bacteria to form 
biofilms is an ancient and evolutionary emergent property which provides greater 
tensile strength and increased genetic potential. This formation of a functional 
community allows for metabolic co-operation between microbes and provides a wide 
source of nutritional recourses so that the bacteria can modify their own environment 
and proliferate.  
 
As the biofilm-forming microcolony begins to grow, signals are passed between the 
cells after a certain density is reached. This is known as the quorum and the cells will 
then begin to release virulence factors as a defence system against the host's 
polymorphonuclear leukocytes (Widgerow, 2009). This cell-cell signalling 
mechanism is known as quorum sensing and is an important part of the biofilm's 
ability to produce both cell-associated and extra-cellular virulence factors for 
survival and to allow synchronization of activities of large groups of cells (Waters & 
Bassler, 2005). Quorum sensing mechanisms allow the population of 
microorganisms to change their phenotype to form a biofilm when a certain density 
is reached (Scali & Kunimoto, 2013). The quorum sensing controlled processes are 
only effective in the simultaneous signalling manner present within a large group of 
bacteria and are therefore exclusive to the biofilm communities (Waters & Bassler, 
2005). This system is generally composed of a transcriptional activator protein, and 
small diffusible molecules which act as autoinducers that increase in concentration in 
response to an increase in cell density (Fuqua, Winans & Greenberg, 1994; Swift et 
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al, 1996; Scali & Kunimoto, 2013). These autoinducers are hormone-like molecules 
which form the basis of the chemical communication within the biofilm; this 
communication network involves the production, release, detection and response to 
these molecules (Waters & Bassler, 2005).  This phenomenon allows the bio-mass to 
act as a single multicelluar organism (Fuqua, Winans & Greenberg, 1994) and the 
bacterial community is able to monitor and alter its behaviour on a population-wide 
scale in response to changes in the number of organisms, and/or the types of species 
present (Waters & Bassler, 2005). Cell-associated virulence factors include those for 
movement and attachment, such as the formation of flagellum for motility 
(Mahenthiralingham, Campbell & Speert, 1994), pilli and other adhesions (Simpson, 
Ramphal & Lory, 1992), and alginate (Chattoraj et al, 2010) particularly in the case 
of Pseudomonas aeruginosa, which aids the impairment of host innate immune 
defences imposed by phagocytes (Learn, Brestel & Seetharama, 1987; Krieg et al, 
1988). The extracellular virulence factors include various enzymes and exotoxins. 
Important enzymes in terms of host tissue degradation and evasion/destruction of 
host physical barriers include elastase, alkaline protease and phopholipase C (Berka, 
Gray & Vasil, 1981; Leidal et al 2003; Lyczak, Cannon & Pier, 2000).  
 
The mechanism of biofilm formation begins with the adherence and colonization of 
single cells of planktonic bacteria to a primed surface and, in terms of wound 
colonization, attachment to the exposed extracellular matrix of the injured tissue, 
developing into microcolonies (Widgerow, 2009). In acute wounds, these bacteria 
are normally rapidly inactivated and destroyed by neutrophils, antibodies and host 
wound bed preparations (Widgerow, 2009). However, in the chronic wound these 
bacteria often proliferate and produce an extracellular polymeric substance (EPS) 
which encases the population of bacteria forming the biofilm structure, providing the 
biofilm with additional protection from external factors including the host‟s immune 
system (Percival et al, 2011). The EPS can vary considerably in terms of pH, charge, 
ionic strength, physiochemical structure and the EPS can also vary depending on 
species (Percival et al, 2011). Figure 2 illustrates the processes involved in normal 
wound healing and the detrimental effects of biofilm formation on wound healing. 
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It is generally noted that biofilm formation is comprised of eight sequential steps: 
preparation of a conditioning film, transport, initial adhesion, co-adhesion, 
anchoring, coaggregation, growth and proliferation, and detachment. Dispersion of 
the individual bacteria from the biofilm matrix allows the activation of the host 
immune response. This action is a positive one in that the biofilm is able to gain 
nutrients from the host exudates produced by the resulting inflammatory response for 
the continual survival of the bacterial community (Widgerow, 2009). This is one 
example of how bacterial communities can take advantage of the host environment 
and in particular the innate host defences and benefit from the stimulation of the 
inflammatory response (Hornef et al, 2002). The resulting increase in wound exudate 
is detrimental to the regeneration of the wound as it continues to break down the 
extracellular matrix and blocks the effectiveness of intervention therapy including 
the use of growth factors and bioengineered skin (Falanga, 2002) and so a positive 
feedback mechanism is formed, leading the wound into a chronic mode of healing. 
Indeed, protease inhibitors have been shown to preserve the activity of growth 
factors within chronic wounds (Wlaschek et al, 1997). Deficiencies in growth factors 
in wounds are likely to be involved in the transformation from acute to chronic 
wounds. A recent study by Roy et al (2014) has also demonstrated the long-term 
impact of biofilm infection in chronic wounds. The study showed that biofilm 
infection can compromise skin barrier function in the closed wound, which could 
potentially lead to further complications post-closure including an increased risk of 
further infection (Roy et al, 2014). 
 
The formation of a biofilm also incorporates channels to facilitate the efficient 
nutrient uptake and sharing by infusing fluid into the biofilm, optimizing nutrient 
delivery and metabolic waste-product removal (Hall-Stoodley, Costerton & 
Stoodley, 2004; Scali & Kunimoto, 2013). Biofilms can also be enhanced through 
their structure according to varying environments. Biofilms can be either flat or 
mushroom-shaped depending on the nutrient source (Hall-Stoodley, Costerton & 
Stoodley, 2004; Klausen et al, 2003). 
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The effects of biofilm culture on exoprotease production have previously been 
demonstrated in a number of pathogenic bacteria. For example, a quorum-sensing 
dependent regulation of exoprotease production in Aeromonas hydophila, affecting 
both the serine and metalloproteases has been established (Swift et al, 1999). 
Similarly, induction of the LasB gene in Pseudomonas aeruginosa encoding for 
elastase, along with other virulence genes, requires LasR and PAI-1 which are 
components of the quorum sensing activation pathway (Pearson, Pesci & Iglewski, 
1997).  
 
One of the major colonising bacteria found within the wound bed is Pseudomonas 
aeruginosa and it has consistently been shown to be a factor in the prognosis of 
cystic fibrosis (CF). This pathogen is known to secrete a range of harmful proteases 
which act as virulence factors in the lungs of CF patients (Cosgrove et al, 2009). 
Phenotypes which enable P. aeruginosa to be successful in the chronic infection of 
CF lungs include mucoidy and reduced twitching motility (Mayer-Hamblett et al, 
2014). Since the bacteria residing in biofilms have limited supply of oxygen, 
anaerobic respiration is a necessary mode of growth which can occur via an 
inorganic terminal electron acceptor resulting in rapid growth or via substrate level 
phosphorylation using arginine, causing a slow mode of growth (Hassett et al, 2002). 
It has been demonstrated that the proteases secreted by P. aeruginosa differ under 
aerobic and anaerobic culture. Cosgrove and colleagues (2009) have shown that 
under aerobic growth, this organism primarily secretes elastase whereas under 
anaerobic culture the major secreted protease is alkaline protease. Furthermore, there 
seems to be a differential role of these proteases in the host‟s anti-protease screen 
(Cosgrove et al, 2009).
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1.7 Bacterial Proteases and their Role in Wound Healing 
 
The proteases of the serine, cysteine and metallo-type are produced by a wide range 
of pathogenic bacteria and are particularly important in the pathogenesis of wound 
healing. The functions of these proteases include colonisation and evasion of host 
defences, acquisition of nutrients for growth and proliferation, dissemination of the 
biofilm forming bacteria to different areas of the wound, and tissue degradation 
(Supuran, Scozzafava & Mastrolorenzo, 2001). However, bacterial proteases may 
have a clinically beneficial role via the debridement of non-viable tissue in the 
wound area or alternatively could be involved in the migration and stimulation of 
host cells (Supuran, Scozzafava & Clare, 2002). A number of specific and ubiquitous 
proteases have been characterised in both the Gram-positive and Gram-negative 
colonising bacteria of wounds (Supuran, Scozzafava & Mastrolorenzo, 2001). Since 
the majority of antibiotics used in the clinical setting are aimed at the mechanical 
inhibition of bacterial cell wall biosynthesis, resistance to these agents, especially 
when targeting biofilms, is a huge problem. Targeting the bacterial proteases as an 
alternative mode of action of antibiotics (i.e. bacterial protease inhibitors) may help 
to solve this problem in the future (Supuran, Scozzafava & Mastrolorenzo, 2001). 
However, at present few potent inhibitors of these proteases have been developed. 
Examples of protease inhibitors which may have potential in terms of infection 
eradication include inhibitors of signal peptidase, clostripain, Clostridium 
histolyticum collagenase, botulinum neurotoxin and tetanus neurotoxin inhibitors 
(Supuran, Scozzafava & Clare, 2002). However, no inhibitors of the critically 
important and ubiquitous AAA proteases (membrane-bound ATP-dependent 
proteases), degP or sortase have been reported (Supuran, Scozzafava & 
Mastrolorenzo, 2001; Supuran, Scozzafava & Clare, 2002).  
 
Microorganisms produce a large array of proteases which act in an intracellular 
and/or extracellular way. Intracellular proteases are important in cellular and 
metabolic processes, for example sporulation and differentiation, protein turnover, 
maturation of enzymes and hormones and maintenance of the cellular protein pool. 
The extracellular proteases are vital for the hydrolysis of proteins in cell-free 
environments and enable the bacteria to absorb and utilise hydrolytic products 
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(Kalisz, 1988; Gupta, Beg & Lorenz, 2002). The proteases are also able to degrade 
growth factors and their receptors and are particularly involved in perturbation of 
host cytokine networks (Wilson, Seymour & Henderson, 1998; Schultz & Wysocki, 
2009). For example, Theander et al (1988) showed that both the alkaline protease 
and the elastase
 
of Pseudomonas aeruginosa were able to inhibit interleukin-2 (IL-
2)-induced proliferation
 
of murine lymphocytes. Furthermore, the alkaline protease
 
of Pseudomonas aeruginosa has also been shown to degrade and inactivate
 
IFN-  
(Horvat & Parmely, 1988) which is the principal T-cell product which activates
 
macrophages. This mechanism therefore is an important example of how these 
bacterial proteases aid the evasion of host defences. In addition, some bacteria are 
able to produce potent modulins such as lipopolysaccharide (LPS) or exotoxins 
which can induce the release of proinflammatory cytokines from the host, creating a 
net proinflammatory affect (Wilson, Seymour & Henderson, 1998), keeping the 
wound in the chronic phase. Proteolytic cleavage of cell surface receptors for 
numerous ligands can also be a target of these bacterial proteases, including cytokine 
receptors. Cytokines that may be targeted include those that
 
modulate leukocytes to 
produce proinflammatory responses and
 
those that have the capacity to down-
regulate inflammatory cells
 
including macrophages and leukocytes (Wilson, 
Seymour & Henderson, 1998). For example, proteases from a number of organisms 
including S.
 
aureus, Pseudomonas aeruginosa, Listeria monocytogenes, and Serratia
 
marcescens have been shown to release the IL-6 receptor (IL-6R)
 
from human 
monocytes (Vollmer et al, 1996). Perhaps one of the most well known examples of 
bacterial proteases in pathogenicity is the elastase produced by Pseudomonas 
aeruginosa, which degrades immunoglobulin G and components of the host's 
complement system. This provides the bacteria with a survival advantage in the host 
environment (Vollmer et al, 1996; Hase & Finkelstein, 1993; Schultz & Miller, 
1974). In addition to substrate inactivation, bacterial proteases can have a biological 
effect through the release of membrane-bound proteins. These proteins are released 
and can have a negative effect in a variety of ways. For example, soluble receptors 
may act as competitive inhibitors of other ligands or could act as agonists. One 
example of this action is the release of the soluble interleukin-6 receptor (sIL-6R) 
which can bind to neighbouring cells through specific interactions which ultimately 
leaves these cells sensitive to the action of IL-6 (Rose-Jonh & Heinrich, 1994). 
Specifically, endogenous membrane-bound metalloproteinases have been shown to 
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shed various host signalling factors including tumour necrosis factor alpha and its 
receptors, IL-6R, and the FAS ligand (Kayagaki et al, 1995; Crowe et al, 1995; 
Mullberg et al, 1995). This shedding mechanism occurs through the proteolytic 
cleavage of membrane anchors at specific sites close to the membrane surface 
(Vollmer et al, 1996). These trans-signalling pathways can lead to the systemic 
inflammatory reactions (Bazil, 1995), particularly seen in chronic wounds. In turn, 
the effects of a heightened immune response can lead to excessive MMP production. 
Indeed, a number of studies have implicated bacterial-derived proteases in the 
activation or increased production of host MMPs. For example, Kernacki and 
colleagues (1997) concluded that mice immunized against Pseudomonas aeruginosa 
alkaline protease displayed lower proteolytic activity corresponding to host and 
bacterial proteases in an In vivo study of corneal infections. It was shown that 
resistant mice produced a lower overall level of proteolytic activity, corresponding to 
a decrease in host cell MMP-2 and MMP-9 production at various time points 
following infection. Using zymography it was demonstrated that those mice which 
were classified as susceptible to infection produced larger proteolytic bands for the 
inactive forms of both MMP-9 and MMP-2 along with the active form of MMP-9 in 
comparison to resistant mice. Likewise, a study by Matsumoto and colleagues (1992) 
found that purified elastase from Pseudomonas aeruginosa was able to cleave the 
inactive form of MMP-2 derived from human corneal fibroblasts into a biologically 
active form shown by the differences in gelatinolytic band weight using zymography 
following a direct in-tube incubation assay. A number of pathogenic bacteria, many 
of which are common wound pathogens, are producers of metalloproteinases 
including Staphylococcus aureus, P. aeruginosa, Serratia marcescens, Listeria 
monocytogenes, and Bacillus subtilis (Vollmer et al, 1996). S. Marcescens 
metalloproteinase (SMP), which is similar in structure to the elastase of 
Pseudomonas aeruginosa, was utilised (Vollmer et al, 1996) to demonstrate the 
ability of this enzyme to shed IL-6R from primary human monocytes using an 
enzyme-linked immunosorbent assay (ELISA) method, concluding that microbial 
proteases are capable of mimicking endogenous membrane-bound proteinases in 
their ability to shed mediator molecules from the host cell surface.
  
 
2
4 
Figure 2: Schematic of the processes involved in normal wound healing and the detrimental effects of infection in terms of virulence factors associated with 
biofilm formation, including the induction of proteases. (1) In the initial stage of wound repair, platelets are recruited to the injury site, followed by an increase in 
fibrin fibers which create a clot serving as a barrier to invading pathogens (2). (3) Inflammatory cells are recruited to the wound bed to create a local inflammatory 
response. (4) Wound closure commences as the fibroblasts/myofibroblasts secrete collagen bundles into the wound site and the inflammatory response declines. 
During bacterial invasion of the wound, various cell-associated virulence factors direct the increase in tissue degeneration through the continued destruction of the 
extracellular matrix. This is achieved through the secretion of various bacterial proteases and further activation of the host‟s immune response. This process aids 
bacterial survival by providing nutrients in the form of matrix breakdown products/exudate, and also allows for the evasion of antimicrobial interventions. 
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1.8 Synthesis and Secretion of Bacterial Proteases 
 
As mentioned previously, one of the major bacterial proteolytic enzymes studied in 
terms of host MMP activity is elastase B, a 33-kDa zinc-metalloprotease 
(Thibodeaux et al, 2007). The extracellular proteases of Pseudomonas aeruginosa 
are of particular interest given the opportunistic nature of this wide spread pathogen 
among individuals with a predilection to nosocomial infection, including sufferers of 
bacteremia in burn wounds, urinary tract infections and keratitis (Lyczak, Cannon & 
pier, 2000; Thibodeaux et al, 2007; Stover et al, 2000; Twining et al, 1993). Elastase 
is one of the many proteases produced by Pseudomonas aeruginosa which is 
secreted via the type II or general secretory pathway and is produced as a 
preproenzyme which is systematically processed into proelastase via autoproteolytic 
processing (Braun et al, 1998).  
 
1.9 Management of MMPs in Wound Healing 
 
At present, it seems to remain unclear as to why certain host MMP levels, 
particularly the gelatinases, are elevated. However, it has been generally accepted 
that by regulating MMPs in wounds this will help enhance the wound healing 
process. Given the large array of studies which have presented clear data to suggest 
an enhanced MMP activity in chronic wound tissue as compared to normally healing 
tissue and normal skin, the utilisation of protease-modulating treatments in chronic 
wounds has been shown to have beneficial effects on healing efficacy (Veves, 
Sheehan & Pham, 2002; Vin, Teot & Meaume, 2002; Kakagia et al, 2007; Chin et 
al, 2003; Timmons, 2010; Fitzgerald, 2009). Furthermore, studies have analysed 
ways of neutralising high levels of proteases in chronic wound fluids utilising topical 
doxycycline, a member of the tetracycline family of antibiotics which inhibits 
metalloproteinases (Chin et al, 2003). Veves et al (2002) have demonstrated the 
effectiveness of Promogran, a wound dressing composed of collagen and oxidised 
regenerated cellulose, in the inactivation of host proteases without affecting the 
activity of the growth factors involved in wound regeneration. Treatment of diabetic 
foot ulcers with this dressing resulted in an increased rate of healing when compared 
with moistened gauze. Similarly, UrgoCell Start is a dressing which is aimed at 
reducing MMP levels within the wound bed through the actions of the healing 
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accelerator nano-oligosaccharide factor (Timmons, 2010). Another novel wound 
dressing aimed at reducing MMP levels within the wound bed is Biostep, which 
contains a semi-denatured porcine collagen that acts to attract and bind excess 
MMPs in the wound environment, with EDTA permanently deactivating the MMPs 
by binding to the zinc ions of these proteases (Fitzgerald, 2009). However, the ability 
of these newly developed dressings to reduce or inhibit the activity and production of 
bacterial-derived proteases within the chronic wound site remains unclear.  
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1.10 Conclusions 
 
It has been consistently and clearly demonstrated that there is a fundamental role for 
host cell MMPs in the healing of chronic wounds. However, there seems to be 
limited evidence to suggest that those extracellular proteases produced by the 
bacteria colonising chronic wounds have a significant influence on the levels of host 
MMPs within infected tissues.  Generally there is a good understanding of the role 
human MMPs and other proteases have on wound healing. However, there appears 
to be a lack of research into the MMP inhibitors that could be used to influence the 
timely and systematic healing of chronic wounds. Excessive levels of MMPs are 
found in chronic wounds and constitute a concern warranting good management 
strategies along with differential clinical intervention depending on bacterial 
phenotype, and it is beginning to be noted that host and bacterial proteases could act 
synergistically to direct tissue degradation. Those studies that have aimed to prove 
the hypothesis that the downregulation of specific MMP related genes may enhance 
healing of chronic wounds have shown the positive actions that novel wound 
dressings and inhibitory treatments can have on chronic wound healing, 
demonstrating a role for these treatments in the restoration of affected tissues, the 
ultimate goal being the production of functionally viable and aesthetically pleasing 
scar tissue. However, there remains a pressing need for further research efforts in the 
development of treatments aimed at targeting both host and bacterial proteases 
within the wound environment. Research also needs to be focussed on the inter-
communication between various bacterial, viral and fungal proteases among infected 
wounds and how these enzymes synergistically interact with host proteases and other 
mediators of the healing pathways involved in both acute and chronic wounds.  
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1.11 Hypothesis 
 
MMPs play a pivotal role in a range of processes that orchestrate cutaneous wound 
healing. The regulation of these proteases is an important part of the healing process 
since excessive levels of MMPs can shift the equilibrium of ECM degradation and 
deposition in favour of tissue breakdown and impaired wound healing. In chronic 
wounds an imbalance in the levels of proteinases and their inhibitors disrupt this 
balance of ECM deposition and degradation (Harding, Morris & Patel, 2002). A 
number of studies have recognised the elevated MMP activity within the wound 
fluid of chronic wounds and that this elevation in protease activity parallels a delay 
in wound closure (Trengove et al, 1999; Yager et al, 1996; Rayment, Upton and 
Shooter, 2008; Rowe & Weiss, 2008). However, there is little evidence on the 
impact of bacterial proteases on wound healing and host MMP expression despite 
the implications for wound infection on healing and evidence of biofilms in the 
wound milieu (Westgate et al, 2011). Furthermore, little is known about the ways in 
which the wound environment may alter this proteolytic activity. A particularly 
interesting pathogen in terms of wound healing is Pseudomonas aeruginosa, which 
is known for its prevalence in chronic wounds and demonstrates various virulence 
characteristics within the wound milieu (Morihara, 1964; Snell et al, 1978; 
Altoparlak et al, 2004; Engel & Balachandran, 2009). Further investigation into the 
response of P. aeruginosa isolates to changes in the culture environment in terms of 
protease production, and the effects of these proteases on wound closure will 
enhance our fundamental understanding of the role of bacterial proteases during the 
various phases of wound healing.  
 
In this project I will address the hypothesis that clinical isolates of P. aeruginosa 
derived from equine wounds display high levels of proteolytic activity in vitro 
and that changes in the culture environment of these isolates (in particular, 
changes to the culture pH, oxygen availability and the biofilm versus the 
planktonic mode of growth) representative of the wound milieu will have an 
impact on protease production in vitro. I also aim to identify any effects of 
protease-rich P. aeruginosa conditioned media and P. aeruginosa elastase on 
host fibroblast viability, MMP/TIMP mRNA expression and wound closure 
using in vitro models. 
  
29 
 
 
1.12 Aims 
 
The aims of this project are threefold: 
 
(1) To investigate the production of proteases in vitro of P. aeruginosa isolates 
obtained from equine wounds throughout a 24 hour culture period and to 
assess the effects of the changing culture environment reflective of the 
wound milieu (i.e. changes in the culture pH and oxygen availability) on 
protease production using biochemical protease assays and gelatin 
zymography. 
 
(2) To investigate the effect of the planktonic versus the biofilm mode of growth 
of P. aeruginosa equine wound isolates on protease production using in vitro 
culture models. 
 
(3) To investigate the effects of protease-rich conditioned P. aeruginosa media 
and P. aeruginosa elastase on equine normal skin fibroblasts and equine 
granulation tissue fibroblasts in terms of cell viability, MMP/TIMP mRNA 
expression and wound closure, using in vitro models. 
 
 30 
 
2.0 Chapter 2 
 
Manuscript 2 
 
Differential protease expression by isolates of Pseudomonas 
aeruginosa derived from equine wounds, under varying pH 
conditions and oxygen levels 
 
 
Sara M McCarty 
1
, Peter D Clegg 
1
,
 
Christine A Cochrane 
1
 
 
 
1
 Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United 
Kingdom 
 
 
Corresponding Author: Sara M McCarty, Institute of Ageing and Chronic Disease, 
University of Liverpool, Liverpool, United Kingdom, smccarty@liverpool.ac.uk 
 
 
Running Title: Pseudomonas aeruginosa protease expression 
 
 
Keywords: Wound healing, Matrix metalloproteinases (MMPs), Pseudomonas 
aeruginosa elastase, pH, Oxygen tension, biofilm, quorum sensing 
 
 31 
 
2.1 Abstract 
 
P. aeruginosa is a common wound pathogen and is capable of inflicting a multitude 
of deleterious effects upon its host. This micro-organism has been shown to secrete a 
number of proteases in the wound milieu, which act to further delay the healing 
process. It was hypothesised that clinical isolates of P.aeruginosa obtained from 
equine cutaneous wounds display high levels of proteolytic activity in vitro and that 
changes to the in vitro culture conditions, in terms of pH and oxygen availability, 
would have an impact on protease production. 
 
In the current study it has been shown that isolates of P. aeruginosa obtained from 
equine wounds cultured in the planktonic mode of growth display a highly variable 
protease expression. Furthermore, changes made to the initial culture pH (i.e. the 
starting pH of the broth in an un-buffered system) and depletion of oxygen in 
anaerobic (0% oxygen) cultures of P. aeruginosa in vitro caused changes in bacterial 
protease expression; however, different isolates responded differently to these 
changes. It is suggested that in future studies, the proteolytic phenotype of bacteria 
should be considered in terms of the clinical progression and outcome of chronically 
infected wounds.
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2.2 Introduction 
 
It is well documented that wound fluid derived from chronic wounds has an inherent 
ability to degrade important factors of healing both in vitro and in vivo. However, the 
mechanisms by which bacterial secretions, including protease production, influence 
tissue destruction and halted healing and the ways in which such mechanisms can be 
manipulated to aid healing requires further investigation.  
 
A particularly interesting pathogen in terms of wound healing is Pseudomonas 
aeruginosa, which has long been known for its prevalence in chronic wounds and 
demonstrates various virulence characteristics within the wound milieu. Recent 
evidence has identified P.aeruginosa as one of the most commonly isolated bacteria 
from equine wound swabs, with 5.6% of bacterial isolates cultured from wound 
swabs tested in a study by Westgate et al (2011) identified as P.aeruginosa 
(Freeman et al, 2009; Westgate et al, 2011b). This micro-organism is a Gram 
negative pathogen which is difficult to eradicate despite the use of antimicrobial 
interventions once the infection has become established, as indicated in a number of 
pathologies. Indeed, P. aeruginosa has been identified as the most common cause of 
burn wound infections (Altoparlak et al, 2004) and multi-resistant strains have been 
identified in the hospital setting (Chitkara & Feierabend, 1981). As described by 
Engel & Balachandran (2009), P. aeruginosa uses a sophisticated secretion system 
to directly administer virulence factors to host cells. This system provides the 
pathogen with a tool to cause mucosal barrier injury and inhibit various aspects of 
the innate immune response and in turn intensifies the delay in wound repair (Engel 
& Balachandran, 2009). 
 
In 1964, Morihara characterised the proteases produced by P. aeruginosa, 
specifically elastase and alkaline protease and following these observations many 
studies have focussed upon the pathogenic nature of P. aeruginosa isolates from 
various infection sites with particular interest placed on the protease profiles of such 
isolates. A study by Snell and colleagues (1978) demonstrated the role of exotoxin 
and proteases in the virulence of P. aeruginosa strains in situ in a mouse burn model. 
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Many confounding factors have been demonstrated to have a role in the 
augmentation or sequestration of enzyme activities within the wound environment, 
not least pH. The pH of the wound bed is indeed an important contributing factor in 
the healing process and different pH ranges are required for the various phases of 
healing (Schneider et al, 2007). Normal skin has an acidic pH in the range of pH4-6, 
whilst in wounds this acidic environment is disturbed and the underlying tissue with 
the body‟s internal pH of 7.4 is exposed (Schneider et al, 2007). Kaufman & Berger 
(1988) highlighted the relationship between wound healing and topical pH and 
concluded that wound healing could be controlled, in part, by changing pH levels at 
the wound site. Regarding protease production, the presence of these enzymes can 
both affect or be affected by changes in pH levels of the wound bed (Greener et al, 
2005; Harjai et al, 2005). Quorum sensing systems, which act in part to direct 
virulence factor production, can also be affected by changes in pH (Horswill et al, 
2007). A decrease in wound pH mirrors the healing process and thus a reduction in 
the nutrients needed for bacterial growth. In contrast, the persistence of slough 
within the wound bed is associated with an elevated pH and minimal reduction in the 
size of the wound (Gethin, Cowman & Conroy, 2008). Proteases produced by 
pathogenic bacteria within the wound act to liberate nutrients from the surrounding 
environment, aid attachment to the host surfaces and inactivate certain host defence 
components (Cicmanec & Holder, 1979; Lyczak, Cannon & Pier, 2000), and so this 
situation may cause an increase in measurable proteolytic activity. Yet, during 
nutrient limitation the mucoid phenotype may be promoted to protect the bacterial 
cells and reduce growth rate (Terry, Piña & Mattingly, 1991; Lyczak, Cannon & 
Pier, 2000). 
 
Oxygen tension has also been shown to be an important factor in the healing of 
wounds, and in particular causes changes in bacterial colonisation and pathogenicity. 
In an in vivo animal model, Hunt and colleagues (1975) demonstrated that rabbit 
wounds infected with P. aeruginosa under hypoxic conditions (12% oxygen) 
displayed increased colonisation longevity than those wounds under hyperoxic (45% 
oxygen) conditions as confirmed by significantly higher bacterial counts following a 
21 day infection period. Although the authors could not confirm a definite 
mechanism, they suggested that this effect may be due to depletion in the host's 
immune function under hypoxic conditions. The authors also noted that under 
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oxygen stress the toxicity of P. aeruginosa supernatants was greater towards a 
hybridoma cell line. In 2002, Sabra, Kim & Zeng carried out a study into the 
physiologic responses of P. aeruginosa to oxygen imitation using a computer-
controlled bioreactor system. The authors found an increased growth rate of the 
bacteria under microaerobic conditions as compared to aerobic cultures. 
Furthermore, the total concentration of extracellular proteins was higher under 
microaerobic culture and also paralleled the growth curve. However, when the 
amount of secreted proteins was considered in terms of biomass, the actual protein 
yield was lower in the microaerobic cultures. Conversely, biochemical analysis 
revealed that only those cultures maintained under microaerobic conditions produced 
elastase with no significant elastase production under high dissolved oxygen 
concentrations. However, severe oxygen limitation led to a reduction in the 
production of virulence factors, including elastase.  
 
A limited number of studies have highlighted the differences in P. aeruginosa 
virulence characteristics among different wound infections. Yet, as mentioned by 
Feltman et al (2001), many of the virulence factors produced by P. aeruginosa are 
variable traits, being produced by some clinical isolates but not others. Rumbaugh, 
Griswold & Hamood (1999) sought to investigate the production of virulence factors 
by P. aeruginosa isolates obtained from a number of clinical environments. They 
found no significant variation in elastase produced from 3 clinical sites. It was also 
noted that despite clinical isolation site, some of the P. aeruginosa isolates produced 
either significantly higher or lower levels of elastase, although no specific data was 
presented. However, no reference strain (non-clinical isolate) was used as a means of 
comparison. Nonetheless, it was concluded that both infection site and length of 
infection can influence the virulence of P. aeruginosa and that, although the 
mechanisms are not certain, the in vivo milieu (including antibiotic treatment) seems 
to have an influence on virulence factor production with such changes in 
pathogenicity being less likely associated with restriction site polymorphism or DNA 
rearrangement.  
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In 2001, Schmidtchen, Wolff & Hansson highlighted the variability in expression of 
elastase and alkaline protease by P. aeruginosa isolates derived from chronic leg 
ulcers, despite all isolates containing the genes for both proteases. The authors found 
that there was a phenotypic variation in protease production among the isolates, 
however protease levels over time was not considered and no reference (non-wound) 
strain was used. 
 
The over abundance of granulation tissue in equine wounds occurs most frequently 
in wounds of the lower limbs and infection has been suggested as one of the 
influential factors, amongst others,  in its generation. Furthermore, exuberant 
granulation tissue itself predisposes the wound to infection and further trauma 
(Engelen et al, 2004; Bertone, 1989). Lower limb equine wounds are particularly 
susceptible to complications caused by infection due to the limited soft tissue, 
muscle, blood supply and reduced tissue oxygenation to aid the healing process 
(Westgate et al, 2010). Wounds in these areas are also prone to bacterial 
contamination due to the ease of contaminant transfer from the surrounding 
environment. The prolonged inflammatory phase of healing seen in equine wounds  
which, in part, leads to the generation of exuberant granulation tissue (EGT) (Berry, 
Douglass & Sullins, 2003) may be augmented by the persistence of infection in turn 
contributing to longer healing times. Until recently, the microbial diversity and 
richness of equine wounds was relatively poorly identified. It is now clear, however, 
that a broad spectrum of bacteria can colonise and infect equine wounds and biofilms 
have also been identified in these wounds (Westgate et al, 2010; Cochrane et al, 
2009; Westgate et al, 2011), with P. aeruginosa being one of the most commonly 
isolated bacteria from equine wounds and Pseudomonas spp being shown to be more 
prevalent among chronic wounds as compared with acute wounds (Westgate et al, 
20011b). Resistant strains of P. aeruginosa to antimicrobials have been identified in 
the clinical setting (Pirnay et al, 2003). There has been little study into the roles of 
bacterial pathogenicity, with particular focus placed on bacterial proteases, on the 
delayed healing of equine wounds and how the local wound environment may 
augment or suppress these proteases in these wounds.  
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It is the aim of the current research study to investigate the production of proteases 
among clinical isolates of P. aeruginosa derived from equine wounds and to 
determine the effects, if any, of changes in initial culture pH and oxygen availability 
on enzyme productivity in vitro during the bacterial growth phases, with a particular 
focus upon P. aeruginosa elastase. Comparisons will also be made in terms of 
protease production and the biofilm forming phenotype (BFP) of these isolates.  
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2.3 Methods 
 
2.3.1 Chemicals and Reagents 
 
All chemicals and reagents were purchased from Sigma Aldrich (Dorset, UK) unless 
otherwise stated. 
 
2.3.2 Ethical Approval 
 
Approval for this study was granted by the Ethics Committee, University of 
Liverpool and informed consent was obtained from the owners of the animals 
participating in this study.  
 
Ethics Approval Number: RETH000355 
 
2.3.3 Identification of P. aeruginosa Clinical Isolates 
 
Standard microbiological culture techniques were used to confirm the identities of 7 
previously collected equine wound isolates, which were obtained from equine skin 
wounds of horses within 1-3 days of attendance at the Philip Leverhulme Equine 
Hospital (PLEH) in Neston, South Wirral following the acquisition of informed 
consent from the horse owner (Westgate, 2011c) (table 1 gives equine case details 
from which P. aeruginosa isolates were obtained). Wounds were swabbed using a 
standardised method; briefly, a cotton-tipped swab was rubbed across a 1cm
2
 area of 
the wound for 5 seconds as described by Levine et al (1976) then stored in Stuart's 
transport medium (Oxoid Limited, Hampshire, UK) for the culture of aerobic 
bacteria which was performed within 24 hours of swab collection. Swab samples 
were stored at 4C. Under sterile conditions, the swab was inoculated onto Tryptone 
soy agar (TSA) and also onto selective agar, namely MaConkey agar (MCA), 
Columbian blood agar (CBA) and Cysteine lactose electrolyte deficient (CLED) agar 
(all from LabM, Bury, UK) as described by Westgate et al (2011c). Agar plates were 
then incubated at 37C (±2C) for 24 hours. Colonies which visually resembled P. 
aeruginosa (i.e. round, convex, pearlescent appearance with a grape-like odour, 
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dependent on culture agar) were sub-cultured onto TSA plates and incubated for 24 
hours at 37C (±2C). Pure bacterial colonies were identified using a Gram stain and 
isolates confirmed as Gram negative rods were further characterised using the 
oxidase test (using oxidase detection strips from Oxoid Limited, Hampshire, UK) 
and API 20 NE
® 
identification strips, which utilise biochemical reactions with 
computer software-interpretation (Biomérieux UK Limited, Hampshire, UK). 
Confirmed P. aeruginosa isolates were stored on cryopreservation beads and frozen 
at -80C until required for further investigation. 
 
A P. aeruginosa reference strain (non-wound isolate) was used as a control; 
American Type Culture Collection (ATCC) 27853 (isolated from blood culture) 
(ATCC, Manassas, USA). This strain was chosen as it produces elastase and alkaline 
protease (O'Callaghan et al, 1996). An additional negative control wound isolate was 
used in the form of Enterococcus faecium, a Gram positive bacterium and common 
nosocomial pathogen. This isolate was identified using the API 20 Strep kit 
(Biomérieux UK Limited, Hampshire, UK) by the team at the Leahurst 
Microbiology Laboratory, University of Liverpool.  
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Table 1: Equine case details for each P. aeruginosa isolate. Cases included 5 chronic wounds, all of which were trauma wounds, and 2 acute 
surgical wounds. 
 
P. aeruginosa Isolate Case Number Case Information Location of Wound Wound Type Acute/Chronic 
Wound Isolate 1 37050 10 year old TB gelding Unknown Surgical Acute 
Wound Isolate 2 37682 2 year old Dx Arab 
gelding 
Fetlock Trauma Chronic 
Wound Isolate 3 Unknown 13 year old COBx mare Unknown Surgical Acute 
Wound Isolate 4 22222 7 year old gelding Unknown Trauma Chronic 
Wound Isolate 5 208642 13 year old COBx mare Medial tarsus/ 
proximomedial 
metatarsus 
Trauma Acute 
Wound Isolate 6 37592 3 year old TB gelding TX of Limb Trauma Chronic 
Wound Isolate 7 37509 21 year old TB gelding Medial aspect of 
limb 
Trauma Chronic 
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2.3.4 P. aeruginosa Growth Curves 
 
Sterile Mueller Hinton broth (MHB) (LabM, Bury, UK) was inoculated with a single 
loop of each corresponding P. aeruginosa isolate or E. faecium isolate (from TSA 
plate cultures) in 30ml portions cultured with shaking at 150rpm in a shaking 
incubator set at 37C for 24 hours to stationary phase in sterile 75cm3 culture flasks. 
The optical density (OD) of each culture was standardised to 0.85600nm in a cuvette 
spectrophotometer (approximate McFarland standard 6). From each of the 
standardised cultures a 500µl aliquot was used to inoculate 75ml sterile MHB in 
75cm
3
 culture flasks. OD measurements were made in triplicate for each culture in a 
multi-well plate spectrophotometer at 600nm at various time points through the 
culture period: T0, T4, T8, T12 and T24 (corresponding to 0, 4, 8, 12 and 24 hours). 
The OD600nm method described above was employed for the generation of growth 
curves for the P. aeruginosa isolates (and E. faecium isolate) grown at varied initial 
pH and under anaerobic conditions (0% oxygen). „Initial‟ or „standard‟ pH is defined 
as the pH at which the culture broth was set to prior to bacterial inoculation; a non-
buffered system was used for the culture of P. aeruginosa isolates, however 
fluctuations in the pH of the cultures were minimal throughout the culture period 
(see Appendix 1). 
 
2.3.5 Preparation of P. aeruginosa Conditioned Media 
 
Sterile MHB (LabM, Bury, UK) was used as a non-buffered nutrient broth for all 
cultures and was made up in batches of 1 litre with distilled water. 75ml portions of 
MHB were inoculated with 500µl of stationary phase cultures corresponding to each 
individual P. aeruginosa isolate (and E. faecium isolate), as described above. 
Cultures were incubated with shaking at 150rpm in a shaking incubator set at 37C 
(ambient O2 conditions, ~21%) for a total culture period of 24 hours in 75cm
3
 culture 
flasks. Culture samples were harvested at T0, T4, T8, T12 and T24 and centrifuged 
at 12000rpm for 10 minutes to pellet the cells. Conditioned culture supernatant was 
filtered through 0.45µm sterile filters to remove cell debris and stored at -80C until 
required for further investigation.  
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For cultures with altered initial pH, MHB was prepared as done previously and pH 
was set using a pH meter and addition of concentrated sodium hydroxide (NaOH) or 
hydrochloric acid (HCl). Media was then autoclaved at 121C and left to cool. Under 
sterile conditions, a sample of the sterile media was taken and the pH checked. All 
MHB stocks remained at the correct pH following autoclaving. The initial pH values 
in this study were chosen on the basis of previous research relating to the pH range 
for growth of P. aeruginosa. The pH values chosen were pH5.5, 6.0, 7.3 
(standard/normal pH of MHB) and 8.0. A pH meter was used to monitor the pH of 
the cultures throughout each phase of growth; no significant pH fluctuations were 
noted throughout the entire culture period (see Appendix 1). Anaerobic cultures were 
prepared in an anaerobic chamber (du Scientific, Modular Atmosphere Controlled 
System); cultures were prepared in the same way as the aerobic cultures, with 
samples taken in a sterile manner at T0, T4, T8, T12, T24 and T48. Cultures were 
prepared once for each isolate and triplicate samples were taken as experimental 
replicates at each time point.
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2.3.6 Polymerase Chain Reaction (PCR) Analysis of P. aeruginosa Elastase 
Gene 
 
Genomic DNA Extraction from Bacterial Isolates 
 
The extraction of genomic DNA from the P. aeruginosa and E. faecium isolates was 
performed using the boiling method, adapted from the methods described by Clarke, 
Millar & Moore (2003) and Sweeney, Whitlock & McAdams (2006); a loop of 
bacteria from an overnight culture from TSA was used to inoculate 1ml of molecular 
grade water in 1.5ml Eppendorf centrifuge tubes. Samples were boiled for 10 
minutes in a heat block, allowed to cool and centrifuged at 12,000xg for 5 minutes. 
The supernatant was collected and stored at 4C. Extracted DNA was used in PCR 
reactions within 48 hours of processing. DNA concentration and purity was 
determined using a Nanodrop (Thermo Scientific, MA, USA). The boiling extraction 
method yielded a range between 50 and 210ng/µl DNA for each of the isolates, and 
was found to be more efficient than a commercially available genomic DNA 
extraction kit.  
 
PCR Conditions 
 
Primers were designed using Primer Express 3.0 software and Primer BLAST 
(NCBI) was used to ensure gene specificity; there were no gene regions of similarity 
within the P. aeruginosa genome for the primers designed for the P. aeruginosa 
elastase (LasB) gene. The forward and reverse primers were 17bp and 24bp, 
respectively; Forward 5'- GCTGAACGACGCGCATT, Reverse 5'- 
AGTGCACCTTCATGTACAGCTTGT (Eurofins MWG Operon, London, UK). The 
primers yielded an amplicon of length 101bp. PCR was carried out in 50µl reactions 
in buffer containing 0.5µl Taq DNA polymerase (from Thermus aquaticus), 0.5µl 
dNTPs (each base), 1.65µl of each primer (300nM) and made up to the final volume 
with molecular grade water. PCR samples were heated at 95C for 10 minutes before 
amplification. Parameters used were; 30 seconds at 94C (denaturation), 45 seconds 
at 57C (annealing), 90 seconds at 72C (extension), 72C for 10 minutes (final 
elongation). Samples were then held at 4C. Amplified DNA was analysed by 1% 
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agarose gel electrophoresis and gels were visualised by staining with ethidium 
bromide using a 1kb molecular weight DNA ladder (Life Technologies, Paisley, 
UK).  
 
2.3.7 Crystal Violet Assay for the Assessment of Biofilm Forming Phenotype 
(BFP) 
 
The BFP of all bacterial isolates was determined using a microtitre plate assay based 
on the method described by Wakimoto et al (2004) and Westgate et al (2011b). Pure 
overnight cultures from TSA of each isolate were inoculated into 10ml of sterile 
MHB at 37C in a shaking incubator set at 50rpm. Following incubation, a 1ml 
aliquot of each overnight culture was transferred to 10ml of fresh sterile MHB and 
the suspensions were adjusted with sterile MHB to 0.5 McFarland turbidity standard, 
giving a final suspension of 10
8
 CFU/ml (Westgate et al, 2011b). ODs were also 
standardised at 600nm using a multi-well plate spectrophotometer. From each 
standardised inoculum, 250µl was transferred into triplicate wells of a Cellstar
®
 96-
well culture plate. Blank wells contained sterile MHB only (made in triplicate). 
Plates were then incubated at 37C for 24 hours. Following incubation, each well 
was carefully washed 3 times with 300µl of sterile physiological saline and the plates 
were shaken vigorously in a shaking incubator set at 150rpm for 5 minutes to 
remove all non-adherent bacteria. Attached bacteria were then fixed with 250µl of 
96% ethanol per well for 15 minutes, after which time the plates were emptied and 
left to dry. For the visualisation of the biofilms, each well was stained with 200µl 2% 
crystal violet solution for 5 minutes. Excess stain was removed from the wells under 
running tap water and the biofilms were visible as purple rings formed on the sides 
of the wells. For quantitative assessment of biofilm formation, 200µl of 33% glacial 
acetic acid was added to each well and the plates were placed on a plate shaker for 5 
minutes. The OD of the stain was measured using a microtitre plate reader at 570nm. 
The average OD570nm of the MHB control wells was subtracted from the ODs of the 
test wells.  
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2.3.8 Milk-Casein Agar Plate Inoculation 
 
Milk-casein agar was prepared with 25g skim milk powder (BD, Oxford, UK) 2.5g 
casein (BDH, VWR, Lutterworth, UK), 1.25g yeast extract (Oxoid, Basingstoke, 
UK), 0.5g D-glucose (BDH, Oxford, UK) and 6.25g No. 1 agar (LabM Bury, UK). 
Agar was sterilised and poured in 20ml portions into 9cm round petri dishes. A 
sterile 8mm punch biopsy was used to bore single wells in each of the milk plates. 
Supernatant samples recovered from the cultures were used to inoculate the milk-
casein agar plates; 100µl aliquots of each sample were applied to the 8mm wells 
made in the milk plates in triplicate. Duplicate plates were prepared and incubated 
for 24 and 48 hours. Following incubation, the caseinolytic area was measured; two 
measurements were made (cm) at right angles to each other and an average 
measurement calculated, minus the 8mm well.  
 
2.3.9 Azocasein Assay for General Protease Activity 
 
To measure the general protease activity of each culture, a chromogenic assay 
utilising azocasein, a non-specific protease substrate conjugated to an azo-dye, was 
performed. Briefly, a working solution was made by adding 5mg/ml of azocasein to 
distilled water in a sterile glass bottle and mixed thoroughly on a stirring plate with a 
magnetic flea. A 50µl aliquot of each test culture was added to 50µl azocasein 
solution and 500µl sterile 1x phosphate buffered saline (PBS) in 1.5ml Eppendorf 
centrifuge tubes. Sterile MHB was used for the controls. All samples were made in 
triplicate. Samples were briefly vortexed and incubated overnight at 37C. After the 
incubation period, 600µl of 5% Trichloric acid (TCA) was added to each sample to 
precipitate non-hydrolysed azocasein and left on ice for 30 minutes. The samples 
were then centrifuged at 11,000xg for 10 minutes at 4C to pellet the undigested 
substrate. From each sample, 200µl of supernatant was added to a 96-well plate and 
the absorbance measured in a microtitre plate reader at 405nm. 
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2.3.10 Elastin-Congo Red Assay for Elastase Activity 
 
To assess the level of elastase produced by each bacterial isolate, the elastin-congo 
red (ECR) method was employed, adapted from the studies by Petermann, Doetkott 
& Rust (2001) and Rust, Messing & Iglewski (1994). An ECR solution was made by 
adding 10mg of ECR powder to 1ml of assay buffer (10mM sodium phosphate 
buffer, pH7.0); the pH optimum of P. aeruginosa elastase is thought to be around 
physiologic pH, although the exact optimum pH seems to depend on the source of 
the P. aeruginosa (Mull & Callahan, 1965). A stock solution was made up in a 
sterile glass bottle for all of the samples and was mixed thoroughly on a stirring plate 
with a magnetic flea. In 1.5ml Eppendorf tubes, 1ml of the ECR solution was added 
along with 5µl of the bacterial test culture. Sterile MHB was used for the controls. 
The samples were made in triplicate and vortexed briefly. The samples were 
incubated for 24 hours at 37C after which the samples were centrifuged at 1200rpm 
for 10 minutes at 4C to pellet any undigested ECR. From each sample, 200µl of 
supernatant was added to a 96-well plate and the absorbance measured in a 
microtitre plate reader at 450nm.
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2.3.11 Gelatin Zymography 
 
Treatment of Samples  
 
Samples were diluted with non-reducing Laemmli sample buffer (Bio-Rad, Hemel 
Hempstead, UK) at a ratio of 1:5 of the total sample volume and distilled water to an 
overall 1:20 dilution of the sample. Samples were then incubated in a 37C water 
bath for 1 hour to activate the enzyme prior to application to the gel.  
 
Gel Electrophoresis and Gel Imaging 
 
A Miniprotean II gel system (Bio-Rad, Hemel Hempstead, UK) was employed for 
zymography gels. A 7.5% acrylamide/bis-acrylamide (Severn Biotech Ltd., 
Kidderminster, UK) resolving gel copolymerised with a 1% gelatin solution (EIA 
grade reagent gelatin) (Bio-Rad, Hemel Hempstead, UK) was prepared to create a 
0.25% gelatin zymogram in a pH8.8 resolving buffer (1.5M Tris/HCl). A volume of 
3.2ml of this was cast between ethanol-washed glass plates and overlain with 
isobutanol to level the gel. The gel was left to set. Once set, the resolving gel was 
layered with a stacking gel made up with a pH6.8 buffer (0.5M Tris/HCl) and was 
left to set with a 10-lane comb inserted in the top of the gel. The gels were placed in 
a tank filled with running buffer and 20µl aliquots of each sample were loaded into 
the gel and subjected to electrophoresis at 200 volts for 1 hour or until the lane 
marker had run off the end of the gel. Mark-12 high molecular weight lane markers 
(Invitrogen, LC5677, unstained standards) or purified MMP standards were run on 
each gel.  Following electrophoresis, gels were carefully removed from the glass 
plates and the Mark-12 lane markers were removed and placed in 0.02% coomassie 
brilliant blue stain (BDH, Oxford, UK) for 15-20 minutes and then de-stained in 
diluted methanol/acetic acid until dark bands appeared on a light background. The 
gels were placed in 2.5% Triton X-100 and agitated on a plate shaker for 1 hour to 
remove all traces of sodium dodecyl sulphate (SDS). The gels were washed 
thoroughly in distilled water and placed in MMP incubation buffer/gelatin refolding 
buffer  overnight. After incubation, the gels were stained for 1 hour in 0.5% 
coomassie stain and then destained in a solution of diluted methanol/acetic acid until 
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clear bands of digested gelatin were visible against a darkly stained blue background. 
Gels were visualised and imaged using Genesnap software. The gels were dried in 
cellophane sheets using a Hoeffer gel drying dock.  
 
2.3.12 Passive elution of proteins from polyacrylamide gels  
(Method adapted from ThermoScientific; Tech Tip #51) 
 
To elute proteins from proteolytic bands in gelatin zymograms, gel bands were cut 
from the gel using a sterile scalpel. Excised bands (gel plugs) were placed in clean 
microcentrifuge tubes. To each band, 0.5ml of elution buffer (50mM Tris-HCl, 
150mM NaCl, and 0.1mM EDTA; pH7.5) was added so that the gel pieces were 
completely immersed. The gel pieces were crushed using a clean pestle and the tubes 
were incubated for 2 hours at 30°C in a rotary incubator. Following incubation, tubes 
were centrifuged at 10,000 xg for 10 minutes and the supernatant was removed and 
placed into a new clean microcentrifuge tube. Supernatant samples were then run on 
an SDS-PAGE gel. Control gel plugs just below and to one side of the proteolytic 
band on the zymogram were excised and processed in separate microcentrifuge 
tubes. 
 
2.3.13 Casein Zymography 
 
The methodology for casein zymography was essentially the same as gelatin 
zymography, however a 2% solution of casein in dH2O was used as the substrate for 
copolymerisation with the acrylamide gel to give an overall 0.2% casein/7.5% 
polyacrylamide gel. Casein refolding buffer (Tris/HCl, CaCl2 [pH7.6]) was used in 
place of gelatin refolding buffer.
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2.3.14 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
 (SDS-PAGE) 
 
A 15% acrylamide mini gel was prepared using 3.2mls resolving gel in a 1.5M 
Tris/HCl buffer, pH 8.8. Once set this gel was overlain with a stacking gel made up 
in a 0.5M Tris/HCl buffer, pH 6.8 in a Miniprotean gel system (Bio-Rad Hemel 
Hempstead, UK). Samples were prepared by adding 13µl original sample, 2µl DTT 
and 5µl non-reducing sample buffer with marker dye (Thermo Scientific, MA, 
USA). Samples were denatured by heating for 10 minutes in a heat block pre-set to 
80C. The samples were vortexed briefly. A 20µl aliquot of each sample was added 
to each corresponding lane of the gel. The gel tank was filled with a 1:20 dilution of 
NUPAGE MES SDS running buffer (Invitrogen, Paisley, UK) in distilled water. The 
gel was run at 15 volts for approximately 2 hours or until the lane marker ran to the 
bottom of the gel. The gels were carefully removed from the glass plates and placed 
in 0.02% Coomassie brilliant blue stain for 2 hours with agitation. Gels were then 
destained in a solution of diluted methanol/acetic acid until dark bands appeared 
against a stain-free background. 
 
2.3.15 Silver Staining of polyacrylamide gels 
 
For silver-stained SDS-PAGE gels, a Pierce
®
 Silver Stain Kit (Thermo Scientific, 
MA, USA) was used according to the manufacturer‟s instructions. In brief, gels were 
washed in ultrapure water followed by a fixing step with a 30% ethanol: 10% acetic 
acid solution. Next, gels were washed in 10% ethanol, followed by washing in 
ultrapure water. Gels were then sensitized in a sensitizer working solution, followed 
by a wash step. Gels were stained with a stain working solution (0.5ml enhancer to 
25ml stain) for 30 minutes. Gels were briefly rinsed in ultrapure water, then placed 
in a developer working solution (0.5ml enhancer to 25ml developer) for 2-3 minutes 
until bands appeared on the gel. The reaction was stopped with 5% acetic acid for 10 
minutes. 
 49 
 
2.3.16 Mass Spectrometry 
 
Following SDS-PAGE of culture supernatant samples, gels were stained with silver 
stain and any bands of particular interest were excised using a sterile scalpel and 
processed for mass spectrometry (MS) analysis.  
 
In-gel protein digest  
Sample preparation 
A small (1mm
3
) plug of the stained protein band (containing typically 10ng-100ng of 
protein) was excised from the gel using a sterile scalpel. Since recoveries from in-gel 
digests are not 100% pure protein, two or three protein bands of the same molecular 
weight were pooled where possible. 
 
Destaining 
The gel plugs were washed with 50µl (per plug) Farmers reagent (15mM potassium 
ferricyanide/50mM sodium thiosulphate) for 15 minutes at 37°C until the bands were 
destained. 
 
Reduction 
To each Eppendorf tube, 25µl of ~10mM dithiothreitol (DTT) diluted in 25mM 
ammonium bicarbonate was added. Samples were vortexed and incubated for 60 
minutes at 60°C. Samples were cooled to room temperature and briefly spun to 
return the liquid to the bottom of the tube. The liquid was aspirated and discarded. 
 
Alkylation 
To each Eppendorf tube, 25µl of ~60mM of iodoacetamide diluted in 25mM 
ammonium bicarbonate was added to prevent disulphide bonds from re-forming. 
Samples were then incubated in the dark at room temperature for 45 minutes. 
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Washing 
Gel plugs were washed alternately with 25mM ammonium bicarbonate and 25mM 
ammonium bicarbonate: acetonitrile (ACN) (2:1). At each wash cycle gel plugs were 
incubated for 15 minutes at 37°C until destained. This step was finished with a wash 
in 25mM ammonium bicarbonate: ACN (2:1) to dehydrate the plug. 
 
Digestion 
To each gel plug, 10µl of molecular grade trypsin (12.5ng/µl diluted in 25mM 
ammonium bicarbonate) was added. Samples were incubated overnight (12-16 
hours) at 37°C. 
 
Peptide Recovery 
Eppendorf tubes were briefly spun to collect the digest at the bottom of the tube. 
Formic acid (10% v/v) was added to attain a final concentration of 1% (this gave a 
final volume of 10µl per Eppendorf/plug). The solution containing the peptides was 
then aspirated and retained for MS analysis (peptides were pooled where 
appropriate). Samples were cleared of particulates with a further centrifugation step. 
 
Protein digests were sent on dry ice to Dundee Cell Products Ltd (Dundee, Scotland) 
for matrix-assisted laser desorption/ionisation (MALDI) time of flight (TOF) MS 
analysis. 
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2.3.17 Statistical Analyses 
 
Statistical analyses were performed on the milk-casein agar plate data and the data 
for the biochemical assays (azocasein and elastin-congo red) for the 24 hour culture 
time points for general protease or elastase activity under aerobic and anaerobic 
conditions; statistical differences in general protease and elastase activity between P. 
aeruginosa isolates were identified using a one-way analysis of variance (ANOVA) 
or a non-parametric test for data which was not normally distributed (Kruskal-Wallis 
test). For analysis of the effect of initial culture pH a general linear model was used. 
For effect of BFP on elastase activity, a one-way ANOVA was used. In all instances, 
Post Hoc analyses were applied with the Tukey test. All statistical analyses were 
performed using Minitab
®
, Version 16. 
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Figure 1: Equine wounds; a: a large, purulent stifle wound with a high degree of tissue loss 
and a cavity (green arrow). The wound exhibited minimal granulation tissue and was 
producing yellow exudate (red arrow). There was some evidence of epithelial 
proliferation/epithelial edge advancement (blue arrow). The black arrow indicates a healthier 
wound appearance with a vascularised granulation tissue bed; b: pastern wound with some 
tissue loss and minimal exudate. The wound bed appeared vascularised; c: a healing stifle 
wound with very minimal tissue loss and some healthy granulation tissue (yellow arrow). The 
wound margins appeared healthy and there was some evidence of epithelial 
proliferation/epithelial edge advancement (purple arrow); d: a cannon bone wound presenting 
with a pale wound bed and no signs of granulation tissue formation; Inset: P. aeruginosa 
isolated from a chronic equine wound. 
a b 
c d 
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2.4 Results 
 
All error margins are displayed as the mean ± standard error of the mean (SEM). 
 
Figure 1 gives examples of equine wounds. 
 
2.4.1 Crystal Violet Assay for the Assessment of Biofilm forming phenotype 
(BFP) 
 
The results of the crystal violet assay for BFP of the wound and non-wound isolates 
revealed a significant variation between isolates, F (8, 71) = 162.06 (P = <0.001) 
[Kruskal-Wallis Test: P=<0.001] (see figure 2). An OD reading at 570nm above 
0.136 was indicative of a biofilm-forming isolate. A scale of biofilm forming 
phenotype was adapted from that described by Stepanovic et al (2000); the cut-off 
OD (ODc) for the assay was set at 3 standard deviations above the mean OD of the 
negative control (MHB only). Each strain was categorised according to the values 
given in table 2.
  
5
4 
 
 
  Classification of Adherence OD570nm  Interpretation (Category) Category Code 
OD≤ODc 0-0.136 Non-Adherent 0 
ODc<OD≤2xODc 0.136-0.272 Weakly Adherent + 
2xODc<OD≤4xODc 0.272-0.544 Moderately Adherent ++ 
4xODc<OD≤6xODc 0.544-0.816 Strongly Adherent +++ 
OD≥6xODc >0.816 Very Strongly Adherent ++++ 
Table 2: Classifications of biofilm forming phenotype (BFP) according to OD570nm Value. 
  
5
5 
Figure 2: Biofilm forming phenotype (BFP) of the ATCC P. aeruginosa control isolate (ATCC Isolate), all 
7 P. aeruginosa wound isolates (Wound Isolate 1- 7) and the E. faecium isolate (EF Isolate). Optical 
densities (ODs) were measured at 570nm. Inset: Left; 24 hour biofilm cultures in wells of a 96-well 
microtitre plate, Right; Biofilms stained with 2% crystal violet. Due to the complex relationships, statistical 
significance grouping information is detailed in Appendix 2. Data is presented as mean ± SEM. 
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2.4.2 PCR Analysis of P. aeruginosa Elastase Gene 
 
 
Figure 3: PCR agarose gel showing presence of the P. aeruginosa elastase (LasB) 
gene for the 8 P. aeruginosa isolates. Lane 1: 1kb Molecular weight marker; Lane 
2: ATCC isolate; Lane 3: Wound isolate 1; Lane 5: E.  faecium isolate (EF 
Isolate); Lane 6: Wound isolate 2; Lane 7: Wound isolate 3; Lane 8: Wound 
isolate 4; Lane 9: Wound isolate 5; Lane 10: Wound isolate 6; Lane 11: Wound 
isolate 7. The isolate in Lane 4 was excluded from further experimentation as it 
was found to be an impure sample. 
 
The results of the PCR analysis clearly indicate that each of the P. aeruginosa 
isolates (including the ATCC reference isolate and all wound isolates) are positive 
for the 101bp amplicon indicative of the P. aeruginosa elastase gene (LasB). As 
expected, the EF isolate was negative for this gene.  
1     2     3     4     5     6     7     8     9    10   11 
100bp 
Isolate excluded from further 
experimentation and analysis 
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2.4.3 Milk-Casein Agar Plate Analysis 
 
Each of the P. aeruginosa isolates (both the wound isolates and the ATCC reference 
isolate) showed some degree of proteolytic activity on milk-casein agar plates when 
streaked on the plates and incubated for 24 hours. The effects of changes in the 
initial pH of broth cultures on the protease activity of the P. aeruginosa isolates 
following sub-culturing on milk-casein agar plates was investigated; broth cultures 
were grown at each initial pH over a 12 hour period and samples of each culture 
were taken at four-hourly intervals. Live bacterial culture samples were inoculated 
onto milk-casein agar plates as previously described. Resulting proteolytic activity 
was measured by the clearance zone, indicating hydrolysis of casein. The 
caseinolytic activity on milk-casein agar plates is considered as general protease 
activity; caseinolytic activity of P. aeruginosa is due mainly to the actions of LasB 
(elastase B), alkaline protease and protease IV (Caballero et al, 2001; Sonawane, 
Jyot & Ramphal, 2006). There was a general trend of increasing protease activity 
over the 48 hour milk-casein agar plate culture period, demonstrating that even after 
long culture periods the isolates maintained their caseinolytic activity (see figures 5-
8).  
 
Statistical analysis was performed for caseinolytic activity after initial 8 hour and 12 
hour broth cultures and for 24 hour and 48 hour milk-casein agar plate cultures for 
each of the isolates, given that at earlier culture time points little caseinolytic activity 
was noted. Given the complex relationships, statistical significance is detailed in 
tables 3-6. There were significant variations in caseinolytic activity between wound 
isolates which was generally maintained over the culture periods and also when the 
initial pH of the culture broth was adjusted (see tables 3 and 4). Although not 
statistically significant, the ATCC reference isolate generally produced less 
caseinolytic activity than the wound isolates, the trend of which was maintained in 
all four initial broth pH cultures over time. Statistical analysis revealed that whilst 
the initial pH of the broth cultures prior to sub-culturing the isolates on milk-casein 
agar had an effect on caseinolytic activity of the isolates, further analysis identified 
that the pH affected different isolates in different ways (see tables 5 and 6). Since 
data was missing for the initial pH8.0 cultures, results for the pH8.0 cultures were 
excluded from the first set of statistical analyses concerning effects of pH on 
Figure 2: Milk-Casein agar plate assay for caseinolytic digest analysis of each isolate over 24 and 48 hour 
periods. Isolates were previously cultured in standard MHB (initial pH7.4) over a 12 hour period.  
Figure 3: Milk-Casein agar plate assay for caseinolytic digest analysis of each isolate over 24 and 48 hour 
periods. Isolates were previously cultured in MHB adjusted to an initial pH of 5.5 over a 12 hour period.  
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caseinolytic activity (see table 5). Results from these analyses showed that whilst at 
24 hours post milk-casein agar plate inoculation (initial 8 hour broth culture) there 
was no significant effect of pH on caseinolytic activity, F(2, 65) = 2.88, P = 0.067, at 
48 hours post plate inoculation there was a significant effect of pH, F(2, 63) = 11.58, P 
= <0.001 which was maintained for the initial 12 hour broth cultures (see table 5). 
However, as previously mentioned, further analysis revealed very strong evidence to 
suggest that there was an interaction between isolate and pH when analysed together, 
i.e. pH had a differential effect on isolates (see table 5). Similarly, when the initial 
pH8.0 broth cultures and corresponding milk-casein agar plate cultures were 
included in to the statistical analyses, pH did not have a significant effect on 
caseinolytic activity at 24 hours post plate inoculation (initial 8 hour culture), F(3, 62) 
= 0.91, P = 0.447. However, at 48 hours post plate inoculation a significant effect was 
noted, F(3, 61) = 4.84, P = 0.006; again, this effect was not the same for all isolates, 
with strong evidence suggestive of a differential effect of pH on caseinolytic activity 
of different isolates (see table 6). Interval plots of the caseinolytic activity of the P. 
aeruginosa isolates at each initial broth culture pH are shown in figures 9 and 10. 
Due to the complex relationships, detailed statistical significance grouping 
information for each initial broth culture pH is presented in Appendix 3.  
 
 
a b c d 
4.1 
4.2 
Figure 4: 4.1: Method of calculation of caseinolytic zone using the milk-casein agar plate method; 
4.2: Example milk-casein agar plate images. All isolates were grown in broth culture at 
standard initial pH (pH7.3) for 12 hours, followed by a 48 hour milk-casein agar plate culture; 
a: ATCC Isolate; b: Wound isolate 1; c: Wound isolate 3; d: E. faecium (EF) isolate. 
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Figure 5: Milk-Casein agar plate assay for caseinolytic 
digest analysis of each isolate over 24 and 48 hour periods. 
Isolates were previously cultured in standard Mueller Hinton 
broth (MHB) (initial pH 7.3) over a 12 hour period. Data is 
presented as mean ± SEM. Statistical significance is detailed 
in tables 2-5. 
*EF = E. faecium 
Figure 6 Milk-Casein agar plate assay for caseinolytic 
digest analysis of each isolate over 24 and 48 hour periods. 
Isolates were previously cultured in Mueller Hinton broth 
(MHB) adjusted to an initial pH of 5.5 over a 12 hour 
period. Data is presented as mean ± SEM. Statistical 
significance is detailed in tables 2-5. 
*EF = E. faecium 
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Figure 7: Milk-Casein agar plate assay for caseinolytic 
digest analysis of each isolate over 24 and 48 hour 
periods. Isolates were previously cultured in Mueller 
Hinton broth (MHB) adjusted to an initial pH of 6.0 over a 
12 hour period. Data is presented as mean ± SEM. 
Statistical significance is detailed in tables 2-5. 
*EF = E. faecium 
 
Figure 8: Milk-Casein agar plate assay for caseinolytic 
digest analysis of each isolate over 24 and 48 hour periods. 
Isolates were previously cultured in Mueller Hinton broth 
(MHB) adjusted to an initial pH of 8.0 over a 12 hour 
period. Data is presented as mean ± SEM. Statistical 
significance is detailed in tables 2-5. 
 
Note: Missing data for isolates 6 and 7; missing data for 
T12 and T24 for isolates 3, 4 and 5. 
*EF = E. faecium 
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Figure 9: Interval plots for caseinolytic activity of the P. aeruginosa isolates at each initial broth culture pH following an initial 12 hour 
broth culture prior to a 48 hour milk-casein agar plate culture. For all statistical analyses the ATCC reference isolate was named isolate 1; 
wound isolates 1-8 were numbered isolates 2-9; the E. faecium (EF) isolate was excluded from statistical analysis. For the initial pH8.0 
broth cultures, due to missing data for the 12 hour broth cultures the 8 hour cultures were used for interval plots. 
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Table 3: P. aeruginosa isolates (ATCC isolate + 7 wound isolates): Differences in general protease activity between isolates, at each initial pH. 
 
 
* Significant at the 0.05 level 
 
 
 
 
 
 
Initial Broth 
Culture Time 
(Hours) 
Milk-Casein 
Agar Plate 
Culture Time 
(Hours) 
Initial pH in Broth Culture One-Way ANOVA Results Non-Parametric  
(Kruskal-Wallis test) Results 
8 24 Standard Broth (7.3) F(7, 23) = 6.11, P = 0.001*  
8 48 Standard Broth (7.3) F(7, 23) = 7.65, P = <0.001*  
12 24 Standard Broth (7.3) F(7, 22) = 3.22, P = 0.027* P = 0.025* 
12 48 Standard Broth (7.3) F(7, 21) = 16.94, P = <0.001* P = 0.009* 
8 24 5.5 F(7, 20) = 7.02, P = 0.001* P = 0.037* 
8 48 5.5 F(7, 20) = 6.60, P = 0.002*  
12 24 5.5 F(7, 20) = 2.06, P = 0.123  
12 48 5.5 F(7, 20) = 7.16, P = 0.001*  
8 24 6.0 F(7, 20) = 15.73, P = <0.001* P = 0.014* 
8 48 6.0 F(7, 18) = 9.62, P = 0.001* P = 0.105 
12 24 6.0 F(7, 20) = 3.07, P = 0.038  
12 48 6.0 F(7, 20) = 6.73, P = 0.002*  
8 24 8.0 F(5, 14) = 4.09, P = 0.033* P = 0.096 
8 48 8.0 F(5, 14) = 4.41, P 0.026* P = 0.052 
12 24 8.0 F(2, 5) = 0.16, P = 0.861 P = 0.682 
12 48 8.0 F(2, 5) = 0.96, P = 0.477 P = 0.530 
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Table 4: P. aeruginosa wound isolates (7 wound isolates): Differences in general protease activity between isolates, at each initial pH. 
 
Initial Broth 
Culture Time 
(Hours) 
Milk-Casein 
Agar Plate 
Culture Time 
(Hours) 
Initial pH in Broth Culture One-Way ANOVA Results Non-Parametric  
(Kruskal-Wallis test) Results 
8 24 Standard Broth (7.3) F(6, 20) = 5.00, P = 0.006*  
8 48 Standard Broth (7.3) F(6, 20) = 6.23, P = 0.002*  
12 24 Standard Broth (7.3) F(6, 19) = 2.49, P = 0.079 P = 0.082 
12 48 Standard Broth (7.3) F(6, 18) = 12.51, P = <0.001*  
8 24 5.5 F(6, 18) = 5.63, P = 0.005* P = 0.066 
8 48 5.5 F(6, 18) = 5.75, P = 0.005*  
12 24 5.5 F(6, 18) = 1.75, P = 0.192  
12 48 5.5 F(6, 18) = 5.39, P = 0.006*  
8 24 6.0 F(6, 18) = 14.52, P = <0.001* P = 0.019* 
8 48 6.0 F(6, 16) = 9.04, P = 0.001* P = 0.114 
12 24 6.0 F(6, 18) = 2.20, P = 0.115  
12 48 6.0 F(6, 18) = 3.72, P = 0.025*  
8 24 8.0 F(4, 12) = 1.92, P = 0.201 P = 0.195 
8 48 8.0 F(4, 12) = 3.78, P = 0.052 P = 0.067 
12 24 8.0 F(2, 5) = 0.16, P = 0.861  
12 48 8.0 F(2, 5) = 0.96, P = 0.477  
 
* Significant at the 0.05 level 
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Table 5: General linear model: P. aeruginosa isolates (ATCC isolate + 7 wound isolates). Effects of initial broth culture pH on caseinolytic 
activity. Analysis includes standard broth pH (7.3), pH5.5 and pH6.0. 
 
 
Initial Broth 
Culture Time 
(Hours) 
Milk-Casein Agar Plate 
Culture Time (Hours) 
Statistical Analysis  
8 24 pH: F(2, 65) = 2.88, P = 0.067 
Isolate: F(7, 65) = 20.31, P = <0.001 
pH*Isolate: F(14, 65) = 3.11, P = 0.002 
8 48 pH: F(2, 63) = 11.58, P = <0.001 
Isolate: F(7, 63) = 14.83, P = <0.001 
pH*Isolate: F(14, 63) = 3.68, P = 0.001 
12 24 pH: F(2, 64) = 8.35, P = 0.001 
Isolate: F(7, 64) = 5.71, P = <0.001 
pH*Isolate: F(14, 64) = 1.50, P = 0.155 
12 48 pH: F(2, 63) = 41.25, P = <0.001 
Isolate: F(7, 63) = 19.56, P = <0.001 
pH*Isolate: F(14, 63) = 3.29, P = 0.002 
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Table 6: General linear model: P. aeruginosa isolates (ATCC isolate + 5 wound isolates). Effects of initial broth culture pH on caseinolytic 
activity. Analysis includes standard broth pH (7.3), pH5.5, pH6.0 and pH8.0. 
 
 
Initial Broth 
Culture Time 
(Hours) 
Milk-Casein Agar Plate 
Culture Time (Hours) 
Statistical Analysis  
8 24 pH: F(3, 62) = 0.91, P = 0.447 
Isolate: F(5, 62) = 10.50, P = <0.001 
pH*Isolate: F(15, 62) = 1.91, P = 0.041 
8 48 pH: F(3, 61) = 4.84, P = 0.006 
Isolate: F(5, 61) = 5.77, P = <0.001 
pH*Isolate: F(16, 61) = 4.01, P = <0.001 
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Figure 10: Interval plots for caseinolytic activity of the P. aeruginosa isolates at each initial broth culture pH following an initial 8 or 12 hour 
broth culture prior to a 24 or 48 hour milk-casein agar plate culture. For all statistical analyses the ATCC reference isolate was named isolate 1; 
wound isolates 1-7 were numbered isolates 2-8; the E. faecium (EF) isolate was excluded from statistical analysis. Standard pH=pH1; 
pH5.5=pH2; pH6.0=pH3; pH8.0=pH4. 
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2.4.4 Azocasein Assay for General Protease Activity 
The azocasein substrate assay for non-specific protease activity was used to 
determine the variability or similarity in general protease activity among P. 
aeruginosa wound isolates in comparison to an ATCC reference P. aeruginosa 
isolate. The degree of proteolytic activity throughout a 24 hour liquid broth culture 
period was examined. Further, the effect if any, of alterations in the initial pH of the 
medium was assessed over the culture period. The azocasein method detects a range 
of enzymes, including metalloproteinases (for instance the elastolytic 
metalloproteinase, elastase B encoded by the LasB gene of P. aeruginosa) (Kuang et 
al, 2011) and serine proteases (Trengove et al, 1999); P. aeruginosa elastase and 
alkaline proteinase degrade azocasein (Schmidtchen, Wolff & Hansson, 2001; 
Döring et al, 1985).  Protease activity was determined for each isolate at each time 
point; however, given the low protease levels at the start of each culture only results 
of protease activity at the end of the 24 hour culture were used for statistical analysis. 
The EF isolate was excluded from statistical analysis.  
 
Given the complex relationships, statistical significance and grouping information is 
detailed in tables 7 & 8 and Appendix 4. As illustrated in figures 11-15, the protease 
activities varied significantly between isolates. In concordance with the milk-casein 
agar assays, wound isolate 1 was considerably less proteolytically active than the 
other wound isolates and the ATCC reference isolate. Wound isolate 2 demonstrated 
a considerably higher proteolytic activity than all other isolates, which was 
maintained when the initial pH was changed. However, when the initial culture pH 
was altered it was noted that those isolates, including the ATCC reference isolate, 
that produced little protease activity in the early stages of culture at a standard broth 
pH of 7.3, produced more protease activity at these early stages of culture. This was 
most prominent at more acidic initial culture pH (i.e. pH5.5 and pH6.0). However, a 
clear trend in increased protease activity at lower pH culture conditions could not be 
confirmed. Generally, the levels of protease activity increased over time, with levels 
commonly peaking after 12 hours. This observation applied to each of the different 
initial pH cultures.  Statistical analysis revealed a significant difference between all 
isolates at each of the initial culture pHs. Interval plots (figures 16 and 17) illustrate 
the protease profiles of each isolate at each initial pH following a 24 hour culture 
period. Further analysis revealed that there was no statistical significance between 
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protease activities of the isolates (ATCC isolate plus 7 wound isolates) when 
cultured at either standard pH (pH7.3), pH5.5 or at pH6.0, F(2, 70) = 2.30, P = 
0.124. However, when pH8.0 was considered there was a significant difference in 
protease activities of the isolates (ATCC isolate plus 5 wound isolates [no wound 
isolates 6 or 7]) when compared to the other initial pH cultures, F(3, 69) = 3.55, P = 
0.016. Yet, as was the case for the milk-casein agar plates, there was strong evidence 
suggestive of an interaction between pH and isolate; alteration of the initial culture 
pH affected isolates in different ways, F(15, 69) = 5.25, P = <0.001. 
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Figure 11: Azocasein assay for caseinolytic digest analysis of each 
isolate over a 24 hour period. Isolates were cultured in standard 
Mueller Hinton broth (MHB) broth (initial pH7.3). Data is presented 
as mean ± SEM. Statistical significance is detailed in tables 6 & 7. 
*EF= E. faecium 
Figure 12: Azocasein assay for caseinolytic digest analysis of each 
isolate over a 24 hour period. Isolates were cultured in Mueller 
Hinton broth (MHB) adjusted to an initial pH of 5.5. Data is presented 
as mean ± SEM. Statistical significance is detailed in tables 6 & 7. 
*EF= E. faecium 
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Figure 13: Azocasein assay for caseinolytic digest analysis of each 
isolate over a 24 hour period. Isolates were cultured in Mueller Hinton 
broth MHB adjusted to an initial pH of 6.0. Data is presented as mean ± 
SEM. Statistical significance is detailed in tables 6 & 7. *EF= E. 
faecium 
Figure 14: Azocasein assay for caseinolytic digest analysis of each 
isolate over a 24 hour period. Isolates were cultured in Mueller Hinton 
broth MHB adjusted to an initial pH of 8.0. Data is presented as mean ± 
SEM. Statistical significance is detailed in tables 6 & 7. *EF= E. 
faecium 
-0.05
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
O
D
4
0
5
n
m
T4
T8
T12
T24
  
   
    
7
1 
-0.05
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
4 8 12 24
O
D
4
0
5
n
m
Time (Hours)
Wound Isolate 1 Normal pH
Wound Isolate 1 pH5.5
Wound Isolate 1 pH6.0
Wound Isolate 1 pH8.0
Figure 15: Azocasein assay data for 4 example isolates, showing variations in caseinolytic activity when cultured at different 
initial pHs. Data is presented as mean ± SEM. Statistical significance is detailed in tables 6 & 7. 
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Table 7: P. aeruginosa isolates (ATCC isolate + 7 wound isolates): Differences in general protease activity between isolates, at each initial pH. 
 
Culture Time 
(Hours) 
Initial Culture 
pH 
Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(7, 22) = 12.99, P = <0.001* Isolate 2 significantly different from 
each other isolate; ATCC isolate 
significantly different from wound 
isolates 1 & 6. 
P = 0.027* 
24 5.5 F(7, 23) = 32.18, P = <0.001* ATCC isolate & wound isolates 1 & 2 
are not significantly different from each 
other but each are significantly different 
from all other isolates. 
P = 0.010* 
24 6.0 F(7, 23) = 19.22, P = <0.001* ATCC isolate & wound isolates 2 are 
not significantly different but each are 
significantly different from all other 
isolates; ATCC isolate & wound isolate 
1 are not significantly different from 
each other; wound isolates 1, 6 & 7 are 
not significantly different from each 
other; wound isolates 3-7 are not 
significantly different from each other. 
P = 0.011* 
24 8.0 
(note: no wound 
isolates 6 or 7) 
F(5, 16) = 38.33,  P = <0.001* ATCC isolate & wound isolates 1 & 2 
are not significantly different from each 
other but are significantly different from 
all other isolates; wound isolates 3-5 are 
not significantly different from each 
other but are significantly different from 
all other isolates. 
P = 0.022* 
 
* Significant at the 0.05 level 
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Table 8: P. aeruginosa isolates (7 wound isolates): Differences in general protease activity between isolates, at each initial pH. 
 
Culture Time 
(Hours) 
Initial Culture pH Statistical Analysis Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(6, 19) = 25.70, P = <0.001* P = 0.030* 
24 5.5 F(6, 20) = 30.69, P = <0.001* P = 0.025* 
24 6.0 F(6, 20) = 18.13, P = <0.001* P = 0.030* 
24 8.0 F(4, 13) = 31.46, P = <0.001* P = 0.037* 
 
* Significant at the 0.05 level
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Figure 16: Interval plots for proteolytic activity of the P. aeruginosa isolates at each initial culture pH following a 24hour broth culture. For 
all statistical analyses the ATCC reference isolate was named isolate 1; wound isolates 1-7 were numbered isolates 2-8; the E. faecium (EF) 
isolate was excluded from statistical analysis. 
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Figure 17: Interval plots for proteolytic activity of the P. aeruginosa isolates at each initial broth 
culture pH following a 24 hour broth culture. For all statistical analyses the ATCC reference 
isolate was named isolate 1; wound isolates 1-7 were numbered isolates 2-8; the E. faecium (EF) 
isolate was excluded from statistical analysis. Standard pH=pH1; pH5.5=pH2; pH6.0=pH3; 
pH8.0=pH4. 
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2.4.5 Elastin-Congo Red Assay for Elastase Activity 
 
The elastolytic activities of each of the P. aeruginosa wound isolates and of the 
ATCC reference isolate were determined using the elastin-congo red (ECR) assay as 
described above; LasB-deficient and active strains can be differentiated using this 
assay (Schaber et al, 2004). Whilst both P. aeruginosa elastase A and elastase B 
degrade elastin, elastase B (an important virulence factor in wounds and burns) has 
been shown to degrade elastin to a greater extent than elastase A (Caballero et al, 
2001). However, the ECR assay cannot definitively distinguish between the products 
of the LasB and LasA genes (Jones et al, 1993; Peters et al, 1992). P. aeruginosa 
alkaline protease and protease IV do not degrade elastin (Caballero et al, 2001). The 
assay demonstrated that the EF isolate, previously confirmed to be negative for the 
LasB gene (see Figure 3), exhibited very minimal elastolytic activity. Elastolytic 
activity was determined for each isolate at each time point; however, as with the 
azocasein assays elastolytic activities were low at the start of each culture, thus only 
results of elastolytic activity at the end of the 24 hour culture were used for statistical 
analysis.  
 
Results demonstrated that there is a significant difference between isolates (see 
figures 18-22), including a large variation between wound isolates which was 
maintained at each initial culture pH after a 24 hour culture period (see tables 9 and 
10). However, there was no clear trend in terms of an increase or decrease in 
protease activity of the isolates when the pH of the culture broth was changed. In 
concordance with both the milk-casein agar plate assays and the azocasein assays, 
wound isolate 1 demonstrated a low elastolytic activity at each initial culture pH 
when compared to the majority of the other isolates (ATCC reference isolate and 
wound isolates). Furthermore, wound isolate 1 did not produce measurable 
elastolytic activity until the 24 hour culture time point, in contrast to the other wound 
isolates. The ATCC reference strain also did not demonstrate elastolytic activity until 
the 24 hour time point at each initial culture pH. In contrast to the azocasein assays, 
wound isolates 2 and 3 did not produce significantly more elastase than the other 
wound isolates at 24 hours, however these isolates exhibited a steady increase in 
elastolytic activity throughout the cultures at each initial pH. Wound isolate 3 
produced little elastolytic activity throughout each of the cultures, at each initial pH. 
Figure 13: Elastin-Congo red assay for elastinolytic activity analysis of each isolate over a 24 hour period. 
Isolates were cultured in MHB adjusted to an initial pH of 5.5.  
  
 77  
 
Generally, the levels of elastolytic activity increased over time, with levels highest at 
the end of the 24 hour culture. This observation applied to each of the different initial 
pH cultures. Interval plots (figures 23 and 24) illustrate the protease profiles of each 
isolate at each initial pH following a 24 hour culture period. Figure 25 illustrates the 
ECR assay plate format. 
 
Further analysis revealed that there was a statistical significance between elastase 
activities of the isolates (ATCC isolate plus 7 wound isolates) when cultured at 
either standard pH (pH7.3), pH5.5 or at pH6.0, F(2, 70) = 4.47, P = 0.015. When 
pH8.0 was considered (ATCC isolate plus 5 wound isolates [no wound isolates 6 or 
7]), however, there was a greater significant difference in elastase activities of the 
isolates (this does not, however, necessarily indicate a greater biological difference), 
F(3, 70) = 7.39, P = <0.001 with the greatest difference between elastolytic activities 
at the standard initial pH (pH7.3) and pH8.0, with more isolates producing low 
levels of elastase at an initial culture pH of 8.0. Yet, as was the case for the milk-
casein agar plates and the azocasein assays, there was strong evidence suggestive of 
an interaction between pH and isolate and so these observations could not be 
validated; alteration of the initial culture pH affected isolates in different ways: F(14, 
70) = 32.39, P = <0.001(comparison between standard pH (7.3), pH5.5 and pH 6.0);  
F(15, 70) = 43.72, P = <0.001 (comparison between standard pH (7.3), pH5.5, pH 
6.0 and pH8.0). Given the complex relationships, Appendix 5 details the grouping 
information which shows how each individual isolate responded at each initial 
culture pH. 
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2.4.6 Association of BFP with Elastolytic Activity 
 
Given the evidence within the literature suggestive of a relationship between a lack 
in the quorum sensing system, which controls the production of several virulence 
factors, and a reduction in LasB and LasA activity (Schaber et al, 2004) further 
statistical analysis was undertaken to define whether there is a relationship between 
the elastolytic activities of the P. aeruginosa wound isolates and BFP. At standard 
initial pH (7.3) there was a statistically significant relationship between BFP and 
elastolytic activity, F(2, 19) = 16.73, P = <0.001, with a significant difference 
between BFP scores of 0, 3 and 4 (the mean elastolytic activity for a BFP score of 3 
was, however, higher than the mean for a BFP score of 4). Likewise, at an initial 
culture pH of 5.5 there was a statistically significant difference between the 
elastolytic activities of isolates identified by their BFP, F(2, 20) = 6.98, P = 0.006 
[Kruskal-Wallis test: P = 0.006], with a significant difference between BFP scores of 
0 and 3. However, at initial culture pHs of 6.0 and 8.0 there was no significant 
difference: F(2, 20) = 2.85, P = 0.084 (pH6.0), F(2, 14) = 3.52, P = 0.063. Results, 
however, were based on limited case numbers; there was only 1 non-adherent isolate 
and 1 moderately adherent isolate with the remaining isolates either highly or very 
highly adherent. Despite the lack of conclusive statistically significant data 
supportive of a link between BFP and protease activity given the limitations in terms 
of numbers of isolates for each BFP score, it was noted that wound isolate 1 (non-
biofilm forming isolate) produced extremely low levels of elastolytic activity during 
the early stages of culture when cultured under each initial pH. Further, after the full 
24 hour culture this wound isolate produced less elastolytic activity than all but one 
of the isolates at each initial pH. Conversely, there seemed to be no correlation 
between the intensity of biofilm formation and elastolytic activity, with wound 
isolate 6 (a very high BFP isolate) not demonstrating significantly more elastolytic 
activity than lower BFP isolates. Further investigation is needed using a larger 
number of isolates, with varying BFP.
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Figure 19: Elastin-Congo red assay for elastinolytic activity analysis of each isolate 
over a 24 hour period. Isolates were cultured in MHB adjusted to an initial pH of 6.0.  
Figure 19: Elastin-Congo red (ECR) assay for elastinolytic activity 
analysis of each isolate over a 24 hour period. Isolates were cultured in 
Mueller Hinton broth (MHB) adjusted to an initial pH of 5.5. Data is 
presented as mean ± SEM. Statistical significance is detailed in tables 
8 & 9. *EF= E. faecium 
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Figure 18: Elastin-Congo red (ECR) assay for elastinolytic activity 
analysis of each isolate over a 24 hour period. Isolates were cultured in 
standard Mueller Hinton broth (MHB) broth (initial pH7.3). Data is 
presented as mean ± SEM. Statistical significance is detailed in tables 
8 & 9. *EF= E. faecium 
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Figure 21: Elastin-Congo red (ECR) assay for elastinolytic activity 
analysis of each isolate over a 24 hour period. Isolates were cultured in 
Mueller Hinton broth (MHB) adjusted to an initial pH of 8.0. Data is 
presented as mean ± SEM. Statistical significance is detailed in tables 8 & 
9. *EF= E. faecium 
Figure 20: Elastin-Congo red (ECR) assay for elastinolytic activity 
analysis of each isolate over a 24 hour period. Isolates were cultured in 
Mueller Hinton broth (MHB) adjusted to an initial pH of 6.0. Data is 
presented as mean ± SEM. Statistical significance is detailed in tables 8 & 
9. *EF= E. faecium 
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Figure 22: Elastin-Congo red (ECR) assay data for 3 example isolates, showing variations in elastinolytic activity when cultured at 
different initial pHs. Data is presented as mean ± SEM. Statistical significance is detailed in tables 8 & 9. 
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Table 9: P. aeruginosa isolates (ATCC isolate + 7 wound isolates): Differences in elastolytic activity between isolates, at each initial pH. 
* Significant at the 0.05 level 
Culture Time 
(Hours) 
Initial Culture pH Statistical Analysis Post-Hoc Observations 
(using the Tukey method) 
Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(7, 22) = 202.57, P = <0.001* ATCC isolate is significantly different from all other isolates; 
wound isolate 1 is significantly different from all other isolates; 
wound isolate 7 is significantly different from all other isolates; 
wound isolates 2 &3 are not significantly different from each 
other but are significantly different from all other isolates; 
wound isolates 4 & 5 are not significantly different from each 
other; wound isolates 4 & 6 are not significantly different from 
each other. 
 
24 5.5 F(7, 23) = 74.11, P = <0.001* ATCC isolate and wound isolate 2 are not significantly different 
from each other but are significantly different from all other 
isolates; Wound isolates 1 & 3 are not significantly different 
from each other but are significantly different from all other 
isolates; wound isolates 4, 5, 6 & 7  are not significantly different 
from each other but are significantly different from all other 
isolates. 
P = 0.003* 
24 6.0 F(7, 23) = 355.74, P = <0.001* Wound isolate 5 significantly different from all other isolates; 
wound isolate 4 is significantly different from all other isolates; 
wound isolates 6 & 7 are not  significantly different from each 
other but are significantly different from all other isolates; ATCC 
isolate and wound isolate 2  are not significantly different from 
each other but are significantly different from all other isolates; 
Wound isolate 1 is significantly different from all other isolates; 
wound isolate 3 is significantly different from all other isolates. 
 
24 8.0 F(5, 17) = 126.96, P = <0.001* Wound isolates 4 & 5 are not significantly  different from each 
other but are significantly different from all other isolates; ATCC 
isolate and wound isolate 2  are not significantly different from 
each other but are significantly different from all other isolates;  
Wound isolate 1 is significantly different from all other isolates; 
wound isolate 3 is significantly different from all other isolates. 
P = 0.007* 
  
   
 
8
3 
 
Table 10: P. aeruginosa isolates (7 wound isolates): Differences in elastolytic activity between isolates, at each initial pH. 
 
Culture Time 
(Hours) 
Initial Culture pH Statistical Analysis Kruskal-Wallis test 
24 Standard Broth (7.3) F(6, 19) = 237.62, P = <0.001  
24 5.5 F(6, 20) = 76.35, P = <0.001 P = 0.006* 
24 6.0 F(6, 20) = 398.05, P = <0.001  
24 8.0 F(4, 14) = 128.32, P = <0.001 P = 0.012* 
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Figure 23: Interval plots for elastolytic activity of the P. aeruginosa isolates at each initial culture pH following a 24hour broth culture. For 
all statistical analyses the ATCC reference isolate was named isolate 1; wound isolates 1-7 were numbered isolates 2-8; the E. faecium (EF) 
isolate was excluded from statistical analysis. 
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Figure 25: Example elastin-congo red (ECR) assay microtitre plate showing 
variations in elastase activity of different P. aeruginosa isolates. Samples 
were assayed in triplicate. 
Samples assayed in 
triplicate wells 
Empty wells 
Figure 24: Interval plots for elastolytic activity of the P. aeruginosa isolates at each initial broth 
culture pH following a 24 hour broth culture. For all statistical analyses the ATCC reference 
isolate was named isolate 1; wound isolates 1-7were numbered isolates 2-8; the E. faecium (EF) 
isolate was excluded from statistical analysis. Standard pH=pH1; pH5.5=pH2; pH6.0=pH3; 
pH8.0=pH4. 
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2.4.7 Intracellular Protease Activity 
 
To determine any intracellular proteolytic activity, cell pellets from P. aeruginosa 
aerobic cultures (initial culture pH of 7.4) were lysed with lysis buffer and cells were 
sonicated using an ultrasonic homogeniser (Bandelin Electronic, Berlin, Germany) to 
disrupt cell walls/cell membranes and release cellular contents. Results revealed very 
minimal intracellular proteolytic activity for each of the P. aeruginosa isolates (see 
figures 26 and 27). However, a number of inherent limitations in this method may 
have led to an underestimation of this proteolytic activity. Firstly, the major secreted 
proteases of P. aeruginosa are activated upon autoproteolytic processing once 
secreted into the surrounding environment (Folders et al, 2000). Secondly, the subtle 
variations in the colour of the cell pellets may have influenced results of the 
colourimetric protease assays.
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Figure 26: Azocasein assay for intracellular proteolytic activity for each P. aeruginosa 
isolate. Data is presented as mean ± SEM. *EF= E. faecium 
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Figure 27: Elastin-Congo red (ECR) assay for intracellular elastolytic activity for each P. 
aeruginosa isolate. Data is presented as mean ± SEM. *EF= E. faecium 
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2.4.8 Anaerobic Cultures 
 
Anaerobic cultures of each of the isolates were prepared in an anaerobic chamber 
(0% oxygen) to determine the effect of oxygen deprivation on growth and protease 
activity. All isolates were cultured using standard MHB (pH7.3). Protease activity 
was measured using the assays described above for the aerobic cultures over a 48 
hour culture period. Statistical analysis was conducted for proteolytic activities at the 
24 and 48 hour time points (the EF isolate was excluded from statistical analyses).  
 
Results of the milk-casein agar plate assays (see figure 28) have shown that there is a 
significant difference between isolates (ATCC isolate plus wound isolates) at the 24 
hour broth culture time point (followed by a 24 hour milk plate culture), F(7, 47) = 
16.03, P = <0.001 which was maintained at the 48 hour time point (followed by a 24 
hour milk plate culture), F(5, 32) = 42.12, P = <0.001. There was a general trend for 
all isolates, apart from wound isolate 3, showing that general protease activity 
peaked following an initial broth culture period of 4 hours followed by a 24 hour 
plate culture, with proteolytic activity declining over time following this time point; 
in comparison to the aerobic cultures, isolates were not able to maintain protease 
activity for extended periods. The difference between general protease activity, as 
demonstrated via the azocasein assay (see figure 26), of each isolate was significant 
at the 24 hour culture time point, F(7, 31) = 9.98, P = <0.001 which was maintained 
following a further 24 hours in culture, F(7, 31) = 11.17, P = <0.001. Azocasein 
assays demonstrated a lack of general protease activity of the ATCC reference 
isolate in comparison to the wound isolates (figure 29); however, elastolytic activity, 
as shown by the elastin-congo red assays (see figure 30), of the ATCC isolate was 
positive with enzyme levels increasing steadily over time. The difference between 
elastolytic activity, as demonstrated via the ECR assay, of each isolate was 
significant at the 24 hour culture time point, F(7, 31) = 7.83, P = <0.001. This 
difference between isolates, however, was not maintained following a further 24 
hours in culture, F(7, 31) = 0.88, P = 0.539. As with the aerobic cultures, wound 
isolate 1 remained the least active isolate in terms of both general protease activity 
and elastolytic activity. In concordance with the aerobic cultures, wound isolate 3 
was also a poor producer of proteolytic activity.  
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Differences between the growth of isolates remained similar to the aerobic cultures. 
Whilst statistical analysis of the bacterial densities of cultures at the 24 and 48 hour 
culture time points revealed a significant difference between isolates, the differences 
noted between proteolytic and elastolytic activities of isolates was not likely due to 
isolates growing at a faster rate (i.e. there was a true difference in proteolytic and 
elastolytic activity between isolates); those isolates which grew more slowly did not 
necessarily produce less proteolytic or elastolytic activity: for instance, wound 
isolate 2 was the slowest growing isolate under anaerobic conditions yet 
demonstrated the greatest elastolytic activity (figure 31). In contrast, wound isolate 3 
was shown to have one of the fastest growth rates yet was a relatively poor producer 
of elastolytic activity. Furthermore, whilst the P. aeruginosa isolates continued to 
grow steadily over the culture period (apart from wound isolate 2), reaching 
stationary phase at 24 hours, general proteolytic or elastolytic activity did not always 
parallel this cell growth. 
 
Whilst overall proteolytic and elastolytic activities of all isolates were lower than 
those of the aerobic cultures, all isolates had slower growth rates. Growth curve 
analysis has also shown that under anaerobic conditions the isolates have a longer 
lag phase with the logarithmic phase beginning at 8 hours. However, when the 
elastolytic activity of isolates cultured for 24 hours was considered in terms of the 
amount of bacteria, the isolates were actually generating more elastolytic activity 
than in aerobic culture. 
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Figure 28: Milk-Casein agar plate assay for caseinolytic digest analysis of 
each isolate over a 48 hour period. Isolates were cultured in Mueller Hinton 
broth (MHB) under anaerobic conditions. Data is presented as mean ± SEM. 
*EF= E. faecium 
Figure 29: Azocasein assay for caseinolytic digest analysis of each isolate 
over a 48 hour period. Isolates were cultured in Mueller Hinton broth 
(MHB) under anaerobic conditions. Data is presented as mean ± SEM. 
*EF= E. faecium 
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Figure 30: Elastin-Congo red assay for elastinolytic activity analysis of each 
isolate over a 48 hour period. Isolates were cultured in Mueller-Hinton broth 
(MHB) under anaerobic conditions. Data is presented as mean ± SEM.  
*EF= E. faecium 
Figure 31: Growth curves of each isolate over a 48 hour period. Isolates were 
cultured in Mueller Hinton broth (MHB) under anaerobic conditions. Data is 
presented as mean ± SEM.  
*EF= E. faecium 
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2.4.9 P. aeruginosa Growth Curves 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 4 8 12 24
O
D
6
0
0
n
m
Time (Hours)
ATCC Isolate
Wound Isolate 1
Wound Isolate 2
Wound Isolate 3
Wound Isolate 4
Wound Isolate 5
Wound Isolate 6
Wound Isolate 7
EF Isolate
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 4 8 12 24
O
D
6
0
0
n
m
Time (Hours)
ATCC Isolate
Wound Isolate 1
Wound Isolate 2
Wound Isolate 3
Wound Isolate 4
Wound Isolate 5
Wound Isolate 6
Wound Isolate 7
EF Isolate
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 4 8 12 24
O
D
6
0
0
n
m
Time (Hours)
ATCC Isolate
Wound Isolate 1
Wound Isolate 2
Wound Isolate 3
Wound Isolate 4
Wound Isolate 5
EF Isolate
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0 4 8 12 24
O
D
6
0
0
n
m
Time (Hours)
ATCC Isolate
Wound Isolate 1
Wound Isolate 2
Wound Isolate 3
Wound Isolate 4
Wound Isolate 5
Wound Isolate 6
Wound Isolate 7
EF Isolate
Figure 32  Figure 33 
Figure 34 Figure 35 
Figures 32-35: Bacterial growth curves; the 7 P. aeruginosa wound isolates, the ATCC P. aeruginosa isolate and the Enterococcus faecium (EF) wound 
isolate were grown over a 24 hour period in Mueller Hinton broth (MHB) at the 4 different initial pHs (standard broth at pH7.3, pH5.5, pH6.0 and pH8.0). At 
four-hourly intervals up to 24hours, samples of the culture broth were taken and measurements were made in triplicate of the OD600nm. Figure 20: initial 
pH7.3; Figure 21: initial pH5.5; Figure 22: initial pH6.0; Figure 23: initial pH8.0. Data is presented as mean ± SEM. Statistical significance is detailed in 
Table 10. 
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Growth curves demonstrated that most of the P. aeruginosa isolates had similar in 
vitro growth patterns despite the differences in protease activity (see figures 32-35). 
Most isolates had a lag phase of 4 hours, after which time isolates entered the 
logarithmic phase of growth at each initial culture pH. Isolates had very similar 
growth curves at each initial culture pH. Whilst statistical analysis revealed a 
significant difference between the ODs of isolates at the 24 hour time point (see table 
11), it is unlikely that the differences observed in protease/elastase activity between 
isolates was due to differences in bacterial density at this time point; those isolates 
which were strong producers of protease/elastase activity did not always have the 
highest OD at T24. Furthermore, differences between actual OD values at T24 were 
very small.  
 
 
Table 11: P. aeruginosa wound isolates: Differences in the optical density (OD600nm) 
of cultures following a 24 hour culture at each initial pH (difference between 
isolates). 
 
Culture Time 
(Hours) 
Initial Culture 
pH 
Statistical Analysis Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(7, 23) = 141.08, P = 
<0.001* 
P = 0.003* 
24 5.5 F(7, 23) = 31.06, P = 
<0.001* 
 
24 6.0 F(7, 23) = 13.71, P = 
<0.001* 
 
24 8.0 F(5, 17) = 52.20, P = 
<0.001* 
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2.4.10 Gelatin Zymography 
 
Gelatin zymography confirmed the results of the biochemical enzyme assays in 
terms of increased protease activity over the 24 culture period; protease bands were 
most intense at the 24 hour time point. Bands were not visible at the 4 hour culture 
period and band intensity increased from 8 hours to 24 hours. All proteolytic bands 
present on the gelatin zymograms were at around the 50kDa mark, indicative of 
alkaline proteinase (Marquart et al, 2005). Whilst the elastin congo-red assay 
detected elastolytic activity of the culture effluents the level of activity may not have 
been high enough for detection on the zymogram gels. Whilst statistical analysis did 
not confirm a significant variation in proteolytic activity of isolates when cultured at 
varying initial pH, the proteolytic intensity seen in the gelatin zymograms appeared 
slightly greater for wound isolate 2 when cultured in broth with an initial pH of 5.5 
which mirrors those results seen in the azocasein assay. Proteolytic bands were not 
as intense or clear for all other isolates, with no bands visible at the 4 hour time 
point. Proteolytic bands for anaerobic culture samples were also around the 50kDa 
mark, however bands were not as intense as those bands from aerobic culture 
samples.  
 
In an attempt to identify the molecular weight of the bands seen in the gelatin 
zymograms, a method was used to purify and elute the protein from the bands in the 
zymogram gel matrix. The proteolytic band obtained following gelatin zymography 
of 24 hour culture supernatant from a wound isolate was excised from the gel. 
Supernatants from eluted proteins were analysed using SDS-PAGE. Unfortunately, 
no protein bands could be seen on the gel (see Appendix 6). It may be that, due to 
dilution of the enzyme during the elution process, the sample requires concentrating 
prior to running on a gel. An alternative elution method, such as electro-elution may 
give a higher protein yield. Furthermore, residual stain on the gel pieces excised 
from the zymogram may have had a negative effect on protein elution. A longer 
incubation period in elution buffer (for example, overnight) may also have produced 
better results. Excised gel plugs from the same sample could also be pooled to 
generate a higher protein yield. 
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~50kDa 
 1 2  3  4   5  6 7 8 
Figure 37: Gelatin zymography of wound isolate 2 conditioned media following a 4, 8, 12 
and 24 hour aerobic culture. All samples are from initial pH6.0 cultures. Lane 2: Wound 
isolate 2, T4; Lane 4: Wound isolate 2, T8; Lane 6: Wound isolate 2, T12. Samples were 
unavailable for T24 cultures. Whilst the MMP-9 standard was used as in figure 24, the band 
could not be visualised on this gel. Lanes 1, 3, 5 & 7 are samples from the isolate found to be 
an impure culture, and were excluded from any analysis (see figure 3). Proteolytic band 
intensity increased over the culture period. Bands were not visible at the 4 hour time point 
(Lane 2). All proteolytic bands were at around the 50kDa mark. 
 
~50kDa 
Tear in zymogram gel 
Figure 38: Gelatin zymography of wound isolate 2 conditioned media following a 4, 8, 12 
and 24 hour aerobic culture. All samples are from initial pH8.0 cultures. Lane 2: Wound 
isolate 2, T4; Lane 4: Wound isolate 2, T8; Lane 6: Wound isolate 2, T12; Lane 8: Wound 
isolate 2, T24. Whilst the MMP-9 standard was used as in figure 24, the band could not be 
visualised on this gel. Lanes 1, 3, 5 & 7 are samples from the isolate found to be an impure 
culture, and were excluded from any analysis (see figure 3). Proteolytic bands were most 
intense at the 24 hour time point (Lane 8). Bands were not visible at the 4 hour time point 
(Lane 2). All proteolytic bands were at around the 50kDa mark. 
 
    1     2      3        4          5             6    7      8 
Purified MMP-9 
Standard 
~92kDa 
 1 2  3  4   5  6 7 8 
Figure 36: Gelatin zymography of wound isolate 2 conditioned media following a 4, 8, 12 
and 24 hour aerobic culture. All samples are from initial pH5.5 cultures. Lane 2: Wound 
isolate 2, T4; Lane 4: Wound isolate 2, T8; Lane 6: Wound isolate 2, T12; Lane 8: Wound 
isolate 2, T24. Lanes 1, 3, 5 & 7 are samples from the isolate found to be an impure culture, 
and were excluded from any analysis (see figure 3). Proteolytic bands were most intense at 
the 24 hour time point (Lane 8). Bands were not visible at the 4 hour time point (Lane 4). All 
proteolytic bands were at around the 50kDa mark. 
~50kDa 
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2.4.11 Casein Zymography 
 
Casein zymography was conducted to confirm the results observed in the gelatin 
zymography gels. The principal for casein zymography is the same as gelatin 
zymography; the proteases present with the loaded sample degrade a substrate bound 
to the gel matrix. For casein zymography, a 2% casein solution is used as the 
substrate, as outlined in the Methods section. As observed for the azocasein assays, 
the proteolytic activity in the culture effluent varied between isolates. In general, the 
caseinolytic bands observed in the gels mirrored those seen in the gelatin 
zymograms. That is, proteolytic bands were visible at around the 50kDa mark, 
indicative of alkaline protease (see figure 40). However, proteolytic bands were 
much less prominent on the casein zymograms when compared to the gelatin 
zymograms. For casein zymography, fresh planktonic cultures were standardised to 
an OD600nm of 1.0 prior to sample loading on to the gel, given that at lower ODs the 
proteolytic bands of the samples were not intense enough to visualise. As such, it 
was not possible to compare proteolytic bands over time.
~50kDa 
Figure 39: Gelatin zymography of P. aeruginosa conditioned media following 24 hour 
anaerobic culture. Lane 1: ATCC isolate; Lane 2: Wound isolate 1; Lane 4: EF isolate; Lane 
5: Wound isolate 2; Lane 6: Wound isolate 3; Lane 7: Wound isolate 4; Lane 8: Wound 
isolate 5; Lane 9: Wound isolate 6. Lane 3 is a sample from the isolate found to be an impure 
culture, and was excluded from any analysis (see figure 3). All proteolytic bands were at 
around the 50kDa mark. 
 
1          2          3          4  5     6     7             8            9 
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Band 1 Band 2 Band 3 Band 4 
Figure 40: Casein zymography of culture effluent from 24 hour aerobic cultures (all samples 
were standardised to OD600nm 1.0 prior to sample preparation). All samples are from initial 
pH7.4 cultures. Band 1: ATCC isolate; Band 2: Wound isolate 2; Band 3: Wound isolate 3; 
Band 4: Wound isolate 4. Whilst an MMP-2 standard was used, the band could not be 
visualised on the captured image of this gel. All proteolytic bands were at around the 50kDa 
mark. 
 
 
Caseinolytic 
bands at ~50kDa 
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2.4.12 SDS-PAGE (Coomassie staining) 
 
SDS-PAGE analysis confirmed protein levels generally increased over the culture 
period, with protein bands most prominent at the 24 hour time point.  In concordance 
with the gelatin zymography, protein bands were strongest for both wound isolate 2 
when cultured in initial pH5.5 broth, with the strongest bands at around the 33kDa 
mark at each time point which corresponds with P. aeruginosa elastase. Strong 
bands were also noted at around the 51kDa mark which is suggestive of proelastase, 
the elastase precursor (alternatively, this band could be the 53kDa preproenzyme of 
elastase); although further investigation using protein analysis would be required to 
confirm these postulations. Another strong band was seen at the 10kDa mark. 
Although it is not possible to determine the protein without further analysis, this low 
molecular weight protein could be the 10kDa chaperonin of P. aeruginosa. The 
protein band observed at the 25kDa mark could be a cytotoxin, previously known as 
leukocidin, which contributes to eukaryotic cell invasion. Again, further 
investigation, is required for protein identification. 
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Figure 41: SDS-PAGE of wound isolate 2 following a 4, 8, 12 and 24 hour aerobic culture. 
All samples are from initial standard pH (pH7.4) cultures. Lane 2: Wound isolate 2, T4; Lane 
4: Wound isolate 2, T8; Lane 6: Wound isolate 2, T12; Lane 8: Wound isolate 2, T24. Lanes 
3, 5, 7 & 9 are samples from the isolate found to be an impure culture, and were excluded 
from any analysis (see figure 3).Whilst the protein bands in this gel were not clear, band 
intensity generally increased over the culture period. 
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Figure 42: SDS-PAGE of wound isolate 2 following a 4, 8, 12 and 24 hour aerobic culture. 
All samples are from initial pH5.5 cultures. Lane 2: Wound isolate 2, T4; Lane 4: Wound 
isolate 2, T8; Lane 6: Wound isolate 2, T12; Lane 8: Wound isolate 2, T24. Lanes 3, 5, 7 & 9 
are samples from the isolate found to be an impure culture, and were excluded from any 
analysis (see figure 3). Protein band intensity increased over the culture period. The most 
intense protein bands were noted at around the 33kDa mark at each time point. 
 
   1     2      3       4         5           6    7             8             9 
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Figure 43: SDS-PAGE of wound isolate 2 following a 4, 8, 12 and 24 hour aerobic culture. 
All samples are from initial pH6.0 cultures. Lane 2: Wound isolate 2, T4; Lane 4: Wound 
isolate 2, T8; Lane 6: Wound isolate 2, T12; Lane 8: Wound isolate 2, T24. Lanes 3, 5, 7 & 9 
are samples from the isolate found to be an impure culture, and were excluded from any 
analysis (see figure 3). Whilst the protein bands in this gel were not clear, band intensity 
generally increased over the culture period. 
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Figure 44: SDS-PAGE of wound isolate 2 following a 4, 8, 12 and 24 hour aerobic culture. 
All samples are from initial pH8.0 cultures. Lane 2: Wound isolate 2, T4; Lane 4: Wound 
isolate 2, T8; Lane 6: Wound isolate 2, T12; Lane 8: Wound isolate 2, T24. Lanes 3, 5, 7& 9 
are samples from the isolate found to be an impure culture, and were excluded from any 
analysis (see figure 3). Whilst the protein bands in this gel were not clear, band intensity 
generally increased over the culture period. 
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2.4.13 SDS-PAGE (Silver-staining) 
 
For further clarity of protein bands on SDS-PAGE gels, fresh 24 hour aerobic 
planktonic cultures for the ATCC P. aeruginosa strain and each of the 7 wound P. 
aeruginosa isolates were prepared using standard pH (pH7.3) MHB. Samples were 
run as previously described on SDS-PAGE gels and stained with silver stain. 
Distinct bands were seen between the 20kDa mark and the 30kDa mark and around 
the 45kDa mark. The intensities of these bands varied between isolates. Of particular 
interest were the protein bands at around the 20-30kDa mark (see figure 45). These 
bands were most intense for culture supernatant samples obtained from wound 
isolate 2 and wound isolate 4. These isolates were also two of the most proteolytic 
isolates, as noted from the azocasein and ECR assays. It was speculated that the 
bands evident at the 20-30kDa mark could be suggestive of mature elastase, which is 
secreted as a 33kDa protein into the culture media, or the 21kDa mature form of 
LasA, a staphylolytic protease. As such, protein bands from lanes 4 and 7 (wound 
isolates 2 and 4, respectively) were excised for MS analysis. 
 
 
1          2           3           4    5      6       7             8            9         10 
~30kDa 
~45kDa 
Figure 45: SDS-PAGE of ATCC isolate and the 7 wound isolates following a 24 hour 
aerobic culture. All samples are from initial pH7.4 cultures. Lane 1: molecular weight 
standards 2; Lane 2: ATCC isolate 2; Lane 3: Wound isolate 1; Lane 4: Wound isolate 2; 
Lane 5: Wound isolate 3; Lane 6: Wound isolate 5; Lane 7: Wound isolate 4; Lane 8: 
Wound isolate 6; Lane 9: Wound isolate 7; Lane 10: E. faecium (EF) isolate. Distinct bands 
were seen between the 20kDa mark and the 30kDa mark and around the 45kDa mark. The 
intensities of these bands varied between isolates. Protein bands from lanes 4 and 7 (wound 
isolates 2 and 4, respectively) were excised for mass spectrometry (MS) analysis. 
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2.4.14 Mass Spectrometry 
 
Following the protein digest process for MS analysis, recovered peptide samples 
were run on an SDS-PAGE gel to verify that the gel plugs had been successfully 
digested (see Appendix 7). The MS sample was run against Uniprot Swall Bacteria 
and filtered using Mascot Significance Threshold of 0.05 as standard. Given that it 
was a general bacteria search carried out, any „hits‟ from other species were 
homologues (i.e. protein #2). Table 12 shows the results from MS analysis. Results 
identified 2 proteins: protein #1 was an uncharacterised protein with a molecular 
weight of 22.1kDa. Given that protein #1 had the highest score and the required 2 
peptides needed to confidently say that the protein is present in the sample, further 
investigation was made into the identity of this protein using the BLAST function in 
UniprotKB. Results revealed a 100% match with Pseudomonas aeruginosa Chitin-
binding protein CbpD.  
 
  
   
 
1
0
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Table 12: Mass spectrometry results for the 2 proteins identified from the in-gel protein digest sample. 
  
Protein# Accession Description Score Coverage #Proteins #Unique 
peptides 
#Peptides #PSMs Molecular 
function 
Biological 
process 
Pfam 
IDs 
#AAs MW 
(kDa) 
Calc. 
pI 
1 G5FXA8 Putative uncharacterized protein 
OS=Pseudomonas sp. 2_1_26 
GN=HMPREF1030_04111 
PE=4 SV=1 - 
[G5FXA8_9PSED] 
142.58 10.68 13 2 2 3   Pf03067 206 22.1 7.78 
2 K8B37K Rhamnulokinase 
OS=Cronobacter dublinensis 582 
GN=BN133_3520 PE=4 SV=1 - 
[K8B3K7_9ENTR] 
63.94 6.98 6 1 1 2 Catalytic 
activity 
Metabolic 
process 
Pf02782 129 14.1 6.89 
 
 
 
     
  
105 
 
2.5 Discussion 
 
P. aeruginosa has been widely implicated in a number of pathologies, not least in 
chronic wound infections, and is one of the most recognised nosocomial pathogens 
(Altoparlak et al, 2004; Bielecki et al, 2008). P. aeruginosa exerts a number of 
secreted virulence factors upon its host, which have been shown to have several 
deleterious effects on host cells and tissues including the inhibition of various 
aspects of the host‟s immunity and induction of apoptosis (Engel & Balachandran, 
2009; Bi et al, 2001). Indeed, proteases secreted by this organism act to degrade host 
proteins, in turn causing huge damage to the host (Travis & Maeda, 1995), including 
degradation of cytokines, growth factors, complement components, 
immunoglobulins and ECM components (Schmidtchen, Wolff & Hansson, 2001). It 
is, therefore, of importance to recognise the many factors involved in the 
pathogenesis of this organism and to address the potential effects they can have on 
various aspects of wound healing in the clinical setting.  
 
The current study has highlighted an obvious variation in protease expression of P. 
aeruginosa isolates from equine wounds, which corroborates previous findings; 
Schmidtchen, Wolff & Hansson (2001) found that P. aeruginosa isolates from 
human leg ulcers displayed a highly variable expression of elastase and alkaline 
proteinase, whilst Jagger, Bahner & Warren (1983) demonstrated the variation in 
protease phenotypes of P. aeruginosa isolates obtained from cystic CF patients. 
Similarly, an early study by Woods and colleagues (1986) showed that the 
exoproduct levels of P. aeruginosa isolates, including levels of total protease, 
elastase, phospholipase C, exotoxin A and exoenzyme S, vary depending on the 
anatomical site of isolation. Likewise, Rumbaugh, Griswold & Hamood (1999) 
found that both the infection site and the duration of infection affects the pathogenic 
nature of P. aeruginosa by altering the production of extracellular virulence factors. 
Given the limited number of P. aeruginosa wound isolates for both chronic and 
acute wounds it was not possible in this study to compare protease levels of culture 
supernatant obtained from chronic versus acute wounds. In future studies it would be 
interesting to ascertain any differences in the proteolytic activity of isolates in the 
healing versus the non-healing wound and the contaminated versus the infected 
wound. Whilst the identification of the mechanism(s) behind such variation in the 
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protease profiles of the P. aeruginosa isolates was beyond the scope of this study, it 
has been suggested that deviation in protease expression could be related to 
epigenetic mechanisms such as transcriptional control or as a result of 
rearrangements within the structural genes or corresponding upstream regions 
(Schmidtchen, Wolff & Hansson, 2001).  
 
In future studies it would be interesting to evaluate the protease profiles of P. 
aeruginosa isolates obtained from repeated cultures of the same wounds; as 
demonstrated by Schmidtchen and team in their 2001 study, isolates obtained from 
repeated cultures from skin ulcers maintained their protease expression patterns, 
suggesting that protease expression may be stable over extended periods in vivo. 
Comparatively, Jagger, Bahner & Warren (1983) found that a lower percentage of  
P. aeruginosa isolates from CF patients who were chronically infected with the 
organism were positive for alkaline protease expression and general protease activity 
compared with those isolates from colonised patients, suggesting that protease 
production from P. aeruginosa could be implicated in the initial colonisation of CF 
patients. The present study revealed that the P. aeruginosa isolates displayed 
caseinolytic activity (as demonstrated using the milk-casein agar substrate plate 
method) over an extended culture period, with most isolates showing a positive 
correlation of general protease/elastase activity throughout the growth of the 
bacteria, with all wound isolates exhibiting some level of protease activity. The 
caseinolytic and elastolytic activities measured in the culture supernatants of each of 
the isolates were generally maximal by the end of the exponential phase of growth, 
which was maintained when the isolates were grown under altered initial pH and 
also when grown anaerobically. It should also be noted that those isolates producing 
low levels of protease activity may be more proteolytically active under alternative 
growth conditions (Jagger, Bahner & Warren, 1983); for instance if different growth 
media was used, given that protease production is influenced by the complexity of 
the medium including cation concentration (Jagger, Bahner & Warren &, 1983). 
Indeed, P. aeruginosa is known to depend on a complex network of regulatory genes 
which act to control the production of various virulence factors in response to 
environmental stimuli (Rumbaugh, Griswold & Hamood, 1999).  It is also worth 
noting that it was not possible to distinguish between true proteolytic activity of live 
cells and protease released from dead cells. One further limitation of this study is 
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that, whilst it is unlikely given the size of P. aeruginosa cells (about 1-5µm long and 
0.5-1.0µm wide), the use of 0.45µm sterile filters may have allowed cells to escape 
into the media which could have altered the protease activity if any live cells were 
still present in the conditioned media. To confirm the absence of viable bacterial 
cells in the conditioned media, aliquots from each sample could be plated onto agar 
and cultured. Sterile filters with a pore size of 0.2µm would ensure complete 
removal of bacterial cells, however the time needed to double filter the conditioned 
media would need to be factored into the experimental plan. Furthermore, additional 
filtration steps may introduce more opportunities for contamination of samples from 
external sources. The variable SEMs for the milk-casein agar analysis and the 
biochemical protease assays highlight the need for further biological and 
experimental replicates in future studies. 
 
In this study, the ATCC P. aeruginosa reference strain (non-wound isolate) 
generally showed lower protease expression throughout the culture period, despite 
changes in initial culture pH and oxygen depletion. This observation alone highlights 
the importance of carefully selecting the most appropriate isolate when studying the 
protease or general virulence characteristics of the bacteria in studies aiming to 
assess the effects of protease modulating therapies.  
 
Additionally, this study has demonstrated that the biofilm forming phenotype (BFP) 
varies significantly between the clinical P. aeruginosa isolates derived from equine 
wounds. Whilst no correlation was observed in the current study in terms of the 
mucoid phenotype (BFP) of the P. aeruginosa isolates and their proteolytic profiles, 
it has been found that non-mucoid P. aeruginosa isolates obtained from CF patients 
are more proteolytic than mucoid isolates (Jagger, Bahner & Warren &, 1983).  
 
Although the case number in this study was not large enough for observations to be 
made in terms of isolate protease profiles and in vivo wound characteristics, in future 
studies it would be of interest to determine whether there is a correlation between 
wound severity and progression with P. aeruginosa protease expression; the 
heterogeneity in protease activity of P. aeruginosa isolates from equine wounds 
could be explained by variations in clinical circumstances and patient status (Woods 
et al, 1986). For instance, Rumbaugh and colleagues (1999) noted that different 
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regulatory P. aeruginosa regulatory genes may respond to different signals within 
different anatomical sites of infection. However, it would be important to keep in 
mind any confounding variables such as antibiotic administration, other wound 
therapies utilised and the duration of infection (including multi-species infections) 
when making such interpretations (Schmidtchen, Wolff & Hansson, 2001). In some 
circumstances, serotyping the P. aeruginosa isolates may lead to correlations 
observed between serotype and protease expression, although this was not found to 
be the case in the early study by Woods et al (1986) who found no correlation 
between serotype and protease expression among P. aeruginosa isolates from a 
variety of clinical sources and site of isolation or exoproduct levels. 
 
Whilst under anaerobic conditions each of the P. aeruginosa isolates (wound isolates 
and ATCC reference strain) expressed considerably less proteolytic activity relative 
to the aerobic cultures, growth curve analysis revealed that the bacteria were 
growing more slowly with an elongated lag phase as compared to the corresponding 
aerobic cultures for each isolate. Yet, further analysis confirmed that when 
considering the level of proteolytic activity for a given bacterial density the 
anaerobic cultures were generating a higher degree of protease activity. Sabra, Kim 
& Zeng (2002) found that the release of certain virulence factors, including elastase 
was significantly enhanced by P. aeruginosa PAO1 under microaerobic conditions. 
In terms of the wound environment, P. aeruginosa tends to live within the biofilm 
state, commonly subjected to microaerobic conditions thus prompting slow growth. 
Further investigation into the response of wound isolates to variations in oxygen 
tension in terms of protease production and how the biofilm mode of growth affects 
protease profiles is a topic of interest for future investigation. 
 
Investigation into the effect of altering initial culture pH on bacterial growth and P. 
aeruginosa protease expression revealed that the isolates responded differently to pH 
change. Whilst it was not possible to conclusively determine the culture pH which 
generated the most protease activity, the results showed that all of the clinical 
isolates were more proteolytically active when compared with the ATCC type strain. 
These results have demonstrated the ability of P. aeruginosa equine wound isolates 
to resist changes in culture pH in terms of virulence in the form of protease 
expression. Indeed, this links in with the notable highly environmentally adaptable 
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nature of P. aeruginosa (Williams & Cámara, 2009); during infection, P. aeruginosa 
must survive environmental changes, including changes to the pH (Suh et al, 1999). 
However, the ways in which the increase in protease expression at a given pH 
reflects the wound milieu and changes in wound pH throughout the healing process 
remain to be elucidated. The ability of P. aeruginosa wound isolates to increase their 
protease expression may serve as a survival mechanism or stress response during the 
lowered pH of the skin observed during healing, however the mechanisms behind the 
observed pH and oxygen sensitivity require further characterisation. The observation 
made in this study may have implications in the use of topical therapeutic agents 
targeted at lowering the skin surface pH; it is apparent that P. aeruginosa is not only 
able to survive and grow but also readily produce proteases at a low pH. In addition, 
occlusive dressings commonly used in wound care act in part to lower the wound 
pH; whilst this will potentially lower the capacity for biofilm formation, elastase 
production may increase or be maintained, potentially allowing for the spread of 
bacteria to other parts of the wound or normal skin. In situ monitoring of the wound 
pH during the different healing phases and the extent of bacterial proteases produced 
may provide a better insight into the effects of pH on various aspects of healing. 
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The mass spectrometry analysis of the P.aeruginosa culture supernatants also 
produced some interesting results. One of the major proteins secreted by P. 
aeruginosa is a 43kDa protein, secreted via the type II secretion pathway (Braun et 
al, 1998; Folders et al, 2000; Folders et al, 2001). This protein is cleaved into 
smaller fragments, including a 30kDa and a 23kDa fragment, by elastase. The 23kDa 
fragment was originally classified as LasD, a staphylolytic protease. However, 
Folders et al (2000) found that the N-terminal half of the 43kDa protein is 
homologous to chitin-binding proteins of other bacterial species. As such, the 
authors renamed this protein as CbpD (chitin-binding protein D). CbpD is produced 
by many clinical isolates of P. aeruginosa (Folders et al, 2000) as is thought to be 
involved in pathogenicity (Frederiksen et al, 2013). Given that elastase is involved in 
the processing of the full length 43kDa protein into smaller fragments, it is 
speculated that the presence of the smaller fragments of CbpD could also act as a 
biomarker for the presence of P. aeruginosa elastase in the culture supernatant, given 
that the full length 43kDa protein is found in large amounts in the cell free 
supernatant of a LasB mutant strain (Folders et al, 2000). Furthermore, given that P. 
aeruginosa elastase is also secreted into the extracellular environment via the type II 
secretory pathway, the low levels elastase activity in the culture supernatant, noted in 
the ECR assays, is not likely a result of failings in its secretory pathway. 
 
Collectively, the data obtained from this study would advocate a more thorough 
approach to wound diagnostics in terms of identifying the proteolytic and biofilm 
phenotype of bacteria isolated from persistent wounds to improve individual patient 
treatment plans. Yet, it should be noted that the true clinical in vivo setting is not 
completely represented in studies using in vitro cultures. For example, it has been 
documented that serum can affect protease activities in vivo. Future studies, 
therefore, should consider additional in situ observations. It would also be beneficial 
to assess the proteolytic profiles of P. aeruginosa isolates from both chronic and 
acute wounds along with more complex studies into the synergistic effects of 
introducing multiple bacterial species on protease expression.  
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2.6 Conclusion 
 
The present study has demonstrated the highly variable expression of proteases, 
including elastase, between P. aeruginosa isolates derived from equine wounds, 
highlighting the apparent deviation in the virulence of this micro-organism amongst 
different host tissues. When the effects of an altered initial culture pH were 
examined in vitro, results showed that different isolates respond differently to 
different pHs. Furthermore, whilst a depletion of oxygen in cultures caused all 
isolates to grow at a slower rate and produce an overall lower level of protease 
activity, when proteolytic activity was considered in terms of biomass isolates grown 
anaerobically were more proteolytic. Overall, each isolate demonstrated a general 
linear increase in protease activity which paralleled the growth curve. The data 
generated from this study has emphasised the potential benefit of identifying the 
proteolytic phenotype of bacterial isolates obtained from chronic wounds in terms of 
improving individual treatment plans in the clinical setting. It is proposed that the 
bacterial phenotype should also be taken into account in future studies on the clinical 
nature of chronic infected wounds.  
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2.7 Appendices to Chapter 2 
 
 
Appendix 1 
 
pH Checks following a 24 hour aerobic culture for each P. aeruginosa isolate (initial 
pH7.4 and initial pH5.5) 
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Note: For all analyses in Appendices 2-5, isolate 1 represents the ATCC isolate and 
isolates 2-8 represent wound isolates 1-7. 
 
Appendix 2  
 
One-Way ANOVA Grouping information for BFP (ATCC isolate plus 7 wound 
isolates) 
 
Isolate  N    Mean  Grouping 
6        8  4.7739  A 
1        8  1.4668    B 
4        8  1.0565    B C 
3        8  1.0121    B C 
7        8  0.9570    B C 
5        8  0.7827      C 
8        8  0.7225      C 
2        8  0.1816        D 
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Appendix 3  
 
One-Way ANOVA Grouping information for milk-casein agar plate analysis (ATCC 
isolate plus 7 wound isolates). Means that do not share a letter are significantly 
different. 
3.1 pH 7.4  
 
3.1.1 T8, 24hrs 
Isolate  N    Mean  Grouping 
5        3  3.4167  A 
4        3  3.1333  A 
8        3  3.0833  A B 
7        3  2.5333  A B 
6        3  2.1333  A B C 
3        3  1.9500  A B C 
1        3  0.9833    B C 
2        3  0.3667      C 
 
3.1.2 T8, 48hrs 
Isolate  N    Mean  Grouping 
5        3  4.4000  A 
8        3  4.1833  A 
4        3  3.9500  A 
7        3  3.6500  A B 
6        3  3.2167  A B 
3        3  2.6333  A B C 
1        3  1.6000    B C 
2        3  0.9000      C 
 
3.1.3 T12, 24hrs 
Isolate  N    Mean  Grouping 
7        3  2.7167  A 
4        3  2.2333  A B 
5        3  2.0500  A B 
8        3  1.7500  A B 
3        3  1.6667  A B 
6        3  1.4667  A B 
1        3  0.8333  A B 
2        2  0.3500    B 
 
3.1.4 T12, 48hrs 
Isolate  N    Mean  Grouping 
7        3  4.7333  A 
5        3  4.2833  A 
8        3  3.7667  A B 
6        3  3.5167  A B 
4        2  3.3500  A B 
3        3  2.6000    B C 
1        3  1.7333      C 
2        2  1.4500      C 
3.2 pH5.5 
 
3.2.1 T8, 24hrs 
Isolate  N    Mean  Grouping 
8        3  4.6500  A 
7        3  3.9167  A B 
5        3  3.6000  A B C 
6        3  2.8000  A B C D 
3        2  2.0250    B C D 
2        2  1.9500    B C D 
4        3  1.6500      C D 
1        2  1.0000        D 
 
3.2.2 T8, 48hrs 
Isolate  N    Mean  Grouping 
8        3  5.7167  A 
7        3  5.2667  A 
5        3  4.6000  A B 
3        2  4.1250  A B 
2        2  4.1000  A B 
6        3  3.6833  A B 
1        2  2.6750    B 
4        3  2.4833    B 
 
3.2.3 T12, 24hrs 
Isolate  N    Mean  Grouping 
6        3  3.3333  A 
5        3  3.0167  A 
8        3  2.4167  A 
7        3  2.2500  A 
4        3  2.0667  A 
3        2  2.0500  A 
1        2  1.2250  A 
2        2  0.9000  A 
 
3.2.4 T12, 48hrs 
Isolate  N    Mean  Grouping 
5        3  5.2333  A 
6        3  5.1833  A 
8        3  4.3667  A B 
7        3  4.3667  A B 
3        2  4.2350  A B 
4        3  3.4333    B 
2        2  3.0500    B 
1        2  2.7500    B 
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3.3 pH6.0 
 
3.3.1 T8, 24hrs 
Isolate  N    Mean  Grouping 
8        3  4.9833  A 
7        3  4.9833  A 
6        3  2.4833    B 
4        3  2.2333    B 
5        3  2.2000    B 
3        2  1.5500    B 
2        2  1.1750    B 
1        2  1.0250    B 
 
3.3.2 T8, 48hrs 
Isolate  N    Mean  Grouping 
7        3  6.0000  A 
8        2  5.8500  A B 
3        2  3.4500    B C 
2        2  3.4000      C 
5        3  3.1833      C 
4        3  3.1833      C 
6        2  3.1750      C 
1        2  2.6000      C 
 
3.3.3 T12, 24hrs 
Isolate  N   Mean  Grouping 
8        3  5.150  A 
5        3  3.367  A B 
4        3  3.183  A B 
7        3  3.033  A B 
6        3  2.767  A B 
3        2  2.225  A B 
2        2  1.625  A B 
1        2  0.875    B 
 
3.3.4 T12, 48hrs 
Isolate  N    Mean  Grouping 
8        3  7.0667  A 
4        3  6.1667  A B 
5        3  5.6833  A B 
7        3  5.3667  A B 
6        3  5.0167  A B C 
3        2  4.3500  A B C 
2        2  3.8250    B C 
1        2  2.4250      C 
 
3.4 pH8.0 
 
3.4.1 T8, 24hrs 
Isolate  N    Mean  Grouping 
3        2  2.9250  A 
6        3  2.8000  A 
5        3  2.2167  A B 
4        3  1.9667  A B 
2        2  1.8500  A B 
1        2  0.9500    B 
 
3.4.2 T8, 48hrs 
Isolate  N    Mean  Grouping 
3        2  4.9750  A 
2        2  4.0000  A B 
6        3  3.7500  A B 
5        3  3.2333  A B 
4        3  2.8500    B 
1        2  2.5750    B 
 
3.4.3 T12, 24hrs 
Isolate  N   Mean  Grouping 
5        2  2.175  A 
4        2  2.025  A 
3        2  1.550  A 
 
2.4.4 T12, 48hrs 
Isolate  N    Mean  Grouping 
5        2  4.2500  A 
4        2  3.9750  A 
3        2  3.0250  A 
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Appendix 4 
 
One-Way ANOVA Grouping information for azocasein assays (ATCC isolate plus 7 
wound isolates). Means that do not share a letter are significantly different. 
 
4.1 pH7.4 T24  
Isolate  N     Mean  Grouping 
3        3  0.38033  A 
1        3  0.25433    B 
5        3  0.20660    B C 
8        3  0.18330    B C 
6        3  0.17617    B C 
4        3  0.14313    B C 
7        3  0.14080      C 
2        2  0.11700      C 
 
4.2 pH5.5 T24 
Isolate  N     Mean  Grouping 
3        3  0.42867  A 
2        3  0.37600  A 
1        3  0.36933  A 
5        3  0.17960    B 
8        3  0.15117    B 
4        3  0.13430    B 
7        3  0.13337    B 
6        3  0.12683    B 
 
4.3 pH6.0 T24 
Isolate  N     Mean  Grouping 
3        3  0.42133  A 
1        3  0.32667  A B 
2        3  0.28667    B C 
8        3  0.18413      C D 
7        3  0.17817      C D 
6        3  0.16793        D 
5        3  0.15633        D 
4        3  0.12820        D 
 
4.4 pH8.0 T24 
Isolate  N     Mean  Grouping 
3        2  0.43400  A 
1        3  0.40700  A 
2        3  0.39800  A 
6        3  0.18937    B 
5        3  0.15400    B 
4        3  0.11973    B 
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Appendix 5 
 
One-Way ANOVA Grouping information for ECR assays (ATCC isolate plus 7 
wound isolates). Means that do not share a letter are significantly different. 
 
5.1 pH7.4 T24 (ATCC isolate plus 7 wound isolates) 
Isolate  N     Mean  Grouping 
8        3  0.47446  A 
7        3  0.34866    B 
5        3  0.31375    B C 
6        3  0.29208      C 
1        3  0.23018        D 
3        2  0.13085          E 
4        3  0.11012          E 
2        3  0.00165            F 
 
5.2 pH5.5 T24 
Isolate  N     Mean  Grouping 
7        3  0.46079  A 
5        3  0.45668  A 
8        3  0.43656  A 
6        3  0.41675  A 
1        3  0.24125    B 
3        3  0.21795    B 
2        3  0.09748      C 
4        3  0.06145      C 
 
5.3 pH6.0 T24 
Isolate  N     Mean  Grouping 
6        3  0.56206  A 
5        3  0.46758    B 
8        3  0.28776      C 
7        3  0.28462      C 
3        3  0.20528        D 
1        3  0.19822        D 
2        3  0.09988          E 
4        3  0.03268            F 
 
5.4 pH8.0 T24 (plus no isolate 7 or 8) 
Isolate  N     Mean  Grouping 
5        3  0.31712  A 
6        3  0.31452  A 
1        3  0.25462    B 
3        3  0.21822    B 
2        3  0.11188      C 
4        3  0.05068        D 
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Appendix 6 
 
SDS-PAGE of eluted proteins from excised gelatin zymogram 
 
The smears seen at the top of the gel are likely to be high molecular weight proteins 
from the gel matrix of the gelatin zymogram. 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular weight ladder 
Protein elution sample from gelatin zymogram proteolytic band 
Protein elution sample from control gel plug 1 
Protein elution sample from control gel plug 2 
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Appendix 7 
 
SDS-PAGE verification of protein digest prior to MS analysis 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular weight ladder 
Protein digest sample (used for MS) 
Protein digest sample (not used for MS) 
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3.1 Abstract 
 
Pseudomonas aeruginosa is a widespread opportunistic pathogen commonly 
implicated in wound infections and has an inherent capacity for the development of 
biofilms. The combination of evasion from host defences and administered 
antimicrobials along with the production of multiple virulence factors, including 
several proteases, makes this pathogen a challenge in the management of chronic, 
infected wounds. In the previous chapter, the variable production of secreted 
proteases of clinical P. aeruginosa isolates obtained from equine wounds in the 
planktonic mode of growth was demonstrated. Furthermore, the effects of the 
changing environment (changes in initial culture pH and oxygen depletion) on the 
production of proteases by these isolates was demonstrated. Given the evidence in 
the literature of the presence of biofilms in chronic wounds, it was hypothesised that 
the biofilm versus the planktonic mode of growth has an impact on protease 
production in vitro. 
 
In this chapter it is shown that isolates of P. aeruginosa obtained from equine 
wounds display a highly variable protease expression during the biofilm mode of 
growth. However, a change in the initial culture pH of developing biofilms in vitro 
did not cause significant fluctuations in the proteolytic profiles of the isolates. It is 
proposed that in future work the proteolytic phenotype should be considered in 
combination with the biofilm-forming potential of bacterial isolates when 
investigating the clinical nature of chronically infected wounds.
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3.2 Introduction 
 
Pseudomonas aeruginosa is an important opportunistic human and animal pathogen 
and is a particular concern in nosocomial infections, including wound infections 
(Hentzer et al, 2003; Bielecki et al, 2008). The inherent ability of P. aeruginosa to 
survive in a range of hostile environments with minimal nutritional requirements 
along with its renowned resistance to various antibiotics allows the microorganism to 
colonise and infect injured tissues (Rumbaugh et al, 1999; Estahbanati, Kashani & 
Ghanaatpisheh, 2002; Harjai et al, 2005).  The virulence of P. aeruginosa results 
from a synergy of both cell-associated and extracellular factors, with the proteases 
LasB elastase, LasA elastase and alkaline protease all implicated in the pathogenic 
characteristics of this bacterium (Petermann, Doetkott & Rust, 2001; Van Delden & 
Iglewski, 1998). Indeed, these proteases have been a major focus in current research 
in terms of their action against host tissues; P. aeruginosa proteases are considered 
as important virulence factors given their capacity to damage host tissues and 
interfere with host antibacterial defence systems (Ołdak E & Trafny, 2005). These 
proteases have wide substrate specificity, with both LasA and LasB mediating the 
degradation of elastin and alkaline proteases and elastases degrading collagen 
(Petermann, Doetkott & Rust, 2001). P. aeruginosa proteases can also work 
synergistically to break down components of connective tissues and the immune 
system (Petermann, Doetkott & Rust, 2001).  Research has shown that these 
proteases act to delay infection resolution, with protease-deficient strains showing 
almost avirulent characteristics (Tang et al, 1996). However, Preston and colleagues 
(1997) noted that neither LasR (the transcriptional activator of LasB and LasA) nor 
elastase production is required for the establishment or maintenance of corneal 
infection in a murine keratitis model (Preston et al, 1997). Nevertheless, it has been 
noted that there exists a wide variation in the proteolytic activity of P. aeruginosa 
between different infection sites and types of disease (Woods et al, 1986; 
Schmidtchen, Wolff & Hansson, 2001) and the wound healing responses to these 
variations in bacterial proteolytic activity in the in vivo environment are poorly 
understood. 
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The P. aeruginosa quorum sensing (QS) systems, las and rhl, direct the production 
of a number of virulence factors, including proteases and so contribute to the 
microorganism's pathogenicity (Rumbaugh et al, 1999).  QS systems allow the 
microorganism to control the production and secretion of virulence factors in a co-
ordinated, cell-density regulated manner (Van Delden & Iglewski, 1998). QS also 
has an important role in the development of biofilms, a growth behaviour which 
allows the bacteria to form surface-associated, multicellular structured and resistant 
complexes which aid persistence of infection (Hentzer et al, 2003; Davies et al, 
1998). Once a critical bacterial density is established, extracellular signalling occurs 
which allows the bacterial population to change its phenotype (Thomson, 2011). 
Biofilms are a particularly problematic feature of chronic wounds, given their 
resilience to antibiotic treatment and host defence mechanisms which is, in part, a 
result of the alginate-containing extracellular polymeric matrix which accumulates at 
the attachment surface (Percival & Bowler, 2004).  
 
Biofilms have been noted for their frequent occurrence within the wound milieu, 
particularly in chronic wounds, with strategies used to disrupt biofilms becoming an 
increasingly important part of wound management regimens (Thomson, 2011). 
Indeed, direct evidence of the presence of biofilms in chronic wounds has been 
provided in recent years; James et al (2008) examined both acute and chronic 
wounds for the presence of biofilms and found that 60% of chronic wound 
specimens contained evidence of biofilm compared to just 6% of acute wound 
specimens. Similarly, the presence of biofilms within equine chronic wounds has 
been identified (Westgate et al, 20011b), with evidence of bacterial clustering found 
in 8 out of 14 debrided wound tissue samples in a recent study (Westgate et al, 
20011c). Furthermore, P. aeruginosa has been identified as one of the most 
commonly isolated bacteria from equine wounds with Pseudomonas spp identified 
as more prevalent among chronic wounds as compared with acute wounds (Westgate 
et al, 20011b; Westgate et al, 20011c).  
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In terms of the wound environment, the pH of the wound can affect a number of 
factors involved in healing including angiogenesis, oxygen release, bacterial toxicity 
and protease activity (Gethin, 2007). Whilst a more acidic environment is a feature 
of the inflammatory phase of healing, the pH of normally healing acute wounds 
gradually increases during the formation of granulation tissue prior to falling again 
during re-epithelialisation (Schneider et al, 2007). In contrast, the pH of chronic 
wounds maintains a prolonged alkaline pH (Schneider et al, 2007). In vivo 
environmental factors and host signals can also affect the formation of biofilms and 
the conversion of the non-mucoid to the mucoid phenotype. Indeed, a number of 
factors including nutrient limitation and osmotic stress have been found to induce the 
mucoid phenotype in previously non-mucoid bacterial strains (Terry, Piña & 
Mattingly, 1991). Mucoidy conversion may occur in response to environmental 
factors encountered during chronic infection or in in vitro adverse growth conditions 
(Terry, Piña & Mattingly, 1991). Furthermore, QS systems, which act in part to 
direct virulence factor production, can also be affected by changes in pH (Horswill et 
al, 2007).  
 
Additionally, the production of proteases can both affect or be affected by changes in 
pH of the wound bed (Harjai et al, 2005; Greener et al, 2005). Other bacterial 
virulence factors can also be affected by the environmental pH, including the 
attachment rate to host tissues.  
 
In relation to the cutaneous wound environment, the effects of the biofilm mode of 
growth and pH change during the healing of wounds on bacterial virulence have not 
been thoroughly investigated. In the previous chapter we demonstrated a highly 
variable protease expression among clinical P. aeruginosa isolates. However, it is 
important to consider how the in vivo mode of growth, i.e. biofilms, may affect 
virulence in terms of the production of proteases. The aim of the present study 
therefore is to investigate the effects of the biofilm mode of growth on the 
production of proteases using in vitro models.  Additionally, the initial culture pH of 
these biofilms will be lowered to provide some insight into the pathogenic response 
of biofilm cells under the acidic conditions associated with the healing wound 
environment and to compare these responses between wound isolates and a non-
clinical reference isolate.
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3.3 Methods 
 
3.3.1 Chemicals and Reagents 
 
All chemicals and reagents were purchased from Sigma Aldrich (Dorset, UK) unless 
otherwise stated. 
 
3.3.2 Ethical Approval 
 
Approval for this study was granted by the Ethics Committee, University of 
Liverpool and informed consent was obtained from the owners of the animals 
participating in this study. 
 
3.3.3 Identification of P. aeruginosa Isolates 
 
Standard microbiological culture techniques were used to confirm the identities of 7 
previously collected equine trauma wound isolates (as described in Manuscript 2). 
Pure bacterial colonies were identified using a Gram stain and isolates confirmed as 
Gram negative rods were further characterised using the oxidase test (using oxidase 
detection strips from Oxoid Limited, Hampshire, UK) and API 20 E
®
 identification 
strips, which utilise biochemical reactions with computer software-interpretation 
(Biomérieux UK Limited, Hampshire, UK). Confirmed P. aeruginosa isolates were 
stored on beads and frozen at -80C until required for further investigation.  
 
A P. aeruginosa reference strain (non-wound isolate) was used as a control; 
American Type Culture Collection (ATCC) 27853 (isolated from blood culture) 
(American Type Culture Collection [ATCC], Manassas, USA). This strain was 
chosen as it produces both elastase and alkaline protease (O'Callaghan et al, 1996). 
An additional negative control wound isolate was used in the form of Enterococcus 
faecium (EF isolate), a Gram positive bacterium and common nosocomial pathogen. 
This isolate was identified using the API 20 Strep kit (Biomérieux UK Limited, 
Hampshire, UK).  
 
 126 
 
Polymerase chain reaction (PCR) analysis of the Pseudomonas aeruginosa elastase 
gene was performed for each isolate; all of the chronic wound isolates and the ATCC 
reference strain were positive for the elastase gene (as reported in Manuscript 2). 
 
The biofilm forming phenotype (BFP) of each of the isolates was determined 
previously (as described in Manuscript 2) using the microtitre plate crystal violet 
staining method. P. aeruginosa isolates were also plated onto tryptone soy agar 
(TSA) to examine the mucoid/non-mucoid phenotype of each isolate (see figure 2).  
 
3.3.4 Biofilm Cultures Using the Glass Microscope Slide Method 
 
The protease activity of developing monospecies biofilms in liquid culture was 
assessed via the glass microscope slide method (adapted from the method described 
by Harrison-Balestra et al in 2003). Each of the chronic equine wound P. aeruginosa 
isolates, the ATCC reference P. aeruginosa strain and the EF isolate were cultured in 
sterile Mueller Hinton broth (MHB) to stationary phase with shaking at 150rpm in a 
shaking incubator set at 37C; isolates were initially cultured on Tryptone Soy agar 
(TSA) and 50ml portions of MHB was inoculate with a single loop of a fresh 
overnight culture for each corresponding isolate. Stationary phase cultures were 
standardised to an optical density (OD) of 0.85600nm, an approximate McFarland 
standard of 6. From each of the standardised cultures a 200µl aliquot was used to 
inoculate 30ml sterile MHB in sterile culture pots to create a standardised initial OD 
(as described in Manuscript 2). To each culture a glass microscope slide (frosted 
microscope slide [25x75x1mm], Thermo Scientific, MA, USA) was placed 
vertically. For each isolate, 2 biofilm cultures were prepared. Protease assays were 
all performed in triplicate for each culture. Biofilms were grown over a 24 hour 
period in a shaking incubator set at 150rpm at a constant temperature of 37C. At the 
end of the culture period the microscope slides were removed using sterile 
disposable forceps and placed consecutively into 10ml aliquots of sterile phosphate 
buffered saline (PBS) and rinsed to remove any non-adherent bacteria. Test cultures 
were used to confirm the growth of biofilms on the microscope slides which were 
stained with 0.2% crystal violet for 2 minutes and visualised using light microscopy. 
Adherent bacterial cells were removed from the microscope slides via sonication; 
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microscope slides were placed into 10ml sterile MHB, ensuring full submersion of 
the microscope slide, and sonicated in a water bath sonicator (Ultrawave, [Q Series], 
Cardiff, Wales) at 100% power (highest sonication setting) for 20 minutes and cells 
were re-suspended with brief vortexing. The degree of sonication used is a standard 
protocol used in the laboratory and was previously standardised to ensure no effect 
on cell viability. Sonicated biofilm cells were then used for milk-casein agar analysis 
and colony-forming unit (CFU) counts. The spent media from each of the original 
cultures was sterile filtered and used for protease assays. Final optical densities 
(ODs) of the spent media of each of the original cultures were taken at 600nm.  
 
For the analysis of protease production during biofilm development in an acidic 
environment, the MHB growth media was altered to an initial pH of 5.5 using a pH 
meter and concentrated hydrochloric acid (HCl). Media was then autoclaved at 
121C and left to cool. Under sterile conditions, a sample of the sterile media was 
taken and the pH checked. All MHB stocks remained at the correct pH following 
autoclaving. Litmus paper and a pH meter were used to monitor the pH of the 
cultures throughout each phase of growth; no significant pH fluctuations were noted 
throughout the entire culture period.  
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3.3.5 Current Downflow Contactor (CDC) Biofilm Reactor Cultures 
 
For further in vitro assessment of protease productivity of P. aeruginosa isolates 
cultured under the biofilm mode of growth (mature biofilms), the current downflow 
contactor (CDC) reactor system was employed using a method adapted from 
Williams and Bloebaum (2010).  The CDC reactor vessel (BioSurface Technologies, 
Bozeman, MT, USA) consists of a 1 litre glass vessel, into which the inoculated 
broth is poured, and a polyethylene lid which supports 8 polypropylene coupon 
holders is fixed into place. The unit has a side arm discharge port which limited the 
culture volume to 350mls. Each coupon holder holds three coupons (coupons had a 
diameter of 12.7mm and a depth of 3mm), providing a total of 24 sampling 
opportunities. In this study, however, alternate coupon holders were loaded with 
three coupons thus providing a total of 12 sampling opportunities. A magnetic stir 
bar was placed in the centre of the vessel, providing constant stirring of the 
inoculated broth during the culture period (48 hours) once placed on a magnetic 
stirrer (Hanna Instruments [HI 190M], Bedfordshire, UK) which was set at 50% 
power (i.e. the speed setting was set at the half way point on the magnetic stirrer) 
(see figure 1).  
 
The vessel was filled with 300ml standard MHB. The entire CDC reactor, with the 
coupons in place, was autoclaved for 15 minutes at 121°C prior to the addition of the 
inoculate broth sample. The ATCC P. aeruginosa isolate, wound isolate 4 and 
wound isolate 6 were used for CDC bioreactor experiments. Wound isolates 4 and 6 
were chosen since they both had a high BFP score; wound isolate 4 was strongly 
adherent and wound isolate 6 was very strongly adherent. As was done for the glass 
microscope slide biofilm cultures, pure P. aeruginosa isolates were cultured in 
sterile Mueller Hinton broth (MHB) to stationary phase with shaking at 150rpm in a 
shaking incubator set at 37C; isolates were initially cultured on TSA and 50ml 
portions of MHB was inoculate with a single loop of a fresh overnight culture for 
each corresponding isolate. Stationary phase cultures were standardised to an OD of 
0.85600nm, an approximate McFarland standard of 6. From each of the standardised 
cultures a 2ml aliquot was used to inoculate 300ml sterile MHB in the CDC reactor 
to create the same standardised initial OD as for the glass slide cultures for each of 
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the P. aeruginosa isolates. The CDC reactor was placed on top of the magnetic 
stirrer in an incubator set a 37°C for 48 hours.  
 
Following the 48 hour incubation, sterile techniques were used to recover the 
coupons from the coupon holders using sterile forceps. The position of each of the 
coupons and coupon holders was noted. For each isolate, 2 top coupons, 2 middle 
coupons and 2 bottom coupons (position from the top to the bottom of the coupon 
holder; 2 coupon holders at opposite positions in the reactor were used) were taken 
for CFU counts and 2 top coupons, 2 middle coupons and 2 bottom coupons were 
taken for milk-casein agar plate analysis of general proteolytic activity of live 
recovered biofilm cells.  
 
Individual coupons were placed consecutively into 10ml aliquots of sterile PBS and 
rinsed to remove any non-adherent bacteria. Adherent bacterial cells were removed 
from the coupons via sonication; coupons were placed into 10ml sterile PBS, 
ensuring full submersion of the coupon, and sonicated in a water bath sonicator at 
100% power for 20 minutes. Cells were re-suspended with brief vortexing. Sonicated 
biofilm cells were then used for milk-casein agar analysis and CFU counts. 
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Coupon 
Magnetic stir bar 
Polypropylene 
coupon holder 
Side arm 
discharge port 
1 litre glass vessel 
Polyethylene 
ported lid 
Figure 1: Photograph of the current downflow contactor (CDC) reactor system (BioSurface 
Technologies, Bozeman, MT, USA). Biofilms were grown on coupons over a 48 hour period, 
whilst subjected to shear forces produced by the rotating magnetic stir bar swirling the media 
around the glass vessel. 
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3.3.6 Milk-Casein Agar Analysis 
 
Milk-casein agar was prepared with 25g skim milk powder (BD, Oxford, UK) 2.5g 
casein (BDH, VWR, Lutterworth, UK), 1.25g yeast extract (Oxoid, Basingstoke, 
UK), 0.5g D-glucose (BDH, Oxford, UK) and 6.25g No. 1 agar (LabM Bury, UK) 
(as described in Manuscript 2). A sterile 8mm punch biopsy was used to bore single 
wells in each of the milk plates. 100µl aliquots of the re-suspended biofilm cells 
were applied to the 8mm wells made in the milk plates in triplicate to determine the 
residual general protease activity of the biofilm cells of each P. aeruginosa isolate. 
Plates were incubated over a 48 hour period and measurements were made of the 
caseinolytic zone after 24 and 48 hours; two measurements were made in mm at 
right angles to each other and an average measurement made, minus the 8mm well.  
 
3.3.7 Azocasein Assay for General Protease Activity 
 
To measure the general protease activity of the spent media of each biofilm culture 
(at each initial pH), a chromogenic assay utilising azocasein, a non-specific protease 
substrate conjugated to an azo-dye, was performed (as described in Manuscript 2). 
Sterile MHB was used for the controls. All samples were made in triplicate. Media 
samples were briefly vortexed after addition of the azocasein solution and incubated 
overnight at 37C. After the incubation period, 600µl of 5% Trichloric acid (TCA) 
was added to each sample to precipitate non-hydrolised azocasein and left on ice for 
30 minutes. The samples were then centrifuged at 11,000xg for 10 minutes at 4C to 
pellet the undigested substrate. From each sample, 200µl of supernatant was added 
to a 96-well plate and the absorbance measured in a microtitre plate reader at 405nm.  
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3.3.8 Elastin-Congo Red Assay for Elastase Activity 
 
To assess the level of elastase produced by each biofilm culture (at each initial pH), 
the elastin-congo red (ECR) method was employed, adapted from the studies by 
Petermann, Doetkott & Rust (2001) and Rust, Messing & Iglewski (1994) and as 
described in Manuscript 2. Sterile MHB was used for the controls. Media samples 
were made in triplicate and vortexed briefly following addition of the ECR solution. 
The samples were incubated for 24 hours at 37C after which the samples were 
centrifuged at 1200rpm for 10 minutes at 4C to pellet any undigested ECR. From 
each sample, 200µl of supernatant was added to a 96-well plate and the absorbance 
measured in a microtitre plate reader at 495nm.  
 
3.3.9 Gelatin Zymography 
 
Gelatin zymography was used to confirm the presence/absence of enzyme activity in 
the spent media of the biofilm cultures at each initial pH. Briefly, sterile filtered 
spent media samples obtained from each of the developing biofilm cultures were 
diluted with non-reducing Laemmli sample buffer (Bio-Rad, Hemel Hempstead, 
UK) at a ratio of 1:5 and distilled water to an overall 1:5 dilution of the sample. 
Samples were then incubated in a 37C water bath for 1 hour to activate the enzyme 
prior to application to the gel. A Miniprotean II gel system (Bio-RadHemel 
Hempstead, UK) was employed for zymography gels and gels were cast, run and 
stained according to the protocol outlined in Manuscript 2. 20µl aliquots of each 
sample were loaded into the gel. MMP-2 standards were run on each gel. Gels were 
visualised and imaged using Genesnap software. 
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3.3.10 SDS-PAGE Analysis of Conditioned P. aeruginosa Media 
 
SDS-PAGE analysis was used to identify protein bands corresponding to P. 
aeruginosa proteases present in the spent media of the developing biofilm cultures. 
A 4-12% Bis-Tris gel was used (Novex, Life Technologies, Paisley, UK). Samples 
were prepared by adding 13µl original sample, 2µl DTT and 5µl non-reducing 
sample buffer with marker dye (Thermo Scientific, MA, USA). Samples were 
denatured by heating for 10 minutes in a heat block pre-set to 80C. The samples 
were vortexed briefly. A 20µl aliquot of each sample was added to each 
corresponding lane of the gel. The gel tank was filled with a 1:20 dilution of 
NUPAGE MES SDS running buffer (Invitrogen, Paisley, UK) in distilled water. The 
gel was run at 15 volts for approximately 2 hours or until the lane marker ran to the 
bottom of the gel. The gels were carefully removed and stained using a Pierce
®
 
Silver Stain Kit (Thermo Scientific, MA, USA), as described in Manuscript 2. 
 
3.3.11 Histology 
 
Tissue sections taken from debrided equine wound granulation tissue were stained 
with both haematoxylin and eosin (H&E) and Gram stain in order to visualise any 
bacterial clusters within the tissues (see figure 30). Staining was performed by the 
team at the University of Liverpool Veterinary Pathology department. 
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3.3.12 Statistical Analyses 
 
Statistical analyses were performed on the data for the biochemical assays (azocasein 
and elastin-congo red) for the 24 hour broth culture time points for general protease 
or elastase activity and the milk-casein agar plate data for the 24 hour initial broth 
culture (24 and 48 hour plate cultures); statistical differences in general protease and 
elastase activity between P. aeruginosa isolates were identified using a one-way 
analysis of variance (ANOVA) or a non-parametric test for data which was not 
normally distributed (Kruskal-Wallis test). The same analyses were performed for 
the data relating to bacterial growth (OD600nm). For analysis of the effect of initial 
culture pH on general protease and elastase activity a general linear model was used. 
Statistical significance was defined as a P value of ≤0.005. In all instances, Post Hoc 
analyses were applied with the Tukey test. All statistical analyses were performed 
using Minitab
®
, Version 16. 
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3.4 Results 
 
Each of the P. aeruginosa isolates were cultured on TSA plates and the mucoid appearance was observed. As shown in figure 2, all but one 
isolate (wound isolate 1, which showed slight mucoid appearance) demonstrated a distinct mucoid phenotype characterised by a smooth and 
slimy appearance.
a b c d
e f g h
Figure 2: Tryptone soy agar (TSA) cultures of the ATCC reference P. aeruginosa isolate and the 7 wound P. 
aeruginosa isolates showing evidence of the mucoid phenotype; all isolates exhibited some degree of the mucoid 
phenotype, having a smooth and slimy appearance. a: ATCC isolate; b: Wound isolate 1; c: Wound isolate 2; d: 
Wound isolate 3; e: Wound isolate 4; f: Wound isolate 5; g: Wound isolate 6; h: Wound isolate 7. All but wound 
isolate 1 demonstrated a distinct mucoid phenotype; wound isolate 1 demonstrated a limited mucoid appearance. 
Wound isolate 1 appeared less slimy, with a more dry appearance. 
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3.4.1 Biofilm forming phenotype (BFP) 
 
As demonstrated in Manuscript 2, the results of the crystal violet assay for biofilm 
forming phenotype of the wound and non-wound isolates revealed a significant 
variation between isolates, F (8, 71) = 162.06 (P = <0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Isolate OD570nm BFP Interpretation 
ATCC Isolate >0.816 Very Strongly Adherent 
Wound Isolate 1 0-0.136 Non-Adherent 
Wound Isolate 2 >0.816 Very Strongly Adherent 
Wound Isolate 3 >0.816 Very Strongly Adherent 
Wound Isolate 4 0.544-0.816 Strongly Adherent 
Wound Isolate 5 >0.816 Very Strongly Adherent 
Wound Isolate 6 >0.816 Very Strongly Adherent 
Wound Isolate 7 0.544-0.816 Strongly Adherent 
EF Isolate 0-0.136 Non-Adherent 
Table 1: Classifications of BFP according to the crystal violet assay. 
 * Enterococcus faecium= EF isolate 
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3.4.2 Azocasein Assays for General Protease Activity 
 
The azocasein substrate assay for non-specific protease activity was used to 
determine the variability in general protease activity among P. aeruginosa wound 
isolates and an ATCC reference P. aeruginosa isolate. In addition, the effect of a 
change in the initial pH of the growth media from pH7.3 to pH5.5 was assessed 
following a 24 hour broth culture. The azocasein assay used detects a range of 
enzymes, including P. aeruginosa elastase and alkaline proteinase. The EF isolate 
was excluded from statistical analysis.  
 
Results have demonstrated that there is a significant variation in the general 
proteolytic profiles between the isolates when cultured as biofilms at an initial pH of 
5.5. Given the complex relationships, statistical significance is detailed in tables 2 
and 3. The general caseinolytic activity did vary between isolates when grown at an 
initial pH of 7.3, however this difference did not reach statistical significance (see 
tables 2 and 3). However, this could have been due to missing data and thus small 
sample sizes. The general trends remained similar between isolates when cultured at 
both initial pHs (see figures 3-7). The ATCC reference isolate and wound isolate 1 
were the least proteolytically active isolates when cultured in MHB with an initial 
pH of either 7.3 or 5.5. Appendix 1 details the grouping information which shows 
the general caseinolytic activity of each individual isolate at each initial pH. 
 
Further analysis revealed that the general proteolytic activity of isolates at the 24 
hour time point did not significantly vary when the culture media was changed from 
an initial pH of 7.3 to an initial pH of 5.5, F(1, 25) = 0.15, P = 0.703. 
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Figure 3: Azocasein assay for caseinolytic digest 
analysis of each isolate following a 24 hour culture 
period. Isolates were cultured in standard MHB (initial 
pH7.3). Data is presented as mean ± SEM. Statistical 
significance is detailed in Tables 2 and 3. 
*Enterococcus faecium= EF isolate 
Figure 4: Azocasein assay for caseinolytic digest analysis 
of each isolate following a 24 hour culture period. Isolates 
were cultured in MHB adjusted to an initial pH of 5.5. 
Note: missing data for wound isolate 4, 5 and 7(n=1 for 
these isolates). Data is presented as mean ± SEM. 
Statistical significance is detailed in Tables 2 and 3. 
*Enterococcus faecium= EF isolate 
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Figure 5: Interval plot for general proteolytic activity of 
each isolate following a 24 hour broth culture (standard 
initial pH7.3). For all statistical analyses and interval plots 
the ATCC isolate was named isolate 1; wound isolates 1-7 
were named isolates 2-8; the Enterococcus faecium (EF) 
isolate was excluded from statistical analyses and interval 
plots. 
Figure 6: Interval plot for general proteolytic activity of 
each isolate following a 24 hour broth culture (initial 
pH5.5). For all statistical analyses and interval plots the 
ATCC isolate was named isolate 1; wound isolates 1-7 
were named isolates 2-8; the Enterococcus faecium (EF) 
isolate was excluded from statistical analyses and interval 
plots. 
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Figure 7: Interval plot for general proteolytic activity of the P. aeruginosa isolates at each 
initial broth culture pH following a 24 hour culture. For all statistical analyses the ATCC 
reference isolate was named isolate 1; wound isolates 1-7 were numbered isolates 2-8; the E. 
faecium (EF) isolate was excluded from statistical analysis. pH1=Standard pH (initial pH7.3); 
pH2=initial pH5.5. 
pH
Isolate
21
8765432187654321
0.3
0.2
0.1
0.0
-0.1
-0.2
O
D
4
0
5
n
m
95% CI for the Mean
Interval Plot of T24 Standard pH, pH5.5
  
1
4
1 
Table 2: P. aeruginosa isolates (ATCC isolate + 7 wound isolates): Differences in general protease activity between isolates, at each 
initial pH. 
 
Culture 
Time 
(Hours) 
Initial Culture 
pH 
Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(7, 14) = 9.66, P = 0.004* Wound isolates 2 & 7 are not 
significantly different from each 
other but are significantly different 
from the ATCC isolate and wound 
isolate 1. All other isolates are not 
significantly different from each 
other. 
P = 0.134 
24 5.5 F(7, 24) = 13.73, P = 
<0.001* 
ATCC isolate, wound isolate 1 and 
wound isolate 3 are not significantly 
different from each other but are 
from the rest of the isolates; the 
remaining wound isolates are not 
significantly different from each 
other. 
 
 
* Significant at the 0.05 level 
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Table 3: P. aeruginosa isolates (7 wound isolates): Differences in general protease activity between isolates, at each initial pH.  
 
Culture Time 
(Hours) 
Initial Culture pH Statistical Analysis Kruskal-Wallis test 
24 Standard Broth (7.3) F(6, 11) = 8.01, P = 
0.019* 
P = 0.220 
24 5.5 F(6, 20) = 11.69, P = 
<0.001* 
 
 
* Significant at the 0.05 level 
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3.4.3 Elastin-Congo Red Assay for Elastase Activity 
 
The elastolytic activities of each of the P. aeruginosa wound isolates were 
determined using the elastin-congo red assay as described above to identify LasB-
deficient and active strains. As described in Manuscript 2, both P. aeruginosa 
elastase A and elastase B degrade elastin although elastase B (an important virulence 
factor in wounds and burns) has been shown to degrade elastin to a greater extent 
(Caballero et al, 2001). The EF isolate was shown to have some elastolytic activity; 
this is likely a result of the activity of the extracellular zinc metalloproteinase (GelE) 
which shares homologies with GelE of Bacillus species and P. aeruginosa elastase 
and has been shown to be an active virulence factor of human and animal EF isolates 
(although to a lesser degree than Enterococcus faecalis) (Gulhan et al, 2006; Su et 
al, 1991). The EF isolate however, was excluded from statistical analysis. 
 
Results have shown that there is a small variation between isolates in terms of 
elastase activity (see figures 8-12), which was maintained at each initial culture pH 
after a 24 hour culture period. This difference did not reach statistical significance. 
However, the overall elastolytic activity observed in this assay was minimal for all 
isolates. Given the complex relationships, statistical significance is detailed in tables 
4 and 5. In concordance with the azocasein assays, the ATCC reference isolate 
displayed less elastolytic activity when cultured in standard pH MHB (pH7.3) 
compared with the wound isolates. 
 
Further analysis revealed that there was not a significant effect of pH on the 
elastolytic activity of the isolates and the 24 hour time point, F(1, 39) = 2.24, P = 
0.144. Appendix 2 details the grouping information which shows the elastolytic 
activity of each individual isolate at each initial pH. 
 
 
 
  
1
4
4 
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
O
D
4
9
5
n
m
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
O
D
4
9
5
n
m
Figure 8: Elastin-Congor red (ECR) assay for 
elastolytic activity of each isolate following a 24 
hour culture period. Isolates were cultured in 
standard MHB (initial pH7.3). Data is presented as 
mean ± SEM. Statistical significance is detailed in 
tables 4 and 5. 
 
*Enterococcus faecium= EF isolate 
 
Figure 9: Elastin-Congo red (ECR) assay for 
elastolytic activity of each isolate following a 24 
hour culture period. Isolates were cultured in MHB 
adjusted to an initial pH of 5.5. Data is presented as 
mean ± SEM. Statistical significance is detailed in 
tables 4 and 5. 
*Enterococcus faecium= EF isolate 
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Figure 10: Interval plot for elastolytic activity of each 
isolate following a 24 hour broth culture (standard initial 
pH7.3). For all statistical analyses and interval plots the 
ATCC isolate was named isolate 1; wound isolates 1-7 
were named isolates 2-8; the E. faecium (EF) isolate was 
excluded from statistical analyses and interval plots. 
Figure 11: Interval plot for elastolytic activity of each 
isolate following a 24 hour broth culture (standard initial 
pH5.5). For all statistical analyses and interval plots the 
ATCC isolate was named isolate 1; wound isolates 1-7 
were named isolates 2-8; the E. faecium (EF) isolate was 
excluded from statistical analyses and interval plots. 
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Figure 12: Interval plot for elastolytic activity of the P. aeruginosa isolates at each initial broth 
culture pH following a 24 hour culture. For all statistical analyses the ATCC reference isolate was 
named isolate 1; wound isolates 1-7 were numbered isolates 2-8; the E. faecium (EF) isolate was 
excluded from statistical analysis. 
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Table 4: P. aeruginosa isolates (ATCC isolate + 7 wound isolates): Differences in elastase activity between isolates, at each initial pH. 
 
 
Culture 
Time 
(Hours) 
Initial Culture 
pH 
Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(7, 14) = 0.93, P = 0.536 None of the isolates are significantly 
different from each other. 
 
24 5.5 F(7, 24) = 2.78, P = 0.040* Wound isolate 2 is significantly 
different from wound isolates 4, 6 & 
7.  
P = 0.214 
 
* Significant at the 0.05 level 
 
 
Table 5: P. aeruginosa isolates (7 wound isolates): Differences in elastase activity between isolates, at each initial pH.  
 
 
Culture Time 
(Hours) 
Initial Culture pH Statistical Analysis Kruskal-Wallis test 
24 Standard Broth (7.3) F(6, 11) = 0.79, P = 
0.612 
 
24 5.5 F(6, 20) = 3.14, P = 
0.037* 
P = 0.184 
 
* Significant at the 0.05 level 
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3.4.4 Milk-Casein Agar Plate Analysis 
 
The milk-casein agar plate method was employed to compare the caseinolytic 
profiles of each of the P. aeruginosa isolates (both the ATCC reference strain and 
the wound isolates). The general protease activity of the isolates following sub-
culturing of the sonicated cells onto milk-casein agar plates was investigated. As 
described above, sonicated biofilm cells were re-suspended in fresh MHB (standard 
pH) and inoculated onto the milk-casein agar plates and incubated for 24 hours. 
Proteolytic activity was measured by the clearance zone, indicating hydrolysis of 
casein, indicative of overall extracellular protease activity (as highlighted in 
Manuscript 2). Caseinolytic activity is caused mainly by elastase B (LasB), alkaline 
protease and protease IV (Caballero et al, 2001; Sonawane, Jyot & Ramphal, 2006). 
Whilst the clearance zones were minimal, each isolate displayed some caseinolytic 
activity at each initial pH (see figure 13).  
 
The results of the milk-casein agar plate analysis have shown that following sub-
culturing of the biofilm cells the isolates retained their caseinolytic activity, with 
similar trends seen between isolates as the azocasein and ECR assays; differences 
between isolates in terms of caseinolytic activity were noted, however these 
differences did not reach statistical significance (see tables 6 & 7). The ATCC isolate 
and wound isolate 1 were the least proteolytically active compared to each of the 
other isolates (except the EF isolate) (see figures 14-16). There was a general trend 
of increasing caseinolytic activity from 24 to 48 hours demonstrating that each of the 
isolates maintained their caseinolytic activity after an extended culture period. 
 
Further statistical analysis using a general linear model revealed that pH did not have 
a significant effect on the caseinolytic activity of isolates at T24, F(1, 39) = 0.44, P = 
0.513 or at T48, (F1, 39) = 1.55, P = 0.223.
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Figure 13: Milk-casein agar plates showing caseinolytic digestion of the sonicated/re-suspended 24 hour biofilm cells (initial pH5.5); 
a: ATCC isolate; b: Wound isolate 1; c: Wound isolate 2; d: Wound isolate 3; e: Wound isolate 4; f: Wound isolate 5; g: Wound 
isolate 6; h: Wound isolate 7; i: E. faecium (EF) isolate. Each milk-casein agar plate was cultured for 48hours. 
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Figure 14: Milk-Casein agar plate assays for caseinolytic 
activity of each isolate following an initial 24 hour broth 
culture prior to a further 24 or 48 hour milk plate culture. 
Standard MHB (initial pH7.3) was used for broth cultures. 
Data is presented as mean ± SEM. Statistical significance is 
detailed in tables 6 and 7. 
*E. faecium= EF isolate 
 
Figure 15: Milk-Casein agar plate assays for caseinolytic 
activity of each isolate following an initial 24 hour broth 
culture prior to a further 24 or 48 hour milk plate culture.) 
Initial pH5.5 MHB was used for broth cultures. Data is 
presented as mean ± SEM. Statistical significance is detailed in 
tables 6 and 7. 
*E. faecium= EF isolate 
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Figure 16: Interval plots for caseinolytic activity of the P. aeruginosa isolates following an initial 24 hour broth culture prior to a 24 or 48 
hour milk plate culture (standard pH and pH5.5). For all statistical analyses the ATCC reference isolate was named isolate 1; wound isolates 
1-7 were numbered isolates 2-8; the E. faecium (EF) isolate was excluded from statistical analysis. 
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Table 6: P. aeruginosa isolates (ATCC isolate + 7 wound isolates): Differences in caseinolytic activity between isolates. 
 
 
* Significant at the 0.05 level 
 
 
pH Biofilm Broth 
Culture Time 
(Hours) 
Milk-Casein Agar 
Plate Culture Time 
(Hours) 
Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
Standard pH 
(pH7.3) 
24 24 F(7, 14) = 0.60, P = 
0.743 
None of the isolates are 
significantly different from each 
other. 
 
Standard pH 
(pH7.3) 
24 48 F(7, 14) = 0.51, P = 
0.803 
None of the isolates are 
significantly different from each 
other. 
P = 0.496 
pH5.5 24 24 F(7, 24) = 0.51, P = 
0.814 
None of the isolates are 
significantly different from each 
other. 
P = 0.329 
pH5.5 24 48 F(7, 24) = 2.87, P = 
0.036* 
Wound isolates 1 & 4 are 
significantly different from each 
other.  
P = 0.095 
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Table 7: P. aeruginosa isolates (7 wound isolates): Differences in caseinolytic activity between isolates. 
 
 
pH Biofilm 
Broth 
Culture 
Time 
(Hours) 
Milk-Casein 
Agar Plate 
Culture Time 
(Hours) 
Statistical Analysis Kruskal-Wallis test 
Standard 
pH (pH7.3) 
24 24 F(6, 11) = 0.55, P = 
0.758 
P = 0.684 
Standard 
pH (pH7.3) 
24 48 F(6, 11) = 0.44, P = 
0.826 
P = 0.356 
pH5.5 24 24 F(6, 20) = 0.28, P = 
0.935 
 
pH5.5 24 48 F(6, 20) = 3.0, P = 
0.042* 
P = 0.113 
 
* Significant at the 0.05 level 
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3.4.5 Growth of Planktonic Bacteria (effluent) 
 
 
Results have revealed that when the P. aeruginosa isolates were cultured at an initial 
pH of 7.3 there was no significant difference between the growths of the planktonic 
bacteria of each isolate within the effluent of the biofilm cultures (see figures 16-18). 
This also applied when the initial pH of the cultures was reduced to 5.5 (see table 8). 
Further analysis has shown that there is no statistically significant effect of pH on the 
growth of the planktonic bacteria within the effluent of the biofilm cultures, F(1, 32) 
= 1.96, p = 0.173. Furthermore, those isolates demonstrating a slightly higher 
OD600nm within the effluent (whilst not statistically significant) did not always 
produce the greatest amount of proteolytic activity and so any variation in proteolytic 
activity was not likely a consequence of variations in growth of the planktonic 
bacteria (i.e. the growth of non-biofilm forming bacterial cells). Additionally, any 
variations observed between isolates in terms of proteolytic activity were not likely a 
result of increased or decreased growth of the planktonic bacteria. 
  
1
5
5
 
 
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
O
D
6
0
0
n
m
0
0.2
0.4
0.6
0.8
1
1.2
O
D
6
0
0
n
m
Figure 16: Optical density (OD600nm) of planktonic bacteria in 
the effluent; samples from each biofilm culture were taken 
from the effluent to determine the growth of the non-adherent 
bacteria at an initial culture pH of 7.3. Data is presented as 
mean ± SEM. Statistical significance is detailed in table 8. 
*E. faecium= EF isolate 
 
Figure 17: Optical density (OD600nm) of planktonic bacteria in 
the effluent; samples from each biofilm culture were taken 
from the effluent to determine the growth of the non-adherent 
bacteria at an initial culture pH of 5.5. Data is presented as 
mean ± SEM. Statistical significance is detailed in table 8. 
*E. faecium= EF isolate 
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Figure 18: Interval plot of the growth trends of planktonic 
bacteria in the effluent for each isolate cultured at each initial pH. 
The E. faecium (EF) isolate was excluded from statistical analysis. 
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Table 8: P. aeruginosa isolates (7 wound isolates): Differences in growth of planktonic bacteria in the culture effluent at each initial 
culture pH. 
 
 
* Significant at the 0.05 level 
Culture 
Time 
(Hours) 
Initial Culture 
pH 
Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(6, 11) = 1.29, P = 0.399 No significant difference between 
any of the isolates 
P = 0.233 
24 5.5 F(6, 20) = 0.72, P = 0.641 No significant difference between 
any of the isolates 
P = 0.533 
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3.4.6 Growth of Biofilm Cells 
 
 
The CFU counts were in concordance with the crystal violet BFP assays, apart from 
wound isolate 1. This isolate was found to be non-adherent in the BFP assay but did 
produce biofilms in the glass microscope slide biofilm cultures. One explanation for 
this variation could be the growth surface used; the BFP assay was conducted using 
polystyrene cell culture plates. 
 
In concordance with the data for the OD600nm of the planktonic cells in the biofilm 
culture effluent, there were no significant differences between the CFU counts of the 
adherent biofilm cells of the 7 wound isolates when cultured in MHB with an initial 
pH value of 7.3 (see figures 19-21 and table 9). The difference, however, between 
isolates was significant for the initial pH5.5 cultures (see table 9). Those isolates 
demonstrating a slightly higher biofilm CFU count (whilst not always statistically 
significant) did not always produce the greatest amount of proteolytic activity and so 
any variation in proteolytic activity was not likely a consequence of variations in 
bacterial proliferation within the biofilm. Additionally, any variations observed 
between isolates in terms of proteolytic activity were unlikely a result of increased or 
decreased biofilm growth. Further analysis has identified no significant variation in 
the CFU counts of the sonicated biofilm cells as a result of initial culture pH, F(1, 
38) = 2.44, P = 0.128. 
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Figure 19: CFU counts of sonicated biofilm cells; samples 
from each biofilm culture were taken and CFU counted to 
determine the growth of the adherent bacteria at an initial 
culture pH of 7.3. Data is presented as mean ± SEM. Statistical 
significance is detailed in table 9. 
*E. faecium= EF isolate 
 
Figure 20: CFU counts of sonicated biofilm cells; samples 
from each biofilm culture were taken and CFU counted to 
determine the growth of the adherent bacteria at an initial 
culture pH of 5.5. Data is presented as mean ± SEM. Statistical 
significance is detailed in table 9. 
*E. faecium= EF isolate 
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Figure 21: Interval plot of the growth trends of adherent bacteria in the biofilm 
culture for each isolate cultured at each initial pH. CFU counts are x10
5
. 
pH1=Standard pH (pH7.3); pH2= pH5.5. E. faecium (EF) isolate was excluded 
from statistical analysis. 
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Table 9: P. aeruginosa isolates (7 wound isolates): Differences in growth of adherent bacteria in the culture effluent at each initial 
culture pH. 
 
 
Culture 
Time 
(Hours) 
Initial Culture 
pH 
Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
24 Standard Broth 
(7.3) 
F(7, 14) = 0.95, P = 0.528 No significant difference between 
isolates. 
P = 0.446 
24 5.5 F(7, 23) = 5.48, P = 0.002* ATCC isolate and wound isolate 1 
are significantly different from 
wound isolates 5 & 7. 
P = 0.005* 
 
* Significant at the 0.05 level 
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3.4.7 CDC Biofilm Reactor Cultures 
 
The CDC biofilm reactor system was used to compare the protease productivity of 
recovered biofilm-forming bacteria from mature 48 hour biofilms of two P. 
aeruginosa equine wound isolates and an ATCC P. aeruginosa isolate.  
 
CFU counts of the sonicated biofilm cells revealed that the ATCC isolate had the 
highest CFU count compared with the wound isolates, which was consistent with the 
BFP assay conducted in Manuscript 2 (there was only a significant difference 
between the CFUs of the ATCC isolate and wound isolate 6: F(2, 8) = 27.26, P = 
0.001). However, CFU counts from sonicated biofilm cells of wound isolate 6 were 
lower compared with wound isolate 4, F(2, 8) = 27.26, P = 0.001, which did not 
correlate with the BFP assay. Yet, results were inconclusive given the large error 
margins for CFU counts of the sonicated coupon biofilms (as a result of their only 
being one culture replicate for each isolate). There were no clear trends in the CFU 
counts from coupons taken from the top, middle or bottom of the coupon holder (see 
figure 21 and table 10). CFU counts are given in figures 22 and 23.  
 
Table 10: Comparison of CFU counts in terms of coupon location from CDC reactor 
experiments. 
 
Isolate Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
ATCC 
isolate 
F(2, 17) = 2.75, P = 
0.096 
No significant difference 
between coupons. 
 
Wound 
isolate 4 
F(2, 17) = 5.25, P = 
0.019* 
Significant difference 
between top and bottom 
coupons. 
P = 0.019* 
Wound 
isolate 6 
F(2, 17) = 1.82, P = 
0.197 
No significant difference 
between coupons. 
P = 0.300 
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Figure 22: Colony forming unit (CFU) counts for sonicated biofilm cells from coupons 
taken from the top, middle and bottom of the coupon holders in the current downflow 
contactor (CDC) bioreactor for each P. aeruginosa isolate. Data is presented as mean ± 
SEM. Statistical significance is detailed in table 10. 
* Significantly different from one another at the 0.05 level 
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Figure 23: Combined colony forming unit (CFU) counts for sonicated biofilm cells from 
coupons taken from the top, middle and bottom of the coupon holders in the current 
downflow contactor (CDC) bioreactor for each P. aeruginosa isolate. Data is presented as 
mean ± SEM. Statistical significance is detailed in table 10. 
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Results from the milk-casein agar plate analysis (24 hour milk-casein agar plate 
incubation) revealed that there was a significant difference between the general 
proteolytic activity of re-suspended biofilm-forming cells following sonication from 
the mature 48 hour coupon biofilms: F(2, 8) = 22.49, P = 0.002, with the significance 
being between the ATCC isolate and the wound isolates (no significant difference 
between wound isolates 4 and 6) (see table 11 and figures 24 and 25). Indeed, wound 
isolates 4 and 6 were the most proteolytically active of the 3 isolates when compared 
in terms of biomass. This correlates well with the planktonic data from Manuscript 2 
and generally with the glass slide biofilm data in that the ATCC isolate was less 
proteolytic than most of the wound isolates. The location of the coupons (i.e. top, 
middle or bottom) in the coupon holder did not have a significant effect on the 
proteolytic activity of the re-suspended biofilm-forming bacterial cells (see table 11). 
 
Table 11: Comparisons between general protease activity (milk-casein agar plate 
analysis) of sonicated biofilm cells in terms of coupon location. 
 
Isolate Statistical Analysis Post-Hoc Observations  
(using the Tukey method) 
Kruskal-Wallis test 
ATCC 
isolate 
F(2, 17) = 1.44, P = 
0.269 
No significant difference 
between coupons. 
P = 0.420 
Wound 
isolate 4 
F(2, 17) = 0.58, P = 
0.571 
No significant difference 
between coupons. 
P = 0.493 
Wound 
isolate 6 
F(2, 16) = 0.69, P = 
0.516 
No significant difference 
between coupons. 
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Figure 24: General protease activity of the 3 P. aeruginosa isolates following 24 hour 
incubation on milk-casein agar plates. Sonicated biofilm-forming cells from the 48 hour 
coupon biofilms (top, middle and bottom coupons) were re-suspended and plated on to 
milk-casein agar plates. Data is presented as mean ± SEM. Statistical significance is 
detailed in table 11. 
 
Figure 25: Combined general protease activity of the 3 P. aeruginosa isolates following 24 
hour incubation on milk-casein agar plates. Sonicated biofilm-forming cells from the 48 
hour coupon biofilms were re-suspended and plated on to milk-casein agar plates. Data is 
presented as mean ± SEM. Statistical significance is detailed in table 11. 
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3.4.8 Gelatin Zymography and SDS-PAGE 
 
Gelatin zymography was conducted to confirm the results obtained from the 
biochemical assays and the milk-casein agar plates. As shown in figure 26, at an 
initial pH of 7.3 in glass microscope slide biofilm cultures, wound isolates 2, 4, 5, 6 
and 7 produced proteolytic bands on the zymograms. The ATTC isolate, wound 
isolate 1 and wound isolate 3 did not produce any bands on the zymograms 
indicating a lack of proteolytic activity within the biofilm culture effluent. These 
results correlate well with the data obtained from both the azocasein and the elastin 
congo-red assays. All proteolytic bands present on the gelatin zymograms were at 
around the 50kDa mark, indicative of alkaline proteinase; whilst the ECR assay 
detected elastolytic activity of the biofilm culture effluents the level of activity may 
not have been high enough for detection on the zymogram gels. Trends in the 
proteolytic bands were the same for initial pH5.5 cultures (see figure 27). However, 
wound isolate 6 produced an additional proteolytic band, with a high molecular 
weight. Whilst further analysis would be needed to identify this enzyme, it may be 
representative of elastase A or elastase B (Caballero et al, 2001; Andrejko et al, 
2012). Alternatively it could indicate a contaminant enzyme given the smear also 
seen for this isolate on gel 1 (figure 26). Results from the SDS-PAGE (figures 28 
and 29) showed large variations in both the molecular weights of proteins present in 
the culture effluent and the intensity of the protein bands. There were also large 
variations in the protein bands present on the gels between the pH7.3 and pH5.5 
biofilm culture samples. Further investigation would be needed to identify these 
variations in the proteins within the culture effluent. 
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Figure 26: Gelatin zymography of glass microscope slide biofilm culture effluents 
following a 24 hour culture period at an initial pH of 7.3: Lane 1: MMP-2 marker 
(the lower molecular weight band indicates active MMP-2; the higher molecular 
weight band is indicative of latent MMP-2 [approximately 72kDa]); Lane 2: ATCC 
isolate; Lane 3: Wound isolate 1; Lane 4: Wound isolate 2; Lane 5: Wound isolate 3; 
Lane 6: Wound isolate 5; Lane 7: Wound isolate 4; Lane 8: Wound isolate 6. All 
effluent samples were loaded onto the gel at a final dilution of 1:20 (15µl per well). 
Wound isolates 2, 4, 5, 6 and 7 produced proteolytic bands on the zymograms. All 
proteolytic bands present on the gelatin zymogram were at around the 50kDa mark. 
The ATTC isolate, wound isolate 1 and wound isolate 3 did not produce any bands. 
64kDa 
~50kDa 
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Figure 27: Gelatin zymography of glass microscope slide biofilm culture effluents following 
a 24 hour culture period at an initial pH of 5.5 (Lane 2: Wound isolate 7 from initial pH7.3 
cultures): Lane 1: MMP-2 marker (the lower molecular weight band indicates active MMP-2; 
the higher molecular weight band is indicative of latent MMP-2 [approximately 72kDa]); 
Lane 2: Wound isolate 7 from initial pH7.3 cultures; Lane 3: ATCC isolate; Lane 4: Wound 
isolate 1; Lane 5: Wound isolate 2; Lane 6: Wound isolate 3; Lane 7: Wound isolate 5; Lane 
8: Wound isolate 4; Lane 9: Wound isolate 6 (dashed red arrow indicates an unknown high 
molecular weight proteolytic band not identified in the other samples); Lane 10: Wound 
isolate 7. All effluent samples were loaded onto the gel at a final dilution of 1:20 (15µl per 
well). Wound isolates 2, 4, 5, 6 and 7 produced proteolytic bands on the zymograms. All 
proteolytic bands present on the gelatin zymogram were at around the 50kDa mark. The 
ATTC isolate, wound isolate 1 and wound isolate 3 did not produce any bands. Wound isolate 
6 produced an additional proteolytic band, with a high molecular weight. 
 
Extra unknown high 
molecular weight band 
64kDa 
~50kDa 
  1          2           3          4           5            6          7          8            9          10  
 169 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1          2            3           4            5            6            7            8            9          10  
Tear 
in gel 
Figure 28: SDS-PAGE of glass microscope slide biofilm culture effluents 
following a 24 hour culture period at an initial pH of 7.3. Each well was loaded 
with 20µlculture supernatant (1:5 dilution). Lane 1: Molecular weight standards; 
Lane 2: ATCC isolate; Lane3: Wound isolate 1; Lane 4: Wound isolate 2; Lane 5: 
Wound isolate 3; Lane 6: Wound isolate 5; Lane 7: Wound isolate 4; Lane 8: 
Wound isolate 6; Lane 9: Wound isolate 7. There were large variations in both the 
molecular weights of proteins present in the culture effluent and the intensity of the 
protein bands. 
 170 
 
Figure 29: SDS-PAGE of glass microscope slide biofilm culture effluents 
following a 24 hour culture period at an initial pH of 5.5. Each well was loaded 
with 20µlculture supernatant (1:5 dilution). Lane 1: Moleular weight standards; 
Lane 2: ATCC isolate; Lane3: Wound isolate 1; Lane 4: Wound isolate 2; Lane 5: 
Wound isolate 3; Lane 6: Wound isolate 5; Lane 7: Wound isolate 4; Lane 8: 
Wound isolate 6; Lane 9: Wound isolate 7. There were large variations in both the 
molecular weights of proteins present in the culture effluent and the intensity of the 
protein bands. 
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3.4.9 Histology
Figure 30: Histological evidence of bacterial clusters 
within equine wound tissue. a: Gram stain showing a 
round cluster of Gram positive cocci (see arrow) 
towards the edge of the tissue section; b: Gram stain 
showing a large cluster of predominantly Gram 
positive cocci at the edges of the tissue section. 
Smaller clusters of bacteria surround the large cluster 
(see arrows); c: Gram stain highlighting small clusters 
of both Gram positive and Gram negative bacteria 
(cocci and bacilli) (see arrows); d: Gram stain 
showing evidence of a mixed bacterial species cluster, 
including Gram positive and Gram negative cocci (see 
elbow arrow) and bacilli (see straight arrow); e: 
Inflammatory cell infiltration at the edge of the tissue 
section (see arrow); f: haematoxylin and eosin (H&E) 
stain showing a large cluster of Gram positive cocci 
(see straight arrow) surrounded by small bacterial 
clusters (see elbow arrow). Scale bars = 10µm 
a b 
c d 
e f 
10µm 10µm 
10µm 10µm 
10µm 10µm 
 172 
 
3.5 Discussion 
 
Whilst it should be kept in mind that the in vitro experimental environment does not 
reflect the complex in-vivo situation, the results of this study have clearly highlighted 
the significant variation among P. aeruginosa isolates obtained from chronic equine 
wounds in terms of both growth rate and protease production within developing 
biofilms and mature biofilms. The study has also indicated that the P. aeruginosa 
biofilms did not respond significantly to changes in pH in terms of proteolytic 
activity in vitro.  
 
The biofilm or sessile mode of growth and the mucoid phenotype of P. aeruginosa 
isolates has been implicated in the proteolytic activity of the microorganism in the 
clinical setting. Some research has suggested that the biofilm mode of growth 
supports a heightened level of proteolytic activity as compared to planktonic 
counterparts (Evans, Brown & Gilbert, 1994), with an increase in alginate paralleling 
an increase in protease production (Harjai et al, 2005). Yet, other studies have 
suggested protease production is inversely correlated with alginate production with 
alginate-producing strains producing lower yields of extracellular proteases than 
their respective alginate-negative strains. This may simply be a result of competition 
for energy or export systems given the large quantities of alginate secreted by 
mucoid strains (Ohman & Chakrabarty, 1982; Mathee et al, 1999). Whilst proteases 
are secreted by biofilm cells, the alginate matrix may 'trap' the enzymes thus 
preventing their release into the surrounding environment (Hoffman & Decho, 
1999). However, it has also been noted that the reduction in protease activity of CF 
alginate-producing P. aeruginosa isolates was not due to a failure of the cells to 
release synthesised proteases (Ohman & Chakrabarty, 1982). Yet, the mucoid 
phenotype alone without a definitive biofilm mode of growth may not be enough to 
cause the entrapment of proteases as previously mentioned. It has also been noted 
that in CF P. aeruginosa proteases play a role in the initial stages of infection 
whereas the role of these enzymes later in the infection when biofilms are formed is 
questionable given the host's ability to produce neutralising antibodies against these 
proteases (Döring et al, 1984; Döring et al, 1983). Despite the widely accepted 
importance of biofilm formation in chronic wounds and also the destructive nature of 
certain bacterial proteases within wounds, the majority of current research into the 
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role that biofilms and extracellular bacterial proteases play in disease seems to focus 
upon CF and limited focus has been placed upon these factors in wounds. 
 
In the present study, it has been noted that whilst the biofilm cultures did produce 
proteases as demonstrated by biochemical assays and milk-casein agar plate cultures, 
as measured in the culture effluent, the cultures were considerably less 
proteolytically active than corresponding planktonic cultures (as described in 
Manuscript 2). Given that protease activity was measured within the effluent this 
may be a result of protease entrapment within the biofilm matrix thus leading to an 
underestimation of protease levels. General proteolytic activity of the re-suspended 
biofilm cells was minimal on milk-casein agar, however proteolytic activity 
increased steadily following a 24 and 48 hour milk-casein agar plate culture, 
indicating that the bacteria are able to retain their proteolytic activity for extended 
periods following sub-culture.  
 
It should be kept in mind, however, that the in vitro cultures used in this study may 
have limited the availability of nutrients when compared to the in vivo wound milieu 
and so protease activity as well as biofilm development may be somewhat over or 
under-estimated. The in vitro scenario does not take into consideration the changes 
in nutrient availability and the presence of host cells and their extracellular mediators 
including antibacterial secretions and proteases. Furthermore, it must be stressed that 
for the glass microscope slide biofilm cultures the proteases produced and measured 
during the biofilm cultures would have incorporated those proteases produced by 
planktonic daughter cells within the effluent.  
 
The change in initial pH of the culture broth of biofilm cultures did not have a 
significant impact on the production of proteases from each of the P. aeruginosa 
isolates during early biofilm development (i.e. in the 24 hour glass microscope slide 
cultures). In future studies it would be interesting to compare results with cultures 
adapted using a wider range of initial culture pHs and nutrient availability. It may 
also prove useful to fully characterise the changes in alginate production together 
with changes in protease production and expression of other extracellular virulence 
factors in both early biofilm development and in mature biofilms in order to 
ascertain the relationship between biofilm development and proteolytic activity 
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within the wound milieu and compare findings with planktonic cultures. Mixed-
species cultures may also cause changes in the proteolytic activity of biofilm cells 
and so a comparison of the results with cultures of a number of wound-related micro-
organisms may produce some interesting data. Whilst in the present study it was not 
logistically possible to use continuous-flow biofilm cultures, in future studies it may 
be beneficial to use such systems alongside static biofilm assays such as the colony 
biofilm assay using nutrient agar for proteolytic analysis under varied environmental 
conditions.  
 
 
3.6 Conclusion 
 
This study has highlighted a clear variation among P. aeruginosa isolates derived 
from equine wounds in terms of both general proteolytic activity and elastase activity 
during early and late biofilm development. Results have also revealed that a change 
in the initial pH of the culture broth of developing biofilms from pH7.3 to pH5.5 
does not have a significant effect on protease production. This could reflect the 
protective role of the biofilm matrix against environmental changes, given that the 
same isolates cultured in the planktonic mode of growth in Manuscript 2 were 
affected by pH fluctuations in terms of protease activity within the culture media. 
When comparing the results to those from Manuscript 2, the biofilm cultures were 
less proteolytically active than the planktonic cultures. In terms of translating these 
findings to the clinical setting, it may be worth considering that treatments aimed at 
disrupting biofilms within chronic wounds could lead to a possible initial increase in 
proteolytic activity from surviving planktonic cells. 
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3.7 Appendices to Chapter 3 
 
 
Note: For all analyses, the first 2 digits in the IsolXpH (Isolate X pH) represent the initial 
culture pH; i.e. 73 represents pH 7.3 and 55 represents pH 5.5. The remaining 2 digits 
represent the isolate number.  
 
Appendix 1 
 
One-Way ANOVA for T24 (Azocasein assay) 
 
Grouping Information Using Tukey Method 
 
IsolXpH   N      Mean    Grouping 
5506      6   0.20528   A 
5508      6   0.20378   A 
5504      6   0.20050   A B 
7303      3   0.19927   A B 
5507      6   0.19310   A B C 
7304      3   0.18847   A B C D 
5505      6   0.18708   A B C D 
5503      6   0.18605   A B C D 
7306      3   0.16577     B C D E 
7307      3   0.16357     B C D E 
7308      3   0.15590       C D E 
5502      6   0.15590         D E 
5501      6   0.12958           E F 
7305      3   0.10423             F 
7302      3   0.04050             G 
7301      3   0.01997             G 
 
Means that do not share a letter are significantly different. 
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Appendix 2 
 
One-Way ANOVA for T24 (ECR assay) 
 
Grouping Information Using Tukey Method 
 
IsolXpH   N      Mean    Grouping 
5504      6   0.24440   A 
5507      6   0.23753   A 
5503      6   0.21278   A B 
5502      6   0.20328   A B 
5506      6   0.19082   A B C 
5508      6   0.17988   A B C 
7307      3   0.17780   A B C D 
5505      6   0.15468     B C D 
7303      3   0.13690     B C D E 
7306      3   0.13003     B C D E F 
5501      6   0.12220       C D E F 
7304      3   0.08120         D E F 
7308      2   0.04205           E F 
7302      3   0.04007           E F 
7305      3   0.02140             F 
7301      3   0.01987             F 
 
Means that do not share a letter are significantly different.
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Appendix 3 
 
One-Way ANOVA for T24 (Growth of planktonic bacteria) 
 
Grouping Information Using Tukey Method 
 
IsolXpH   N      Mean    Grouping 
7305      3   0.51427   A 
7302      3   0.49093   A 
7306      3   0.49053   A 
7304      3   0.47773   A B 
7303      3   0.47767   A B 
7307      3   0.47330   A B 
7308      3   0.46710   A B 
5505      6   0.41298     B 
5502      6   0.31432       C 
5508      6   0.24560         D 
5503      6   0.23372         D E 
5504      6   0.23252         D E 
5507      6   0.22847         D E 
5506      6   0.19160           E 
 
Means that do not share a letter are significantly different. 
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4.1 Abstract 
 
Previous findings in Chapters 2 and 3 demonstrated differential protease production 
in vitro of Pseudomonas aeruginosa clinical isolates derived from equine wounds.  
The aim of this chapter was to investigate the hypothesis that protease-rich P. 
aeruginosa conditioned media and purified P. aeruginosa elastase have an effect on 
the viability, growth and MMP/TIMP mRNA expression of equine dermal 
fibroblasts in vitro.  
 
Preliminary findings have demonstrated that P. aeruginosa exoproducts, including 
purified elastase exert deleterious effects on both normal skin fibroblasts and 
granulation tissue fibroblasts in a concentration-dependent manner in terms of 
viability and growth. Immunohistochemistry analysis revealed the presence of 
bacterial clusters disseminated throughout the wound bed and this bacterial staining 
occurred in conjunction with moderate staining of MMPs -2, -3 and -13 throughout 
the tissue. qRT-PCR analysis showed that mRNA of each of the MMPs and TIMPs 
of interest were expressed by normal skin fibroblasts and granulation tissue 
fibroblasts at a higher level than GADH, with cells from different equine donors 
responding differently in terms of MMP/TIMP mRNA expression when treated with 
P. aeruginosa conditioned media and P. aeruginosa elastase. However, due to 
limited numbers of biological replicates it was not possible to confirm whether these 
changes in MMP/TIMP mRNA expression were statistically significant.
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4.2 Introduction 
 
Pseudomonas aeruginosa is an opportunistic bacterial pathogen and cause of 
community and nosocomial-acquired infections, including wound infections (Cowell 
et al, 2003; Hoge et al, 2010). Many virulence characteristics are attributed to this 
pathogen, not least the proteases elastase B and alkaline protease. These proteases 
play a role in the pathogenic interaction between bacterium and host, and protease-
deficient strains of P. aeruginosa have been shown to be generally less virulent than 
protease-producing strains (Holder & Haidaris, 1979; Pavlovskis & Wretlind, 1979).  
 
A range of bacterial proteases have been shown to affect host cells in a number of 
ways. For instance, it was reported by Uronowey and colleagues (2006) that 
proteases produced by the oral pathogen Porphyromonas gingivalis affected 
bacteria-host interactions and showed evidence of the promotion of apoptosis via 
intracellular proteolytic activation of caspase-3. Similarly, a purified cysteine 
proteinase from P. gingivalis has been shown to cause disruption of the basement 
membrane of human epithelial cell lines cultured in monolayer, but with no 
cytotoxic effects (Shah, Gharbia & O'Toole, 1992).  
 
P. aeruginosa elastase B, a 33kDa protease also named LasB or pseudolysin, is one 
of the major proteins secreted by P. aeruginosa into the surrounding environment 
(Andrejko & Mizerska-Dudka, 2012). A number of investigations have highlighted 
the cytotoxic actions of P. aeruginosa towards host cells. Sawa et al (1998) 
demonstrated that an invasive strain of P. aeruginosa was cytotoxic to epithelial 
cells in vitro in a bacterial density-dependent manner which was correlated to 
increased elastase production. Supernatant from P. aeruginosa cultures has also been 
shown to slow the migration velocity of airway epithelial cells whilst delaying or 
inhibiting the re-establishment of epithelial cell integrity following wound closure 
(De Bentzmann et al, 2000).What is more, culture supernatant of P. aeruginosa 
caused over-activation of host MMP-2 and MMP-9. The over-activation of MMP-2, 
was also associated with a decrease in the inhibitor TIMP-2; with this effect being 
limited to elastase-producing P. aeruginosa strains (De Bentzmann et al, 2000). 
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Furthermore, LasB along with LasA has been implicated in the modulation of 
invasion of epithelial cells (Cowell et al, 2003).  
 
P. aeruginosa has consistently been implicated in delayed wound healing and in 
particular LasB has been shown to have an important role in the pathogenicity of this 
bacterium within the wound milieu (Schmidtchen et al, 2003; Schmidtchen, Wolff & 
Hansson, 2001). In addition to the effects of elastase-producing strains of P. 
aeruginosa on the degradation of important matrix components and growth factors, 
LasB from ulcer-derived P. aeruginosa has also been reported to not only degrade 
proteins in wound fluid and human skin proteins during infection ex vivo as well as 
antiproteinases and other important wound healing molecules, but also inhibits 
human skin fibroblast cell growth (Schmidtchen et al, 2003). Whilst other 
mechanisms of P. aeruginosa pathogenicity including the secretion of exotoxins 
have been shown to exert an apoptotic effect on host cells (Morimoto & Bonavida, 
1992; Valente et al, 2000; Keppler-Hafkemeyer, Brinkmann & Pastan, 1998; 
Andersson, Juell & Fodstad, 2004; Schmidtchen et al, 2003) Schmidtchen et al 
(2003) concluded that the P. aeruginosa strain studied in their investigation exerted 
most of its effect on fibroblast cell growth via an apoptosis-independent, proteinase-
mediated mechanism, however the exact mechanisms involved were not studied. 
 
P. aeruginosa elastase has been shown to inactivate human plasma alpha 1-
proteinase inhibitor, an important inhibitor of tissue destruction by endogenous 
serine proteinases (Morihara, Tsuzuki & Oda, 1979). P. aeruginosa elastase has also 
been implicated in the direct and indirect degradation of type 1 collagen; Nagano et 
al (2001) demonstrated the deleterious effect of P. aeruginosa conditioned medium 
on collagen degradation in a 3-dimensional collagen gel in vitro model used to 
represent the collagen matrix in corneal tissue. It was P. aeruginosa elastase which 
caused degradation of collagen directly and also stimulated keratocyte-mediated 
collagen degradation. Comparatively, culture supernatant of elastase-deficient P. 
aeruginosa mutants did not affect collagen degradation in either the absence or 
presence of keratocytes. Additionally, P. aeruginosa elastase caused activation of the 
inactive precursors of keratocyte MMPs-1, -2, -3 and -9 (Nagano et al, 2001). 
MMPs, along with the serine, cysteine and aspartic proteases are important in normal 
physiologic and pathologic tissue remodelling processes, including during wound 
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healing (Dong et al, 2000) and yet augmented expression of these proteases within 
the wound environment has implications in delayed wound healing. In an early 
study, Twining and colleagues (1993) used an in vitro cornea culture model to assess 
the effect of P. aeruginosa conditioned media, elastase, alkaline protease and 
exotoxin A on corneal proteins and proteinases. They found that P. aeruginosa 
elastase activated host MMP-2 and MMP-9. At a higher concentration, however, the 
elastase degraded these host proteinases. Dong et al (2000) also reported on the 
upregulation of MMP-9 alongside alkaline protease in mouse corneas infected with 
P. aeruginosa, with this upregulation corresponding to the inflammatory response on 
a temporal basis. The induction of membrane-type MMPs (MT-MMPs) in mouse 
corneas infected with P.aeruginsoa (characterised by inflammation) during wound 
development at the mRNA and protein levels has also been demonstrated by Dong 
and colleagues (2000). Importantly, the MT-MMPs also play a role in the activation 
of latent MMPs and so the induction of MT-MMPs in the mouse cornea as a result of 
P. aeruginosa infection may also have implications in the damage of tissue caused 
by other activated proteases (Dong et al, 2000). In a later study, Dong and colleagues 
(2001) further reported on the correlation between over-expression of MT-MMPs in 
P. aeruginosa infected mouse corneas and the inflammatory response.  
 
Interestingly, an early study demonstrated that the use of protease inhibitors may aid 
healing in P. aeruginosa infected wounds by inhibiting the proteolytic (but not 
elastolytic) activities of P. aeruginosa alkaline protease and elastase in burned skin 
(Holder, 1983). Similarly, the survival of mice with burns infected with protease-
producing P. aeruginosa was enhanced via the administration of antiprotease serum, 
whereas this addition had no effect on burns infected with protease-deficient strains 
of P. aeruginosa (Pavlovskis & Wretlind, 1979). Conversely, antielastase 
immunoglobulin G (AE-IgG) showed no significant protective role against P. 
aeruginosa infection in a murine burn wound sepsis model (Cryz, Furer & 
Germainier, 1983).  
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MMPs -2, -3, -9 and -13 were chosen as MMPs of interest in this study given their 
importance in a range of processes involved in wound healing. The gelatinases 
MMPs -2 and -9 are particularly important in the remodelling and re-epithelialisation 
of wounds (Rayment, Upton and Shooter, 2008; Rowe & Weiss, 2008) and have 
consistently been shown to be upregulated in chronic wound fluids (Trengove et al, 
1999; Yager et al, 1996; Rayment, Upton & Shooter, 2008; Rowe & Weiss, 2008). 
MMP-2 and MMP-9 have been shown to correspond with an increase in the 
degradation of epidermal growth factor in wound fluid samples (Trengove et al, 
1999). An increase in MMP-9 in chronic wound fluid has also been linked with poor 
ulcer healing (Rayment, Upton & Shooter, 2008). MMP-3 is also induced by 
multiple cell types in the skin during normal and pathological tissue remodelling in 
the dermis and epidermis (McCrawley et al, 2008) and it has been shown to regulate 
the function of biologically active molecules (Vu & Werb, 2000). MMP-3 has also 
been shown to be important during wound contraction (Bullard et al, 1999; Gill and 
Parks, 2008) and MMPs -3 and -13 are involved in the remodelling of collagen 
(Parks et al, 2004). Epithelial and stromal cells in wounded tissue express multiple 
MMPs, including MMPs-2, -9 and -13 (Gill & Parks, 2008). Furthermore, the 
MMP/TIMP ratio is an important factor in wound healing, with a general decrease in 
the ratio being associated with healing (Ladwig et al, 2002). 
 
Given the current evidence relating to the effects of bacterial proteases on host cell 
viability and MMP expression together with the identified gaps in the literature 
pertaining to the effects of bacterial proteases in cutaneous equine wounds, three 
main objectives were identified. The first aim was to assess the effects of P. 
aeruginosa protease-rich conditioned media from 3 isolates shown to be positive for 
the LasB gene in addition to purified P. aeruginosa elastase (dose-response) on the 
viability and growth of equine dermal fibroblasts. Secondly, the influence of P. 
aeruginosa elastase on wound closure in vitro using a scratch wound model was 
investigated. Finally, the effect of conditioned media and P. aeruginosa elastase on 
the levels of MMP-2, -3, -9, -13 and TIMP -1 and -3 mRNA expressed by equine 
dermal fibroblasts was explored.
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4.3 Methods 
 
4.3.1 Chemicals and Reagents 
 
All chemicals and reagents were purchased from Sigma Aldrich (Dorset, UK) unless 
otherwise stated. 
 
4.3.2 Ethical Approval 
 
Approval for this study was granted by the Ethics Committee, University of 
Liverpool and informed consent was obtained from the owners of the animals 
participating in this study. 
 
4.3.3 Identification of P. aeruginosa Isolates 
 
Standard microbiological culture techniques were used to confirm the identities of 2 
previously collected equine trauma wound isolates (as described in Manuscript 2). 
Pure bacterial colonies were identified using a Gram stain and isolates confirmed as 
Gram negative rods were further characterised using the oxidase test (using oxidase 
detection strips from Oxoid Limited, Hampshire, UK) and API 20 E
®
 identification 
strips, which utilise biochemical reactions with computer software-interpretation 
(Biomérieux UK Limited, Hampshire, UK). Confirmed P. aeruginosa isolates were 
stored on beads and frozen at -80C until required for further investigation.  
 
A P. aeruginosa reference strain (non-wound isolate) was used as a control; 
American Type Culture Collection (ATCC) 27853 (isolated from blood culture) 
(ATCC, Manassas, USA). This strain was chosen as it produces all of the major 
virulence factors of this organism, including elastase and alkaline protease 
(O'Callaghan et al, 1996). 
 
Polymerase chain reaction (PCR) analysis of the P. aeruginosa elastase gene was 
performed for each isolate; the chronic wound isolates and the ATCC reference 
strain were positive for the elastase gene (as reported in Manuscript 2). 
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4.3.4 Preparation of P. aeruginosa conditioned media 
 
Sterile Mueller Hinton broth (MHB) (LabM, Bury, UK) was used in 75ml aliquots 
for all cultures inoculated with 500µl of stationary phase cultures corresponding to 
each individual P. aeruginosa isolate, as described above. Cultures were incubated 
with shaking at 150rpm in a shaking incubator set at 37C for 24 hours in 75cm3 
culture flasks. Culture samples were harvested and centrifuged at 12000rpm for 10 
minutes to pellet the cells. Conditioned culture supernatant was filtered through 
0.45µm sterile filters to remove cell debris. A bicinchoninic acid (BCA) protein 
assay (Pierce, Thermo Scientific, MA, USA) was used to standardise the amount of 
protein present in each sample of conditioned media; three total protein 
concentrations were used in the cell culture experiments to determine the dose 
response of the fibroblasts to the conditioned media in terms of cell viability and 
MMP/TIMP expression following treatment (50µl, 100µl and 300µl). The total 
protein concentrations used in the study were chosen on the basis of previous 
optimisation experimentation. 
 
4.3.5 Purification of P. aeruginosa Elastase using DEAE-Sepharose Ion 
Exchange Chromatography 
 
Supernatant from an overnight culture of P. aeruginosa (in MHB) was recovered by 
centrifugation at 15,000g for approximately 10 minutes. Supernatant was then 
filtered through 0.45µm filters. Supernatant was then concentrated using centrifugal 
ultrafiltration in Amicon filter devices (30kd cut-off) (Merck Millipore, Watford). 
The concentrates were then washed twice with 20mM sodium phosphate buffer, 
pH8.0, in Amicon filter devices (30kd cut-off).  
 
A diethylaminoethanol (DEAE)-sepharose column was set up with a 20ml syringe 
and glass wool and was mounted on a stand out of direct sunlight and draughts (to 
help prevent temperature fluctuations). A 5ml aliquot of DEAE solution (pre-mixed 
with a starting buffer of 20mM sodium phosphate, pH8.0 as per the manufacturer's 
instructions) was poured into the column and allowed to flow gently down the side 
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of the column, avoiding bubble formation. Once the gel had set, the column was 
washed successively with a total of 350ml of 0.1M NaOH buffer and then a total of 
350ml of 1M NaCl buffer and the flow-through discarded accordingly. The column 
was then equilibrated with 20mM sodium phosphate buffer, pH8.0. To check that the 
pH of the buffer going in to the column was the same as the pH of the buffer coming 
out of the column, pH indicator paper was utilised. The P. aeruginosa supernatant 
concentrates were passed through the column and eluted with equilibration buffer 
and several fractions collected. The fractions were then tested for the presence of 
elastase using SDS-PAGE. Where necessary, the fractions were concentrated, again 
using Amicon filter devices (30kd cut-off) and tested again using SDS-PAGE. 
 
4.3.6 BCA Protein Assay 
 
To determine and optimise the concentration of total protein in the eluted P. 
aeruginosa elastase fractions a BCA protein assay kit was utilised (Thermo 
Scientific, MA, USA). This kit is based on colorimetric detection using a plate reader 
at approximately 562nm. The concentration of total protein from pooled fractions 
(previously identified as purified P. aeruginosa elastase) was determined using the 
kit as per the manufacturer's instructions. Albumin standards, as supplied in the BCA 
protein assay kit, were used to generate a standard curve from which the 
concentration of total protein in the samples was determined. 
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4.3.7 Fibroblast Cell Culture for MMP/TIMP mRNA Expression Studies 
 
Equine wound granulation tissue and normal equine skin were used to source 
fibroblasts for the cell culture experiments (2 donors for granulation tissue and 2 
donors for normal skin). Equine dermal tissue was obtained either at post mortem of 
horses which had been euthanized for medical reasons or from tissue debrided during 
wound management procedures, with informed consent being given by the owner. 
All ethical considerations were made. Tissue sections were washed twice in 1x 
Hank's balanced salt solution (HBSS) (Gibco, Invitrogen, Paisley, UK) and minced 
into 3-5mm
2
 pieces and placed into 25cm
2
 culture flasks. Fibroblasts were cultured 
in DMEM (Gibco, Invitrogen, Paisley, UK) supplemented with 10% foetal calf 
serum (FCS), 20mM Hepes buffer, 1% penicillin-streptomycin (Invitrogen, Paisley, 
UK) and 0.5µg/ml amphotericin B (fungizone). The cultures were incubated in 5% 
CO2 in air at 37C. Following a culture period of 5-10 days cells were examined 
microscopically (Nikon Eclipse, Melville, USA) for outgrowth and confluency. 
When confluent, cells were passaged in a ratio of 1:4 with 0.05% trypsin/EDTA and 
cells of passage 3-8 were used experimentally. 
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4.3.8 Experimental Design and Cell Treatment 
 
Figure 1 illustrates the experimental design. Fibroblasts were seeded at a density of 
0.3x10
6
 cells per well of a 6-well plate in a total of 4ml of DMEM (DMEM 
supplemented as described above) per well. Cells were incubated in 5% CO2 in air at 
37C for 2 days or until cells were almost confluent. The media in each well was 
changed to serum-free DMEM and plates were incubated for a further 24 hours. 
Following incubation the media was removed and cells were washed with Hank‟s 
buffered salt solution (HBSS). Treatments were added to the corresponding wells as 
indicated in figure1 and plates were incubated as described above for 24 hours. 
Images of the cells in each cell culture plate well were taken microscopically prior to 
and following treatment using a Nikon Eclipse microscope (Melville, USA). 
Following the 24 hour incubation period of the cells with the relevant treatments, the 
conditioned media was removed and stored at -80°C (for gelatin zymography 
analysis). The cell layer in each well was washed twice with HBSS. To each well of 
the plate 1ml Tri reagent was added and using a disposable pipette tip the cell layer 
was removed from the bottom of each well (separate pipette tips were used for each 
well). Cells were stored in 1.5ml Eppendorf centrifuge tubes at -80°C until further 
investigation.  
  
1
8
9 
Figure 1: Experimental design and cell treatment. Fibroblasts were cultured in 6-well culture plates and treatments applied to the cells for 24 
hours. Conditioned media from cultures of an ATCC P. aeruginosa type strain (I1) and a chronic wound P. aeruginosa isolate (high biofilm 
forming potential [BFP]) (I2) were used to treat cells; 3 concentrations of total protein were used (50, 100 and 300µg) [equating to 12.5µg/ml, 
25µg/ml and 75µg/ml]. Purified P. aeruginosa elastase was also used to treat cells (2, 10 and 25µg) [equating to 0.5µg/ml, 2.5µg/ml and 
6.25µg/ml]. The concentrations of elastase used in the study were chosen on the basis of previous optimisation experimentation and studies by 
Twining et al (1993) and Miyajima et al (2001). Duplicate wells were used for each treatment type. A separate plate was set up to include negative 
controls (cells only, no treatments). A total of 5 culture plates were set up for each cell type; fibroblasts from normal equine skin from 2 different 
donors were used in addition to fibroblasts from equine granulation tissue from wounds of 2 different donors. The cells from each well following 
treatment were used for QRT-PCR analysis. For each cell type, an additional 5 culture plates were prepared in the same way and were used for 
crystal violet assays for cell viability following treatment.  
Key 
F + I1: Fibroblasts + ATCC P. aeruginosa conditioned media 
F + I2: Fibroblasts + chronic wound P. aeruginosa (high biofilm forming potential [BFP]) conditioned media 
F + PE: Fibroblasts + P. aeruginosa elastase 
-ve controls: Fibroblasts + DMEM, no treatment 
*Plate 3 is a repeat of plate 1 
**Plate 4 is a repeat of plate 2 
F + DMEM
Plate 5: -ve controls (no treatment)
F + DMEM
F + DMEM
F + DMEM
F + DMEM
F + DMEM
F + I1
50µg
Plate 1
F + I1
100µg
F + I1
300µg
F + I2
50µg
Plate 2
F + I2
100µg
F + I2
300µg
F + PE
2µg
F + PE
10µg
F + PE
25µg
F + I1
50µg
Plate 3*
F + I1
100µg
F + I1
300µg
F + I2
50µg
F + I2
100µg
F + I2
300µg
F + PE
2µg
F + PE
10µg
F + PE
25µg
Plate 4**
Empty 
well
Empty 
well
Empty 
well
Empty 
well
Empty 
well
Empty 
well
 190 
 
4.3.9 Crystal Violet Assay for Cell Viability 
 
The crystal violet assay is a colorimetric method of determining cell viability, 
proliferation or cytotoxicity caused by the application of a test treatment (Vega-
Avila & Pugsley, 2011). The assay is used to obtain quantitative information about 
the relative cell density of monolayer cultures since the dye stains DNA; the amount 
of dye taken up by the monolayer and thus the colour intensity are proportional to 
cell number (Vega-Avila & Pugsley, 2011). This method was used to determine the 
effect of increased concentrations of P. aeruginosa elastase (2µg, 10µg and 25µg) 
and varying concentrations of total protein (50µg, 100µg and 300µg) from P. 
aeruginosa conditioned media from 2 different P. aeruginosa isolates on the 
viability of equine normal skin (NF) fibroblasts and equine wound granulation tissue 
(GT) fibroblasts following a 24 hour treatment period. Two biological replicates 
were used for normal equine skin fibroblasts (NF) and two biological replicates were 
used for equine wound granulation tissue fibroblasts (GT). For each cell type and 
treatment, 2 technical replicates were used. 
 
A solution of 0.4% crystal violet was prepared in methanol; this was stirred using a 
magnetic flea until all of the crystal violet powder had dissolved. Following cell 
culture and the treatment period, the culture medium was carefully removed, without 
disturbing the cell layer on the bottom of the plate wells. Each of the plate wells 
were then gently washed with 2ml of warmed 1x HBSS. The crystal violet solution 
(500µl per well) was added to the plate wells and incubated for 10 minutes at room 
temperature. Following incubation, the plates were washed carefully in tap water by 
immersion in to a large, clean beaker changing the water between washes. The plates 
were allowed to drain upside down on paper towel and left to dry. Once the plates 
were dry, 1% SDS was added to each well (1ml per well) to solubilise the crystal 
violet stain and plates were agitated on a plate shaker for approximately 5  minutes 
until the colour was uniform in each well and no areas of dense colour on the 
sides/bottom of the wells were visible. From each of the plate wells, a 200µl aliquot 
of the solubilised crystal violet stain was added to a 96-well plate in triplicate. The 
absorbance of the resulting solution in each well was measured in a plate reader at 
570nm. 
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4.3.10 qRT-PCR 
 
RNA Extraction from Cells 
 
To each of the cell samples (previously stored in Tri reagent) 200µl of chloroform 
was added and vortexed. Samples were left at room temperature for 10 minutes. 
Samples were then centrifuged at 4°C for 15 minutes at 13,000rpm. Following 
centrifugation, the clear supernatant was transferred into clean 1.5ml Eppendorf 
centrifuge tubes, ensuring that the DNA layer was not disturbed and the remaining 
solution was discarded as appropriate. Equal volumes of 70% ethanol (made up with 
molecular grade ethanol and DEPC water) were added to each sample and samples 
were mixed by pipetting. A Qiagen RNeasy mini kit (Qiagen, Manchester, UK) was 
used to continue the RNA extraction process according to the manufacturer's 
instructions. A DNase treatment stage was included in the process. This process 
generated 30-50µl RNA per sample. 
 
cDNA Synthesis- Reverse Transcription 
 
To 16µl of each of the RNA samples 1µl of random primers (Promega, WI, USA) 
were added and spun down for 5-10 seconds. Samples were placed into a PCR 
machine (2720 Thermal Cycler, Applied Biosystems, Life Technologies, CA, USA) 
and run for 5 minutes on a 70°C manual programme. Samples were then placed on 
ice. Master mix was prepared with dNTPs (Promega, WI, USA), 5x buffer 
(Promega, WI, USA) and reverse transcriptase (Promega, WI, USA) as per the 
manufacturer's instructions. The RNA samples (8.5µl of each sample) were added to 
individual Eppendorf tubes with 4µl mastermix. Samples were run in the PCR 
machine as per the reverse transcription protocol; 1 hour at 37°C, 10 minutes at 95°C 
and samples were then held at 4°C. DEPC water was added to the cDNA samples to 
dilute each sample 1:3. 
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Real-Time PCR 
 
To each well of the qRT-PCR plate 17µl of master mix (made up with 5µl DEPC 
water, 2µl (3µM in DEPC water) forward and reverse primer mix and 10µl SYBR 
green (Thermo Scientific, MA, USA)) was added. To each well 3µl of the 
corresponding cDNA sample was added to create a total of 20µl per well of the 96-
well plate. The plate was covered with a clear film and centrifuged for approximately 
15 seconds. The plate was run in a QRT-PCR machine (7300 Real Time PCR 
System, Applied Biosystems, Life Technologies, CA, USA) using a relative 
quantification programme using 7300 system software. Samples were assayed for 
MMP-2, MMP-9, MMP-3, MMP-13, TIMP-1 and TIMP-3 mRNA expression 
(GapDH was used as the house-keeping gene). For analysis, the comparative CT 
method was used which compares the Ct value of one target gene to an internal 
control/reference gene (in this case GapDH) using the formula 2^^CT. Primer 
sequences are listed in Appendix 1. 
 
 
4.3.11 Immunohistochemistry 
 
Equine wound tissue samples were retrieved during standard debridement 
procedures. Tissue sections were collected into paraformaldehyde for 
immunohistochemistry staining using standard procedures and were processed by the 
University of Liverpool pathology department for staining; tissue sections were 
paraffin embedded and stained for MMP-2, MMP-9 and MMP-13 (method described 
in Appendix 2). Tissue sections were also stained with Gram stain for the 
identification of bacteria within the tissue, and Haematoxylin and Eosin (H&E). 
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4.3.12 Scratch Wound Assay 
 
The most common in vitro model used to study cell migration and wound closure is 
the scratch wound method, given its simplicity, ease of use and cost efficiency 
(Liang, Park & Guan, 2007). Following the creation of a wound along the confluent 
monolayer, cells at the wound edge polarise and migrate into the wound area (Cory, 
2011). Images can be taken of the wounded area before and after treatment and the 
change in surface area of the wounded site can be calculated (see figure 2a). 
 
Granulation tissue fibroblasts from equine wounds (n=2) and normal equine skin 
fibroblasts (n=2) were sourced and put into primary culture as described previously. 
Fibroblasts were seeded at a density of 1x10
5
 cells per well in 12-well plates in a 
total of 1ml of DMEM (DMEM supplemented as described above) per well. Cells 
were incubated in 5% CO2 in air at 37C for 2 days or until cells were almost 
confluent. Cells were then serum-starved for 24 hours. Following incubation the 
media was removed and cells were washed with HBSS.  Wounds were created 
manually using a 200µl sterile filter pipette tip. The pipette tip was scratched down 
the centre of the well and dislodged cells were removed via washing with HBSS. 
Wound size was found to be generally consistent, with a width of approximately 
1mm. In order to inhibit fibroblast proliferation so that wound closure could be 
measured on the basis of fibroblast migration, fresh DMEM was supplemented with 
2mM hydroxyurea. Treatments were added to the corresponding wells (see figure 
2b) and plates were incubated as described above for a total of 72 hours. To ensure 
consistency of imaging, black markers were drawn in the centre of each well, 
indicating the section of the scratch wound to be imaged at each time point. Images 
of the scratch wounds in each cell culture plate well were taken microscopically 
prior to and following treatment at each time point (0, 36, 60 and 72 hours) using a 
Nikon Eclipse microscope (Melville, USA). The total wound surface area was 
measured using GNU Image Manipulation Program (GIMP), Version 2.8 and 
percentage wound closure over time was calculated in comparison to the surface area 
of the wound at time point zero.
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Figure 2: (a) Scratch wound assay method. A sterile filter pipette tip was used to create a scratch wound in each well of the cell culture plate. Dislodged cells 
were then rinsed away with HBSS and varying concentrations of P. aeruginosa elastase were added to the corresponding wells; (b) Fibroblasts were cultured in 
12-well culture plates and treatments applied to the cells for a total of 72 hours following the creation of a scratch wound in each well. Triplicate wells were 
used for each treatment dose (0.1µg/ml, 0.2µg/ml, 0.5µg/ml and 2.5µg/ml). A separate plate was set up for each cell type (i.e. 2 normal fibroblast (NF) and 2 
granulation tissue (GT) fibroblast cultures). Images of the wounded area were taken immediately after wounding (0 hours) and at 36, 60 and 72 hours post 
wounding for each well. Separate culture plates were prepared for controls (no treatment). Some wells in the control plates were used for crystal violet staining 
to monitor cell proliferation (the hydroxyl urea treatment of cells should have prevented proliferation). 
Fibroblast monolayer
Wound closure
0 hours
36-72 hours
Scratch wound
a 
0.1µg/ml 0.1µg/ml 0.1µg/ml 0.2µg/ml
0.2µg/ml 0.2µg/ml 0.5µg/ml 0.5µg/ml
0.5µg/ml 2.5µg/ml 2.5µg/ml 2.5µg/ml
b 
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4.4 Results 
 
4.4.1 Crystal Violet Assay for Cell Viability 
 
Results suggest that variations could exist between different P. aeruginosa isolates 
in terms of the effect of conditioned media on cell viability, particularly at higher 
concentrations of total protein (see tables 1 and 2, figures 3-6); it was noted that in 
general the conditioned media obtained from the ATCC P. aeruginosa type strain 
(I1) inflicted little effect on cellular viability to both the NF and GT cells as 
compared to the untreated control cells. Comparatively, the conditioned media from 
the chronic equine wound P. aeruginosa isolate (I2) caused a reduction in cellular 
viability of both cell types, which was dependent on concentration of total protein; as 
the concentration of total protein increased from 50µg to 300µg cell viability was 
reduced in a dose-dependent manner (see Figures 3-10). There was a statistically 
significant difference between I1 and I2 at concentrations 100µg (F(1, 23) = 7.77, P 
= 0.050) and 300µg (F(1, 23) = 13.46, P = 0.001) in terms of the mean NF fibroblast 
viability, with the I2 conditioned media resulting in a significantly reduced cell 
viability (see table 2). 
 
P. aeruginosa elastase also had an effect on cell viability of both NF and GT cells 
(see Figures 3-10); whilst this effect was not as prominent as the effect observed on 
cell viability of those cells treated with total protein from P. aeruginosa conditioned 
media, as the concentration of P. aeruginosa elastase increased from 2µg to 10µg, 
cell viability decreased. However, this was not statistically significant (see table 3). 
Yet, there was a significant difference between GT1 cells treated with 2µg P. 
aeruginosa elastase and GT1 cells treated with 25µg P. aeruginosa elastase, with 
cell viability decreasing in a dose-dependent manner, F(2, 3) = 16.81, P = 0.023 (see 
table 3, figure 5). Figures 7 and 8 show interval plots for the percentage cell viability 
for both NF and GT cells following treatment with either P. aeruginosa conditioned  
media or P. aeruginosa elastase following the 24 hour treatment period as compared 
to untreated control cells.
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Table 1: Statistical analysis of the effect of P. aeruginosa conditioned media on normal equine skin fibroblasts (NF) and equine granulation 
tissue fibroblasts (GT); analyses were conducted to determine whether differences exist between the 2 treatment types (conditioned media from 
2 different P. aeruginosa isolates) in terms of the effect on cell viability at each concentration of total protein. 
 
Cell Type Concentration of 
Treatment 
Statistical Analysis 
One-Way ANOVA Kruskal-Wallis 
NF1 50µg F(1, 11) = 0.03, P = 0.861 P = 0.873 
NF1 100µg F(1, 11) = 9.86, P = 0.011* P = 0.010* 
NF1 300µg F(1, 11) = 7.16, P = 0.023* P = 0.025* 
NF2 50µg F(1, 11) = 5.19, P = 0.046* P = 0.150 
NF2 100µg F(1, 11) = 2.81, P = 0.124 P = 1.000 
NF2 300µg F(1, 11) = 8.06, P = 0.018* P = 0.055 
GT1 50µg F(1, 11) = 15.89, P = 0.003*  
GT1 100µg F(1, 11) = 2.39, P = 0.153  
GT1 300µg F(1, 11) = 0.63, P = 0.446 P = 0.200 
GT2 50µg F(1, 11) = 2.55, P = 0.141 P = 0.423 
GT2 100µg F(1, 11) = 9.46, P = 0.012*  
GT2 300µg F(1, 11) = 0.01, P = 0.914 P = 0.337 
 
* Significant at the 0.05 level 
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Table 2: As table 1; results for both normal skin fibroblast (NF) cell donors and both granulation tissue (GT) cell donors were averaged prior to 
statistical analysis. 
 
Cell Type Concentration of 
Treatment 
Statistical Analysis 
One-Way ANOVA Kruskal-Wallis 
NF 50µg F(1, 23) = 1.64, P = 0.213  
NF 100µg F(1, 23) = 7.77, P = 0.011* P = 0.050* 
NF 300µg F(1, 23) = 13.46, P = 0.001* P = 0.003* 
GT 50µg F(1, 23) = 0.00, P = 0.999 P = 0.453 
GT 100µg F(1, 23) = 1.47, P = 0.239 P = 0.204 
GT 300µg F(1, 23) = 0.04, P = 0.837 P = 0.184 
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Table 3: Statistical analysis of the effect of P. aeruginosa elastase on equine normal skin fibroblasts (NF) and granulation tissue fibroblasts 
(GT); analyses were conducted to determine whether differences exist between the 3 different concentrations of P. aeruginosa elastase (2µg, 
10µg and 25µg)  in terms of the effect on cell viability. 
 
Cell Type Statistical Analysis 
One-Way ANOVA Post-Hoc Observations 
(using the Tukey method) 
Kruskal-Wallis 
NF1 F(2, 3) = 1.86, P = 0.298  P = 0.156 
NF2 F(2, 3) = 2.58, P = 0.223  P = 0.276 
NF1/NF2 
averaged 
F(2, 3) = 0.28, P = 0.774 
 
 P = 0.565 
GT1 F(2, 17) = 7.12, P = 0.007* There is no statistically significant 
difference between 2µg and 10µg 
and there is no statistically 
significant difference between 10µg 
and 25µg. There is, however, a 
statistically significant difference 
between 2µg and 25µg. 
P = 0.009* 
GT2 F(2, 17) = 4.02, P = 0.040* There is a statistically significant 
difference between 2µg and the other 
two concentrations of PE 
P = 0.011* 
GT1/GT2 
averaged 
F(2, 35) = 1.70, P = 0.199  P = 0.117 
 
*Significant at the 0.05 level 
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Figure 3 Figure 4 
Figure 6 Figure 5 
Figures 3-6: % cell viability of normal skin (NF) fibroblasts and granulation tissue (GT) fibroblasts following 24 hours treatment with varying concentrations of 
total protein from P. aeruginosa conditioned media (2 different isolates) and P. aeruginosa elastase (PE). Figure 3: % cell viability of NF1 and NF2 cells 
following treatment; Figure 4: % cell viability of NF1/NF2 cells (averaged data); Figure 5: % cell viability of GT1 and GT2 cells following treatment; Figure 6: 
% cell viability of GT1/GT2 cells (averaged data). Data is presented as mean ± SEM. * Significant at the 0.05 level. Statistical significance is detailed in Tables 
1-3. 
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Figure 7b 
Figure 7c 
Figure 7d 
Figure 7: Interval plots for % cell viability of normal skin (NF) fibroblasts following 24 hours treatment with varying concentrations of total protein from P. 
aeruginosa conditioned media (3 different isolates). Figures 7a/7b: % cell viability of NF1 cells (Figure 7a) and NF2 cells (Figure 7b) following treatment 
with varying concentrations of total protein from P. aeruginosa conditioned media (3 different isolates); Concentration 1: 50µg; Concentration 2: 100µg; 
Concentration 3: 300µg.  Figures 7c/7d: % cell viability of NF1 cells (Figure 7c) and NF2 cells (Figure 7d) following treatment with varying concentrations of 
P. aeruginosa elastase; Concentration 1: 2µg; Concentration 2: 10µg; Concentration 3: 25µg. 
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Figure 8c 
Figure 8d 
Figure 8: Interval plots for % cell viability of granulation tissue (GT) fibroblasts following 24 hours treatment with varying concentrations of total protein from 
P. aeruginosa conditioned media (3 different isolates). Figures 7a/7b: % cell viability of GT1 cells (Figure 8a) and GT2 cells (Figure 8b) following treatment 
with varying concentrations of total protein from P. aeruginosa conditioned media (3 different isolates); Concentration 1: 50µg; Concentration 2: 100µg; 
Concentration 3: 300µg.  Figures 8c/8d: % cell viability of GT1 cells (Figure 8c) and GT2 cells (Figure 8d) following treatment with varying concentrations of 
P. aeruginosa elastase; Concentration 1: 2µg; Concentration 2: 10µg; Concentration 3: 25µg  
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The images taken of NF cells following treatment illustrate variations in cell morphology between treatment types. At a concentration of 300µg, the 
conditioned media obtained from I1 had little effect on NF cell viability; as compared to the un-treated control NF cells (9.4), those NF cells treated at this 
concentration (9.1) showed a slight reduction in cell viability; cells appeared slightly less elongated with less contact between cells. Cells were also less 
densely populated. When NF cells were treated with 300µg I2 conditioned media (9.2) cells appeared much less elongated with little contact between cells, 
with fewer adherences to the bottom of the culture plate well.  Cells were also less densely populated that the control cells. Cells treated with 25µg P. 
aeruginosa elastase (9.3) appeared non-viable; cells were less adherent to the surface of the culture plate well and whilst densely populated they were 
irregularly shaped, small and much more rounded than the control cells. Cells appeared ruptured, with blebbing of the cell membrane and a ridged 
appearance. 
Figure 9: NF cell images following 24 hours of 
treatment with P. aeruginosa conditioned media 
(300µg) and 25µg P. aeruginosa elastase: 8.1: 
normal skin fibroblast (NF) cells treated for 24 
hours with I1 conditioned media; 8.2 NF cells 
treated for 24 hours with I2 conditioned media; 
8.3: NF cells treated for 24 hours with PE; 8.4: 
Un-treated control NF cells. Scale bars = 100µm 
9.3 9.4 
9.1 9.2 
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The images taken of GT cells following treatment illustrate variations in cell morphology between treatment types. As with the NF cells, at a concentration of 
300µg, the I1 conditioned media had little effect on GT cell viability; as compared to the un-treated control GT cells (10.4), GT cells treated at this concentration 
(10.1) showed a slight reduction in cell density but viability did not seem to be affected. Cells demonstrated typical fibroblastic shape. GT cells treated with 300µg 
I2 conditioned media (10.2) appeared less elongated with little contact between cells and cells were much less densely populated than the control cells, with less 
contact between cells than un-treated control cells. A high proportion of cells were not adhered to the culture plate well; these cells appeared small and round. 
Cells treated with 25µg P. aeruginosa elastase (10.3) had similar morphology to those cells treated with I1 conditioned media but were less densely populated with 
little contact between viable cells. Overall, with each treatment, the GT cells did not seem to be affected to the same extent as the corresponding NF cells (see 
figures 9.1-9.4). For both cells types, the cells treated with I1 conditioned media were only slightly affected in terms of cell density and viability, whereas those 
cells treated with I2 conditioned media and PE seemed to be less densely populated with altered cell morphology as compared to un-treated cells. 
10.3 
10.1 10.2 
10.4 
Figure 10: Granulation tissue (GT) cell images 
following 24 hours of treatment with P. 
aeruginosa conditioned media (300µg) and 
25µg P. aeruginosa elastase: 10.1: GT cells 
treated for 24 hours with I1 conditioned media; 
10.2 GT cells treated for 24 hours with I2 
conditioned media; 10.3: GT cells treated for 
24 hours with PE; 10.4: Un-treated control GT 
cells. Scale bars = 100µm 
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4.4.2 qRT-PCR 
 
Quantitative real time PCR (qRT-PCR) was conducted in this study to ascertain 
whether the treatment of equine dermal fibroblasts with protease-rich P. aeruginosa 
conditioned media and P. aeruginosa elastase at varying concentrations affected the 
expression of MMPs and their inhibitors, TIMPs in vitro. Given the limited number 
of cells available for experimentation along with some missing data from qRT-PCR 
results it was not possible to perform robust statistical analysis from the data 
obtained. However, some observational trends have been observed within the data in 
terms of MMP and TIMP expression of NF and GT cells following treatment. 
Figures 11 and 12 show the mRNA expression of each MMP and TIMP analysed for 
the NF cells. Figures 13 and 14 show the mRNA expression of each MMP and TIMP 
analysed for the GT cells. The mRNA expression of each MMP and TIMP analysed 
was up-regulated relative to the housekeeping gene, GapDH, for NF1, NF2, GT1 and 
GT2, regardless of treatment indicating a general expression of MMPs and TIMPs 
during fibroblast culture. 
 
qRT-PCR revealed that relative mRNA expression relative to GapDH of un-treated, 
control NF cells of MMP-2, TIMP-1 and TIMP-3 were relatively high in comparison 
to the other MMPs measured. MMP-9 mRNA expression was also high but 
somewhat lower than the aforementioned mRNA levels. In contrast, MMP-13 and 
MMP-3 mRNA expression was considerably lower. However, whilst these trends 
were comparable between both NF cell types used, differences exist in terms of the 
overall levels of mRNA expression between cell types. It is, therefore, worth 
highlighting that results obtained from such data must be considered in terms of the 
cell type and variations between cell cultures from the same source/donor. In 
contrast, relative mRNA expression of un-treated, control GT cells of MMP-2, 
TIMP-1 and TIMP-3 were not as obviously different from those mRNA levels of 
other target MMPs; generally, MMP-9 and MMP-13 mRNA expression was lower 
than most other target MMPs and TIMPS, whilst MMP-3 mRNA expression was 
relatively high. 
 
With the treatment of P. aeruginosa elastase, NF cells responded by a dose-
dependent increase in MMP-13 mRNA expression, and a slight increase in MMP-3 
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mRNA and MMP-9 mRNA expression. TIMP-1 and TIMP-3 mRNA expression 
along with MMP-2 mRNA expression generally remained high at each concentration 
of P. aeruginosa elastase but did not differ considerably from the un-treated control 
cells. The relative mRNA expression of MMPs and TIMPs varied considerably 
between GT cell types. GT1 cells treated with P. aeruginosa elastase demonstrated a 
reduction in TIMP-3 mRNA expression; however TIMP-3 mRNA expression of 
GT2 cells remained relatively unchanged as compared to the untreated control cells. 
TIMP-1 and MMP-3 mRNA expression of GT1 cells was increased compared to 
untreated control cells. For the GT2 cells, MMP-9 and MMP-13 mRNA expression 
was up-regulated as compared to untreated control cells. MMP-9 mRNA expression 
was only slightly increased for the GT1 cells at a P. aeruginosa elastase 
concentration of 25µg. For GT cells, there was a general decline in TIMP-3 mRNA 
expression in most cases as the concentration of P. aeruginosa conditioned media 
increased. This was not observed for the NF cells.  
 
Whilst the current study has identified variations in the effects of P. aeruginosa 
conditioned media and P. aeruginosa elastase on MMP and TIMP mRNA 
expression among different fibroblast cell types, further investigation with a larger 
number of NF and GT cells from different donors is needed along with more 
technical repeats in order to generate definitive conclusions as to which MMPs and 
TIMPs are expressed to the greatest extent when cells are treated with protease-rich 
P. aeruginosa conditioned media and P. aeruginosa elastase.
 206 
 
 
0.00001
0.0001
0.001
0.01
0.1
1
10
100
MMP-2 MMP-3 MMP-9 TIMP-1 TIMP-3
2
-^
C
t
I1 50µg
I1 100µg
I1 300µg
I2 50µg
I2 100µg
I2 300µg
PE 2µg
PE 10µg
PE 25µg
0.00001
0.0001
0.001
0.01
0.1
1
10
100
MMP-2 MMP-3 MMP-9 MMP-13 TIMP-1 TIMP-3
2-
^
C
t
I1 50µg
I1 100µg
I1 300µg
I2 50µg
I2 100µg
I2 300µg
PE 2µg
PE 10µg
PE 25µg
Control- No Treatment
Figure 10 
Figure 11 
Figure 11 
Figure 12 
Figures 11-12: QRT-PCR results for MMP/TIMP mRNA expression of normal fibroblasts 
following treatment with increasing concentration of total protein of P. aeruginosa conditioned 
media or increasing concentrations of purified P. aeruginosa elastase (PE). Figure 11: Normal 
skin fibroblast (NF1) fibroblasts (for NF1 fibroblasts no data available for MMP-13 mRNA 
expression or for control [no treatment] cells); Figure 12:NF2 fibroblasts. 
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Figures 13-14: QRT-PCR results for MMP/TIMP mRNA expression of granulation tissue 
fibroblasts following treatment with increasing concentration of total protein of P. aeruginosa 
conditioned media or increasing concentrations of purified P. aeruginosa elastase (PE). Figure 13: 
Grnulation tissue fibroblast (GT1) fibroblasts (for GT1 fibroblasts no data available for MMP-13 
mRNA expression); Figure 14:GT2 fibroblasts (for GT2 fibroblasts missing data for MMP-2 [I1 
50µg, I1 100µg, I1 300µg] and missing data for TIMP-3 [I1 50µg]). 
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4.4.3 Immunohistochemistry 
Figure 15: Immunohistochemistry images of equine wound granulation tissue taken from the middle of the wound area; tissue sections were stained for MMP-2, 
MMP-9 and MMP-13. MMPs are stained light brown. 15.1: MMP-2 staining with bacterial clusters (see arrow) at the outer edge of the tissue section and darkly 
stained inflammatory cell (see elbow arrow); 15.2: MMP-2 staining around inflammatory cells (see arrows) at the edge of the tissue section; 15.3: MMP-9 staining 
with a large bacterial cluster (see arrow); 15.4: MMP-9 staining showing small clusters of bacteria (see arrows) and dark staining around inflammatory cells (see 
elbow arrow); 15.5: MMP-13 staining with clusters of bacteria (see arrow) and dark staining around inflammatory cells (see elbow arrow). Scale bars = 10µm 
15.1 15.2 15.3 
15.4 15.5 
10µm 10µm 
10µm 10µm 10µm 
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Figure 16: Immunohistochemistry images of equine wound granulation tissue taken from the outer edge of the wound area; tissue sections were stained for 
MMP-2, MMP-9 and MMP-13. MMPs are stained light brown. 16.1: MMP-2 staining towards the centre of the tissue section with dark staining around 
inflammatory cells (see arrows); 16.2: MMP-9 staining; dense areas of staining towards the middle of the tissue section (see arrows); 16.3: MMP-13 
staining; dense staining at the edge of the tissue section (see arrow) with small bacterial clusters (see elbow arrow). Scale bars = 10µm 
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Figure 17: Immunohistochemistry images showing no secondary antibody staining controls for MMP-2 (17.1), MMP-9 (17.2) and MMP-13 (17.3). 
Scale bars = 10µm 
17.1 17.2 17.3 
Images taken from immunohistochemistry slides (figures 15-17) reveal bacterial clusters both within tissue sections taken from the centre of the wound 
area and from the edges of the wound, indicating bacterial dissemination throughout the wound bed with both cocci and rod-shaped bacteria evident. 
These tissue sections also stained positively for MMPs -2, -3 and -13, with dark staining around immune cells which seems to link evidence of 
infection, inflammation and protease expression throughout the wound tissue. More prominent staining for MMPs was noted on those tissue sections 
taken from the outer edges of the wound area as compared with the centre of the wound.  
10µm 10µm 10µm 
 211 
 
4.4.4 Scratch Wound Assay 
 
The scratch wound assay was used to ascertain whether increasing concentrations of 
P. aeruginosa elastase has an effect on the wound healing capacity of both normal 
skin equine fibroblasts (NF) and equine granulation tissue fibroblasts (GT). 
Hydroxyurea was used as an inhibitor of proliferation so that wound closure was 
based on migration alone. Hydroxyurea (HU) is a metabolic inhibitor or 
ribonucleotide reductase (Stone et al, 2012) and inhibits DNA synthesis without 
affecting RNA or protein synthesis in a dose-dependent manner (Zungu et al, 2009). 
In the study by Jacobsen, Andersen and Krogfelt (2012), a concentration of 50µM 
HU inhibited fibroblast proliferation in an in vitro scratch wound assay. In the 
present study, a preliminary scratch wound assay was conducted and results revealed 
that this concentration of HU did not inhibit equine NF or GT fibroblast 
proliferation. Studies by Cai et al (2000), Sarkar et al (1996), Brown, Pan and 
Hassid (1999) and Zungu et al (2009) used concentrations in the range of 2mM-
5mM HU. Yet, higher concentrations of HU appeared to completely inhibit wound 
closure and cell viability was lost in the present study and so a concentration of 2mM 
HU was used in further experimentation. Cai et al (2000) showed that at this 
concentration of HU proliferation was completely inhibited whilst having a minimal 
effect on migration of human umbilical vein endothelial cells (HUVECs). Brown, 
Pan and Hassid (1999) also showed that HU did not have a significant effect on cell 
migration of aortic smooth muscle cells.  
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Crystal violet staining of control scratch wound wells (containing only fibroblasts 
plus HU-supplemented DMEM) revealed that during the course of the study 
fibroblasts were still proliferating given an increase in crystal violet staining. As a 
result, it was not possible to differentiate between the effects of treatment on 
proliferation and migration. Alternative methods for the study of cell migration and 
wound closure are considered in the discussion section. Furthermore, control cells 
died after 36 hours of incubation for unknown reasons and so percentage wound 
closure at 36, 60 and 72 hours post wounding (0 hours) following treatment with 
each concentration with P. aeruginosa elastase could not be compared with no 
treatment controls, but comparisons were made between the four different 
concentrations of P. aeruginosa elastase to determine if there was a dose-dependent 
response to treatment. 
 
Results revealed that both the GT1 and GT2 scratch wounds were between 25-70% 
healed by 36 hours and by 72 hours all wounds were completely or very nearly 
healed (see figures 18 and 19). Similar trends were noted for the NF scratch wounds 
(see figures 20 and 21), however the NF1 scratch wounds had reached a higher level 
of closure at 36 hours compared to NF2, GT1 and GT2 scratch wounds. Whilst not 
statistically significant (see table 4), it was noted that there was a wider variation in 
percentage wound closure at each time point between P. aeruginosa elastase 
treatment concentrations for the GT scratch wounds compared with the NF scratch 
wounds (see figures 18-21). Although it was not possible to determine if there was a 
significant effect of PE in general on wound closure compared with no treatment, 
results have shown that there was not a dose-dependent response to P. aeruginosa 
elastase treatment in terms of wound closure, i.e. an increase in P. aeruginosa 
elastase concentration did not adversely affect wound closure in this in vitro model. 
It should be kept in mind, however, that this model does not reflect the „true‟ in vivo 
environment, where several matrix proteins, cell types and cellular mediators are 
involved in wound closure. Suggestions for future work in terms of mimicking the 
clinical milieu are considered in the discussion section. 
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Table 4: Statistical analysis of scratch wound assay results. Comparisons were made 
between the percentage wound closure following varying concentrations of P. 
aeruginosa elastase for normal equine skin fibroblasts (NF) and equine wound 
granulation tissue fibroblasts (GT). 
 
Cell Type Time Point 
(hours) 
One-Way ANOVA Kruskal-Wallis 
test 
NF 36 F(3, 21) = 0.82, P = 0.500 P=0.944 
 60 F(3, 21)= 1.52, P= 0.243 P=0.087 
 72 F(3, 21)= 1.39, P= 0.277 P=0.261 
GT 36 F(3, 23)= 0.27, P= 0.845  
 60 F (3, 23)= 0.45, P= 0.718 P=0.652 
 72 F(3, 23)= 1.01, P= 0.408 P=0.564 
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Figure 18: Effect of P. aeruginosa elastase (0.1µg/ml, 0.2µg/ml, 0.5µg/ml and 2.5µg/ml) 
on scratch wound healing of equine granulation tissue fobroblasts (GT1). The surface of 
the wound area was measured at 0, 36, 60 and 72 hours post-wounding and the percentage 
wound closure over time was calculated. Data is presented as mean ± SEM. Statistical 
significance is detailed in table 4). 
 
Figure 19: Effect of P. aeruginosa elastase (0.1µg/ml, 0.2µg/ml, 0.5µg/ml and 
2.5µg/ml) on scratch wound healing of equine granulation tissue fobroblasts (GT2). The 
surface of the wound area was measured at 0, 36, 60 and 72 hours post-wounding and 
the percentage wound closure over time was calculated. Data is presented as mean ± 
SEM. Statistical significance is detailed in table 4). 
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Figure 20: Effect of P. aeruginosa elastase (0.1µg/ml, 0.2µg/ml, 0.5µg/ml and 2.5µg/ml) 
on scratch wound healing of normal equine skin fobroblasts (NF1). The surface of the 
wound area was measured at 0, 36, 60 and 72 hours post-wounding and the percentage 
wound closure over time was calculated. Data is presented as mean ± SEM. Statistical 
significance is detailed in table 4). 
 
Figure 21: Effect of P. aeruginosa elastase (0.1µg/ml, 0.2µg/ml, 0.5µg/ml and 2.5µg/ml) 
on scratch wound healing of normal equine skin fobroblasts (NF2). The surface of the 
wound area was measured at 0, 36, 60 and 72 hours post-wounding and the percentage 
wound closure over time was calculated. Data is presented as mean ± SEM. Statistical 
significance is detailed in table 4). 
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4.5 Discussion 
 
Despite the limited number of fibroblast cell donors available for use in the current 
study, clear detrimental effects of P. aeruginosa conditioned media and purified P. 
aeruginosa elastase on fibroblast viability and growth were highlighted. The crystal 
violet cell viability method has demonstrated that with increasing concentrations of 
total protein in P. aeruginosa conditioned media and increasing concentration of 
purified elastase generally the percentage decrease in cell viability became more 
prominent. This trend is consistent with earlier work conducted by Schmidtchen et al 
(2003) which demonstrated that LasB from ulcer-derived P. aeruginosa inhibited 
fibroblast growth. Microscopy images taken during the course of the experiment also 
confirmed that fibroblast growth and viability was hampered when cells were treated 
with P. aeruginosa elastase. In future experiments, further assays could be used in 
addition to the crystal violet staining method to assess cell changes following 
treatment, including assays to measure apoptosis and necrosis. 
 
Equine fibroblasts were used in this study given the prevalence of non-healing 
wounds with the generation of exuberant granulation tissue (EGT) in horses 
(Engelen et al, 2004; Lepault et al, 2005; Stashak, 2008). Furthermore, equine 
wounds are susceptible to bacterial contamination; recent investigation has identified 
the presence of microbial diversity and biofilms within the equine wound milieu 
(Westgate et al, 2010; Cochrane et al, 2009; Westgate et al, 2011) and thus the 
presence of bacterial proteases is important in these wounds. The 
immunohistochemistry images presented in this study also identified the presence of 
bacterial clusters within equine granulation tissue. Evidence of bacterial 
contamination was not only present at the edges of the wound area but also within 
tissue sections taken from the centre of the wound, demonstrating that bacteria are 
disseminated throughout the wound area. Furthermore, this bacterial staining 
appeared alongside MMP-2, -3 and -13 staining; MMP staining was also more 
prominent on tissue sections derived from the edge of the wound area and 
particularly around immune cells highlighting the correlation between infection, 
inflammation and protease expression.  
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It would be interesting in further investigations to analyse the expression of MMPs 
via the staining patterns in tissue sections used in an in vitro organ culture model 
used to assess the effects of conditioned P. aeruginosa medium and purified elastase 
on regulation of host MMPs. This would help to establish the localisation of MMP 
staining within tissue sections following treatment. Furthermore, the effects of live 
P. aeruginosa inoculation of cultured fibroblasts on MMP expression from host 
fibroblasts could be assessed to provide a better insight into the in vivo environment. 
Alternatively, 3D matrix models can be used, such as the collagen gel method 
adopted by Nagano et al (2001). The use of in vitro wound healing models which 
incorporate matrix proteins may influence the effect of P. aeruginosa proteases on 
mRNA MMP/TIMP expression and wound healing.  An organotypic co-culture 
wound model, such as that used by Schneider et al (2008), would also more closely 
reflect the in vivo environment. A chemical method of in vitro fibroblast wounding 
could be employed as an alternative to the scratch wound model (De Bentzmann et 
al, 2000). Alternative techniques can also be utilised to fully examine the effects of 
bacterial proteases on proliferation and migration, such as the Boyden Chamber 
method, whereby migration is analysed as the cells migrate through a simulated 
matrix (Decaestecker et al, 2007). The ways in which the migrating edge cells 
migrate to heal a wounded area in vitro can also be more closely monitored; random 
migration versus cohesive sheet migration can be measured, for example (Moreo-
Bueno, 2009). 
 
In terms of MMP and TIMP mRNA expression following treatment of equine 
dermal fibroblasts with P. aeruginosa conditioned medium and purified P. 
aeruginosa elastase, mRNA of each of the MMPs and TIMPs of interest were 
expressed by normal skin fibroblasts and granulation tissue fibroblasts at a higher 
level relative to GapDH.  However, due to a limited number of fibroblast cell donors 
it was not possible to come to definitive conclusions about the effects of elastase on 
the regulation of host MMP and TIMP mRNA expression. Yet, it was highlighted 
that fibroblasts derived from different sources/donors behave and respond to 
treatments with P. aeruginosa conditioned media and purified elastase in different 
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ways and therefore it is important to appreciate this variation in future studies. 
Samples from the fibroblast culture media were collected for analysis of protease 
content using zymography. However, no detectable host-derived protease bands 
were noted on gelatin zymograms; the proteolytic activity of culture supernatants 
may need to be concentrated in future experiments in order to detect lower protease 
levels from short culture periods.  
 
The use of specific protease inhibitors and specific inhibitors of toxins and other 
important P. aeruginosa virulence factors could be utilised in further investigations 
to establish the most important exoproducts within the P. aeruginosa conditioned 
media in terms of host cell growth and viability and MMP/TIMP mRNA expression. 
Since the regulation of MMPs is controlled at different levels including gene 
transcription, translation and pro-enzyme activation (Dong et al, 2000) it may be that 
P. aeruginosa elastase acts by activating pro-elastase rather than altering mRNA 
expression. As such, there are limitations in the use of immunohistochemistry and 
PCR techniques for the evaluation of MMP activity given the complex relationships 
between the presence of the protein, enzyme activation and the presence of MMP 
inhibitors. To further clarify the role of elastase on cell viability and MMP/TIMP 
mRNA production elastase-deficient strains of P.aeruginsoa could be utilised 
(Nagano et al, 2001).  
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4.6 Conclusion 
 
Whilst the data presented in this study should be interpreted as preliminary findings, 
this study has highlighted clear evidence of the deleterious effects of P. aeruginosa 
exoproducts, including purified elastase on the viability and growth of equine dermal 
fibroblasts. P. aeruginosa conditioned media and P. aeruginosa elastase caused a 
reduction in the growth of both normal skin fibroblasts and granulation tissue 
fibroblasts in a dose-dependent manner. Immunohistochemistry analysis revealed the 
presence of bacterial clusters disseminated throughout the wound bed. Furthermore, 
bacterial staining occurred in conjunction with moderate staining of MMPs -2, -3 
and -13 throughout the tissue. Whilst the study was limited in terms of cell donors 
available for qRT-PCR analysis, mRNA of each of the MMPs and TIMPs of interest 
were expressed by normal skin fibroblasts and granulation tissue fibroblasts at a 
higher level relative to GapDH, with cells from different sources/equine donors 
responding differently in terms of MMP/TIMP mRNA expression when treated with 
increasing concentrations of P. aeruginosa conditioned media or P. aeruginosa 
elastase.
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4.7 Appendices to Chapter 4 
 
Appendix 1 
 
Primer sequences 
 
Gene Primer Sequence 
MMP-2 F: GCCACTTGAGTTCGCCC 
R: ATCGCTGCGCCCTGTGTCTGTG 
MMP-3 F: TCTTGCCGGTCAGCTTCATATAT 
R: CCTATGGAAGGTGACTCCATGTG 
MMP-9 F: TTGGACATGCACGACGTCTT 
R: AGGGGTCCTGGGAGAAGTAA 
MMP-13 F: GAGCATCCTTCCAAAGACCTT 
R: CATAACCATTAAGAGCCCAAAATT 
TIMP-1 F: GCC AGG GCT TCA CCA AGA 
R: GGA TGG ATG AAC AGG GAA ACA 
TIMP-3 F: CTGCAACTTCGTGGAGAGGT 
R: ACTCGTTCTTGGAGGTCACG 
GAPDH F: GCATCGTGGAGGGACTCA 
R: GCCACATCTTCCCAGAGG 
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Appendix 2 
 
MMP-2 Immunohistochemistry Staining Method 
 
1. Xylene 2x 5mins 
100% ethanol 2x 2mins 
96% ethanol 1x 2mins 
2. Endogenous Block 
360ml methanol + 6ml H202 
30mins 
Wash dH20 
3. Citrate 6 Pre-treatment (30mins at 96°C, 20mins cool, then dH20) 
4. Rack up in sequenza clips using TBS 
5. 1x 5min TBS wash 
6. Block 50% swine serum in TBS, 10mins  
7. ~100µl MMP-2 Primary Antibody 
Mouse MAb MMP-2 Ab-4 (A-Gel VC2), MS-806-P1, NeoMarkers 
1:50 (dilute in TBS) 
4°C overnight 
8. 1x 5min TBS wash 
9. Apply ~100µl Secondary Antibody  
Rat anti Mouse (Jackson Immuno Research, 415-005-166) 1:100 in TBS 
30mins, room temp 
10. 1x 5min TBS wash 
11. Apply ~100µl PAP Mouse 
Mouse Peroxidase α Peroxidase, Jackson Immuno Research, 223-005-024 
1:500 in TBS 
30mins, room temp 
12. 1x5min TBS wash 
13.  Remove from sequenza clips to dH20 
14. DAB 10mins 
0.2g Diaminobenzidine in 400mls Imidazole Buffer: 
(280ml 0.1M Imidazole/120ml 0.42MHCl pH 7.2), filtered, activate with 
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140µl 30% Hydrogen Peroxide H202 (Fisher Scientific BP2633-500) 
15. 3x 5min washes dH20 
16. Counterstain with Papanicolaou‟s 1b Hematoxylin Solution (Merck 
1.09254.0500) 20mls in 400mls dH20 
stain 1min 
“blue” running tap water 5min 
17. Dehydrate, Clear & Mount: 
96% ethanol 1min 
100% ethanol 2min, 100% ethanol 3min 
Xylene 2min, Xylene 3min, Xylene 3min 
Coverslip with DPX 
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MMP-9 Immunohistochemistry Staining Method 
*Steps 1-6 as protocol for MMP-2 
7. ~100µl MMP-9 Primary Antibody 
Mouse MAb MMP-2 Ab-5 (IIA5), MS-817-P1, NeoMarkers 
1:10 (dilute in TBS) 
4°C overnight 
8. 1x 5min TBS wash 
9. Apply ~100µl Secondary Antibody  
Rat anti Mouse (Jackson Immuno Research, 415-005-166) 1:100 in TBS 
30mins, room temp 
10. 1x 5min TBS wash 
11. Apply ~100µl PAP Mouse 
Mouse Peroxidase α Peroxidase, Jackson Immuno Research, 223-005-024 
1:500 in TBS 
30mins, room temp 
12. 1x 5min TBS wash 
13.  Remove from sequenza clips to dH20 
14. DAB 10mins 
0.2g Diaminobenzidine in 400mls Imidazole Buffer: 
(280ml 0.1M Imidazole/120ml 0.42MHCl pH 7.2), filtered, activate with 
140µl 30% Hydrogen Peroxide H202 (Fisher Scientific BP2633-500) 
15. 3x 5min washes dH20 
16. Counterstain with Papanicolaou‟s 1b Hematoxylin Solution (Merck 
1.09254.0500) 20mls in 400mls dH20 
stain 1min 
“blue” running tap water 5min 
17. Dehydrate, Clear & Mount: 
96% ethanol 1min 
100% ethanol 2min, 100% ethanol 3min 
Xylene 2min, Xylene 3min, Xylene 3min 
Coverslip with DPX 
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MMP-13 Immunohistochemistry Staining Method 
*Steps 1-5 as protocol for MMP-2 
6. Block 20% swine serum in TBS, 10mins  
7. ~100µl MMP-13 Primary Antibody 
Rabbit PAb MMP-13, Abcam ab39012 
 1:100 (dilute in 20% swine serum in TBS) 
4°C overnight 
8. 1x5min TBS wash 
9. Apply ~100µl Secondary Antibody  
Polyclonal Swine α Rabbit, Dako Z0196 
1:100 (dilute in 20% swine serum in TBS) 
30mins, room temp 
10. 1x5min TBS wash 
11. Apply ~100µl PAP Rabbit 
PAP Rabbit, Covance SMI-4010L  
1:250 in TBS 
30mins, room temp 
12. 1x5min TBS wash 
13.  Remove from sequenza clips to dH20 
14. DAB 10mins 
0.2g Diaminobenzidine in 400mls Imidazole Buffer: 
(280ml 0.1M Imidazole/120ml 0.42MHCl pH 7.2), filtered, activate with 
140µl 30% Hydrogen Peroxide H202 (Fisher Scientific BP2633-500) 
15. 3x5min washes dH20 
16. Counterstain with Papanicolaou‟s 1b Hematoxylin Solution (Merck 
1.09254.0500) 20mls in 400mls dH20 
stain 1min 
“blue” running tap water 5min 
17. Dehydrate, Clear & Mount: 
96% ethanol 1min 
100% ethanol 2min, 100% ethanol 3min 
Xylene 2min, Xylene 3min, Xylene 3min 
Coverslip with DPX 
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5.1 Abstract 
 
The present study outlines the potential of a novel therapeutic dressing for the 
management of chronic wounds. The dressing incorporates polyphosphate, a non-
toxic compound with a number of beneficial characteristics in terms of wound 
healing, in a foam matrix. The aim of this study was to explore the hypothesis that 
polyphosphate incorporated into a foam dressing is able to sequester the activity of 
MMPs and proteases derived from Pseudomonas aeruginosa in vitro. Methods used 
included gelatin zymography and milk-casein agar plate analysis. Results have 
shown that this dressing is effectively able to reduce the levels of MMP-2 and MMP-
9 in both their active and latent forms using an in vitro model. The dressing also 
demonstrated its potential in the regulation of Pseudomonas aeruginosa derived 
proteases. Dressings that are able to alter proteolytic activity within the wound 
milieu, including the sequestration of bacterial proteases, could help to promote the 
healing of chronic wounds that remain in a state of prolonged inflammation 
characterised by an increase in protease levels and tissue degeneration. 
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5.2 Introduction  
 
Cutaneous wound healing is a complex process which involves a careful balance 
between tissue synthesis, deposition and breakdown. A number of cell types and 
molecular mediators are involved in the process, which work synergistically to 
achieve rapid restoration of tissue architecture and function (Ribeiro et al, 2009). If 
this balance is disrupted, however, healing is hampered leading the wound into a 
state of chronicity (Cullen et al, 2002; Wright et al, 2002). Such instances include 
chronic ulcers in which excessive tissue degradation prevails and keloid scars which 
are instigated by excessive extracellular matrix production (Ravanti & Kahari, 2000). 
Proteases including the matrix metalloproteinases (MMPs) and their inhibitors, 
particularly the natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), 
play a vital role in this equilibrium and are important factors of the healing process 
(Cullen et al, 2002). A number of cell types including keratinocytes, fibroblasts and 
endothelial cells contribute to the proteolytic environment within the wound bed. 
Whilst fibroblasts produce MMPs, invading neutrophils and macrophages produce 
elastase and collagenase (Trengove et al, 1999; Tarnuzzer & Schultz, 1996; McCarty 
et al, 2012).  
 
All chronic wounds are characterised by an elevated inflammatory response, 
resulting in increases in protease activity and abundance and decreased growth factor 
activity (Cullen et al, 2002). MMPs are able to break down peptide links of growth 
factors thus indirectly inhibiting matrix remodelling (Timmons, 2010). This dual 
biochemical imbalance in wound tissues is, in part, responsible for the failing of 
healing in such wounds, given the net loss of tissue (Cullen et al, 2002). MMPs have 
also been implicated in the pathogenesis of cancer metastasis, as a result of increased 
tissue breakdown and remodelling during invasive tumour growth and angiogenesis 
(Komorowski et al, 2002). Indeed, raised blood plasma levels of MMP-3 and MMP-
9 have been found in patients with medullary carcinoma (Komorowski et al, 2002). 
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MMPs are of particular interest in terms of cutaneous wound healing since a number 
of MMPs have been shown to be upregulated within the tissues of chronic wounds 
which fail to heal adequately. Indeed, research has revealed that the expression of 
various MMPs are upregulated during wound repair and regeneration, with mRNAs 
encoding specific MMPs being upregulated in wounded skin as compared to normal 
uninjured skin.  For example, a study by Lund et al (1999) demonstrated via a 
murine wound model that MMP-2, -9, -3, -13, -11, 12 and -14 were all upregulated 
in terms of mRNA expression in skin wounds when compared to normal control skin 
(Lund et al, 1999).  
 
Given the extensive evidence which suggests excessive MMP levels as a central 
pathological feature of chronic wounds, much research interest has been aimed at 
redressing this proteolytic imbalance and is an important goal of medical material 
science (Edwards & Howley, 2007). While many wound dressings are aimed at 
promoting healing through the absorption of exudates and reduction in bioburden 
through antimicrobial actions (Timmons, 2010), a number of dressings are now 
available which are aimed at sequestering MMP levels in the wound bed. Such 
dressings are aimed at modulating the biological molecules including growth factors 
and MMPs involved in wound healing (Veves, Sheehan & Pham, 2002).  
 
A limited number of studies have demonstrated the ability of polyphosphate 
dressings to sequester various proteinases within the wound bed. Unbound 
polyphosphate has been shown to promote healing of chronic wounds though the 
inhibition of proteases, in turn maintaining a robust extracellular matrix (Richardson 
et al, 2009). A number of polyphosphates have been used including 
trimetaphosphate and hexametaphosphate. Such polyphosphates may be used 
externally in wound dressings or may be administered enterally and have been 
shown to be effective against pepsin, collagenase, elastase and hyaluronidase and are 
active at a broad pH range of 2-6.  A number of enzyme dose response assays 
revealed that polyphosphates are active against wound associated proteases in a 
concentration-dependant manner (Richardson et al, 2009). Such dressings may prove 
to be more cost effective for the patient and health care services alike, when 
compared to other high technology approaches such as skin substitutes used to 
balance tissue degeneration (Hart et al, 2002).  
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The aim of the present study was to examine the potential MMP modulating capacity 
of a  foam dressing containing polyphosphate compared with a commercially 
available sterile, freeze-dried dressing with a collagen/oxidised regenerated cellulose 
(ORC) composition, a soft adherent foam dressing with Technology Lipido-Colloid 
(TLC) with the healing accelerator nano-oligosaccharide factor (NOSF) and a 
standard polyurethane foam dressing. Given the evidence which suggests an elevated 
level of MMPs -2 and -9 within the chronic wound milieu (Wysocki, Staiano-Coico 
& Grinnell, 1993), this study has focussed specifically on the ability of the selected 
dressings to sequester these MMPs. 
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5.3 Methods 
 
5.3.1 Chemicals and Reagents 
 
All chemicals and reagents were purchased from Sigma Aldrich (Dorset, UK) unless 
otherwise stated. 
 
5.3.2 Ethical Approval 
 
Approval for this study was granted by the Ethics Committee, University of 
Liverpool and informed consent was obtained from the owners of the animals 
participating in this study. 
 
5.3.3 Dressings 
 
Dressings used in this study included a standard polyurethane foam dressing (Smith 
and Nephew), a Collagen/ORC dressing (Johnson and Johnson), a TLC-NOSF 
dressing (Urgo Medical) and a foam dressing containing polyphosphate (Advanced 
Medical Solutions Plc). 
 
5.3.4 MMP-2 Isolation 
 
Equine dermal tissue was obtained either at post mortem of horses which had been 
euthanised for medical reasons or from tissue debrided during wound management 
procedures, in which case consent was given by the owner. All ethical considerations 
were made. Tissue sections were washed twice in 1x Hank's balanced salt solution 
(HBSS) (Gibco, Invitrogen, Paisley, UK) and minced into 3-5mm
2
 pieces and placed 
into 25cm
2
 culture flasks. Fibroblasts were cultured in Dulbecco's Modified Eagle 
Medium (DMEM) (Gibco, Invitrogen, Paisley, UK) supplemented with 10% foetal 
calf serum (FCS), 20mM Hepes buffer, 1% penicillin-streptomycin (Invitrogen, 
Paisley, UK) and 0.5µg/ml amphotericin B (Fungizone). The cultures were 
humidified in 5% CO2 in air at 37C. Following a culture period of 5-10 days cells 
were examined microscopically (Nikon Eclipse, Melville, USA) for outgrowth and 
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confluency. When confluent, cells were passaged in a ratio of 1:4 with 0.05% 
trypsin/EDTA and cells of passage 3-8 were used experimentally. Once cells 
regained confluency the media was removed and the cell layer washed with HBSS to 
remove all traces of FCS. Cells were then cultured in serum-free DMEM with 20mM 
Hepes buffer and 1% penicillin-streptomycin (Invitrogen, Paisley, UK) to 
confluency (approximately 5 days). The media was removed and cells were 
centrifuged at a speed of 1400rpm for 5 minutes. The supernatant media was 
removed and stored at -80C ready for enzyme purification and the pellet discarded 
appropriately.  
 
5.3.5 MMP-9 Isolation 
 
Equine peripheral blood was collected by venepuncture, anticoagulated with heparin 
and refrigerated for 30 minutes. Monocytes were isolated using Histopaque solution 
according to the manufacturer's instructions. In brief, the anticoagulated blood was 
layered on top of the Histopaque at a 1:1 ratio in 50ml centrifuge tubes. Blood 
samples were centrifuged at 400xg for 30 minutes to separate the monocyte layer 
from the blood plasma and red blood cells. Differential migration resulted in the 
clearly identifiable monocyte cell layer which was removed and successively washed 
in 1x HBSS. The monocytes were pelleted and stored in 0.5ml 1x HBSS. Cells were 
lysed with 1ml 0.1% triton X-100 per pellet and freeze-thawed 4 times to release the 
enzyme. The lysed cells were stored at -80C ready for enzyme purification.  
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5.3.6 MMP-2 and MMP-9 Purification using Gelatin Sepharose 
Chromatography 
 
A gelatin sepharose (GE Healthcare, Little Chalfont, UK) chromatography column 
was prepared using a 20ml disposable syringe (without needle) with a small amount 
of glass wool applied to the bottom and overlaid with 5mls gelatin sepharose 
solution. A separate column was prepared for MMP-2 and for MMP-9. The column 
was washed twice with equilibration buffer; 0.05M Tris base, 0.5M NaCl2 (Fisher 
Bioreagents, Fisher Scientific, Loughborough, UK), 0.005M CaCl2, 0.05% Brij, 
0.02% sodium azide, pH7.6. The fibroblast spent media or lysed cell suspensions 
were passed through the appropriate column and discarded. The column was washed 
with 5x 5ml equilibration buffer. The gelatin sepharose-bound enzyme was eluted 
with 10ml 10% dimethyl sulphoxide in 80% elution buffer (0.05M Tris 
hydrochloride, 1M NaCl, 0.005M CaCl2, 0.05% Brij 35%, 0.02% sodium azide) and 
collected in 15ml centrifuge tubes. The eluent was then dialysed overnight in MMP 
dialysis buffer (0.05M Tris hydrochloride, 0.005M CaCl2, 0.05% Brij 35, 0.02% 
sodium azide) at 4C. Dialysed aliquots were then stored at -80C until required for 
dressing incubation experiments. The columns were rehydrated with equilibration 
buffer, sealed and stored at 4C for further use.  
 
5.3.7 Dressing Interaction Studies Using Purified MMPs 
 
In order to assess the ability of each dressing to sequester MMP-2 and MMP-9 
activity an In vitro model was used, as adapted from the study by Walker et al 
(2005).  Dressing samples weighing 0.01g were prepared and incubated with 250µl 
of either MMP-2 or MMP-9 in triplicate for each of the four dressings in 24-well 
culture plates. Separate samples were incubated for 0 (1 minute), 3, 6, 24 and 48 
hours. At each corresponding time point 500µl 1x sterile phosphate buffered saline 
(PBS) was added to each well of the plate, to stop the action of the dressing and to 
aid in the elution of the enzyme solution from the dressing samples, and the enzyme 
samples were recovered and the supernatant stored at -80C until further analysis of 
enzyme activity using gelatin zymography. 
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5.3.8 Dressing Interaction Studies Using Pseudomonas aeruginosa Conditioned 
Media 
 
Bacterial Isolation and Identification 
 
P. aeruginosa isolates were obtained from chronic equine wounds using an 
optimised swab method and stored in Stuart's transport medium (Oxoid, 
Basingstoke, UK). Individual colonies were isolated on tryptone soy agar (TSA) 
(LabM, Bury, UK) plates and colonies were confirmed as P. aeruginosa on 5% 
blood agar plates and MacConkey agar (LabM, Bury, UK), followed by Gram 
staining and analysis under oil immersion. Oxidase tests and API identification strips 
(API 20 E, Biomerieux, Basingstoke, UK) were used for final identification. An 
ATCC type strain of P. aeruginosa (ATCC 27853) was used as a control.  
 
P. aeruginosa Conditioned Media Preparation 
 
Sterile Mueller Hinton broth (MHB) was inoculated in 30ml portions with each of 
the corresponding P. aeruginosa isolates and cultured with shaking at 150rpm in a 
shaking incubator set at 37C for 24 hours in 75cm3 culture flasks. Cultures were 
harvested and centrifuged at 12000rpm for 10 minutes to pellet the cells. 
Conditioned culture supernatant was filtered through 0.45µm sterile filters.  
 
Dressing Interaction Studies 
 
In order to assess the ability of each dressing to sequester P. aeruginosa derived 
protease activity in vitro, 0.01g dressing samples were prepared and incubated with 
250µl of each corresponding P. aeruginosa conditioned media in triplicate for each 
of the four dressings in 24-well culture plates. Separate samples were incubated for 0 
(1 minute), 3, 6, 24 and 48 hours. At each corresponding time point 500µl sterile 
PBS was added to each well of the plate and the enzyme samples were recovered and 
the supernatant stored at -80C until further analysis of enzyme activity. Dressing 
interaction studies were also performed with a combination of MMP-2 and P. 
aeruginosa conditioned media: 125µl of MMP-2 was added to the plate wells with 
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50µl conditioned P. aeruginosa media. Samples were treated as previously described 
following incubation, and supernatants harvested ready for analysis via the milk-
casein agar plate method. 
 
5.3.9 Milk-Casein Agar Plate Inoculation  
 
Whilst the milk-casein agar plate method for detecting proteolytic activity is only 
semi-quantitative, it provides an initial visual representation of the levels of general 
proteolytic activity of different bacterial isolates over time prior to further 
investigation. This method is commonly used for the screening of general proteases 
produced by both Gram negative and Gram positive bacteria, as reviewed by Kasana, 
Salwan & Yadav, (2011). Whilst some studies have measured the proteolytic activity 
of various microorganisms from the proteolytic halo zone formed around colonies 
from microorganisms isolated from various settings (Sokol, Ohman & Iglewski, 
1979; Howe & Iglewski, 1984; Nicas & Iglewski, 1984; Wery et al, 2003; 
Ponmurugan, 2007), in this study the method was standardised using wells cut into 
the agar plates into which an aliquot of conditioned bacterial media from a culture 
sample normalised to a set optical density (OD) was placed. This method has been 
used previously to detect the presence of bacterial proteolytic activity in the clinical 
setting (Palolahti et al, 1993; Wladyka et al, 2008). 
 
Milk-casein agar was prepared with 25g skim milk powder (BD, Oxford, UK) 2.5g 
casein (BDH, VWR, Lutterworth, UK), 1.25g yeast extract (Oxoid, Basingstoke, 
UK), 0.5g D-glucose (BDH, Oxford, UK) and 6.25g No. 1 agar (LabM, Bury, UK). 
Agar was sterilised by autoclaving and poured to equal levels into 9cm round petri 
dishes. A sterile 8mm punch biopsy was used to bore single wells in each of the milk 
plates. Samples recovered from the dressing incubations with P. aeruginosa 
conditioned cell-free media were used to inoculate milk-casein agar plates. A 100µl 
aliquot of each sample was applied to the 8mm wells made in milk plates in 
triplicate. Plates were incubated for 24 and 48 hours. Following incubation, the 
caseinolytic area was measured; two measurements were made in mm at right angles 
to each other and an average measurement made, minus the 8mm well (see Figure 1). 
For calculations of percentage decrease in caseinolytic activity, the average 
measurement of the clear caseinolytic zone (mm) (minus the 8mm well) for each 
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sample was given as a percentage of the average measurement of the clear 
caseinolytic zone (mm) (minus the 8mm well) for the wells containing conditioned 
media which was previously incubated without any of the test dressings (control 
wells). Percentage decrease in the caseinolytic zone, as compared with the control 
wells, was then calculated. 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.10 Dressing Interaction Studies with P. aeruginosa Live cultures 
 
P. aeruginosa cultures, both wound-isolates and ATCC type strain, were prepared as 
previously described in Chapter 2. Live cultures were standardised to an optical 
density of 0.85 at 600nm using a spectrophotometer. 100µl aliquots of each 
individual culture were applied, in triplicate, to 8mm wells in milk-casein agar 
plates, prepared as previously described. 0.01g portions of each dressing were 
overlaid over the cultures in the corresponding wells. Plates were incubated at 37C 
for 24 and 48 hours. Caseinolytic zones were measured as described above and 
averages taken.  
 
Figure 1: Method of calculation of caseinolytic zone using the milk-casein agar plate method. 
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5.3.11 Treatment of Samples for Gelatin Zymography 
 
Samples were diluted with non-reducing Laemmli sample buffer (Bio-Rad, Hemel 
Hempstead, UK ) at a ratio of 1:5 and distilled water to an overall 1:5 dilution of the 
sample. Samples were then incubated in a 37C water bath for 1 hour to activate the 
enzyme prior to application to the gel. A Miniprotean II gel system (Bio-Rad, Hemel 
Hempstead, UK) was employed for zymography gels. A 7.5% acrylamide/bis-
acrylamide (Severn Biotech Ltd., Kidderminster, UK) resolving gel copolymerised 
with a 1% gelatin solution (EIA grade reagent gelatin) (Bio-Rad, Hemel Hempstead, 
UK) was prepared to create a 0.25% gelatin zymogram in a pH8.8 resolving buffer 
(1.5M Tris/HCl). A volume of 3.2ml of this was cast in between ethanol washed 
glass gel plates and overlain with isobutanol to level the gel. The gel was left to set. 
Once set, the resolving gel was layered with a stacking gel made up with a pH6.8 
buffer (0.5M Tris/HCl) and was left to set with a 10 lane comb inserted in the top of 
the gel. The gels were placed in a tank filled with running buffer and 20µl portions 
of each sample were loaded into the gel and subjected to electrophoresis at 200 volts 
for 1 hour or until the lane marker had run off the end of the gel. Mark-12 high 
molecular weight lane markers (Invitrogen, LC5677, unstained standards) were run 
on each gel.  Following electrophoresis, gels were carefully removed from the glass 
plates and the lane markers were removed and placed in 0.02% coomassie brilliant 
blue stain (BDH, Oxford, UK) for 15-20 minutes. The gels were placed in 2.5% 
Triton X-100 and agitated on a plate shaker at rpm for 1 hour to remove all traces of 
SDS. The gels were washed thoroughly in distilled water and placed in MMP 
incubation buffer/gelatine refolding buffer overnight. After incubation, the gels were 
stained for 1 hour in 0.5% coomassie stain and then destained in a solution of diluted 
methanol/acetic acid until clear bands of digested gelatin were visible against a 
darkly stained blue background. Gels were visualised and imaged using Genesnap 
software. The gels were dried in cellophane sheets using a Hoeffer gel drying dock.  
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5.3.12 Gel Quantification 
 
Gel images were captured and analysed using the GeneGenius Gel Documentation 
System (Syngene, Cambridge, UK). The relative activity value (RAV) was 
calculated using the following equation: 
 
RAV =   Peak area of sample 
                 Peak area of positive control 
 
 
5.3.13 SDS-PAGE Analysis of Conditioned P. aeruginosa Media 
 
A 15% acrylamide mini gel was prepared using 3.2mls resolving gel in a 1.5M 
Tris/HCl buffer, pH 8.8. Once set this gel was overlaid with a stacking gel made up 
in a 0.5M Tris/HCl buffer, pH 6.8 in a Miniprotean gel system (Bio-Rad Hemel 
Hempstead, UK). Samples were prepared by adding 13µl original sample, 2µl DTT 
and 5µl non-reducing sample buffer with marker dye (Thermo Scientific,). Samples 
were denatured by heating for 10 minutes in a heat block pre-set to 80C. The 
samples were vortexed briefly. A 20µl aliquot of each sample was added to each 
corresponding lane of the gel. The gel tank was filled with a 1:20 dilution of 
NUPAGE MES SDS running buffer (Invitrogen, Paisley, UK) in distilled water. The 
gel was run at 15 volts for approximately 2 hours or until the lane marker ran to the 
bottom of the gel. The gels were carefully removed from the glass plates and placed 
in 0.02% Coomassie brilliant blue stain for 2 hours with agitation. Gels were then 
destained in a solution of diluted methanol/acetic acid until dark bands appeared 
against a stain-free background. 
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5.4 Results 
 
5.4.1 Dressing Incubations with MMP-2 and MMP-9 
 
Following incubation at 37
o
C with all of the dressings tested, the residual proteinase 
activity was assayed at 0 (1 minute), 1, 3, 6, 24 and 48 hours to evaluate the capacity 
for each dressing to inactivate both purified MMP-2 and MMP-9. All of the 
dressings tested were able to reduce the levels of active and latent enzymes when 
compared to the control (no dressing) from 1 minute onwards. The standard foam 
dressing was less effective than the other dressings, yet was still able to actively 
reduce MMP levels. This could be attributed to the dressing‟s active fluid 
management system.  Samples incubated with the Collagen/ORC dressing 
demonstrated complete inhibition of both MMP-2 and MMP-9 in their latent (figures 
2 and 4) and active forms (figures 3 and 5) from 1 hour onwards. The foam dressing 
containing polyphosphate consistently outperformed both the standard foam dressing 
and the TLC-NOSF dressing in terms of the sequestration of the active and latent 
forms of MMP-2 and MMP-9. Samples treated with the foam dressing containing 
polyphosphate demonstrated a time-dependant reduction in MMP activity, 
decreasing MMP-2 and MMP-9 by more than 50% by 48 hours in both the active 
and latent forms.  
 
Incubations with MMP-2 and 9 showed that the foam dressing containing 
polyphosphate sequestered significantly more latent enzyme than the TLC-NOSF 
dressing at  3 and 48 hours (P<0.005). The performance of the foam dressing 
containing polyphosphate was significantly greater when compared to the standard 
foam dressing following 1, 3, 6, 24 and 48 hours incubation with the enzymes 
(P<0.001) (see figures 2-7). 
 
The foam dressing containing polyphosphate significantly reduced the active 
enzymes (both MMP-2 and MMP-9) when compared to the TLC-NOSF dressing at 
1, 3, 6 and 24 hours (P<0.005).  Likewise there was a significant reduction (P<0.001) 
in active MMP-2 and 9 when tested against the standard foam dressing at 1, 3, 6, 24 
and 48 hours. 
  
 239 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
0 1 3 6 24 48
M
M
P
-2
 A
c
ti
v
it
y
 (
R
A
V
)
Time (hours)
Control
Standard Foam Dressing
Collagen/ORC Dressing
Foam Dressing Containing 
Polyphosphate
TLC-NOSF Dressing
Figure 2: Action of each of the test dressings against the activity of MMP-2 in the latent 
form. Dressings were incubated with MMP-2 (n=3) for 0, 1, 3, 6, 24 and 48 hours. 
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Figure 3: Action of each of the test dressings against the activity of MMP-2 in the active 
form. Dressings were incubated with MMP-2 (n=3) for 0, 1, 3, 6, 24 and 48 hours. 
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Figure 4: Action of each dressing against the activity of MMP-9 in the latent form. 
Dressings were incubated with MMP-9 (n=3) for 0, 1, 3, 6, 24 and 48 hours. 
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Figure 5: Action of each dressing against the activity of MMP-9 in the active form. 
Dressings were incubated with MMP-9 (n=3) for 0, 1, 3, 6, 24 and 48 hours. 
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1          2          3          4          5          6         7       8         9          10        
72 kDa 
64 kDa 
Figure 6: Example zymogram of samples from dressing incubations with MMP-2. 
The 72 kDa bands are indicative of latent MMP-2 whereas the 64 kDa bands are 
indicative of active MMP-2. Lanes 1-3: T0, standard foam dressing; Lanes 4-6: T0, 
Collagen/ORC dressing; Lanes 7-9: T0, Polyphosphate; Lane 10: T0, Control 
MMP-2 (no dressing treatment). There was an initial reduction in the level of 
MMP-2 activity (latent and active enzyme) following incubation with each 
dressing. The Collagen/ORC dressing resulted in the greatest reduction in MMP-2 
activity at 0 hours (1 minute). 
 
 
1          2          3          4          5          6         7       8         9          10        
72 kDa 
64 kDa 
Figure 7: Example zymogram of samples from dressing incubations with MMP-2. The 
72 kDa bands are indicative of latent MMP-2 whereas the 64 kDa bands are indicative 
of active MMP-2. Lane 1: T3, Control MMP-2 (no dressing treatment), Lanes 2-4: T3, 
standard foam dressing; Lanes 5-7: T3, Collagen/ORC dressing; Lanes 8-10: T3, 
Polyphosphate. There was a reduction in the level of MMP-2 activity (latent and active 
enzyme, but particularly the active enzyne) following 3 hours incubation with each 
dressing. The Collagen/ORC dressing resulted in the greatest reduction in MMP-2 
activity at 3 hours, followed by the foam dressing containing polyphosphate. 
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5.4.2 Dressing Interaction Studies Using Pseudomonas aeruginosa Conditioned 
Media 
 
Each of the test dressings were incubated as described for the MMP incubations, 
with 250µl filtered 24 hour conditioned culture media from 1 ATCC type strain and 
2 chronic wound-isolated strains of P. aeruginosa. Milk-casein agar plate evaluation 
demonstrated a reduction in caseinolytic activity following dressing incubation with 
each of the dressings when compared with the bacterial conditioned media alone. 
The percentage decrease in caseinolytic zone area showed that the foam dressing 
containing polyphosphate sequestered P. aeruginosa derived proteases to a greater 
extent when compared to the standard foam dressing and the TLC-NOSF dressing 
after 24 hours (figure 8) when incubated with the ATCC type strain derived 
conditioned media. In contrast, the proteolytic activity of the ATCC P. aeruginosa 
conditioned media incubated with the TLC-NOSF dressing and the standard foam 
dressing returned after 24 hours. The Collagen/ORC dressing had the greatest effect 
against the proteases of this strain, reducing the proteolytic activity from 1 hour 
onwards when compared in terms of percentage decrease with the other dressing 
types. The foam dressing containing polyphosphate showed an optimum activity at 
each time point against the wound-isolated strain with high biofilm forming 
capacity, when compared to each of the other 3 dressings.  
 
The activity of the Collagen/ORC dressing peaked following 3 hours incubation with 
the conditioned media of each strain but this dressing demonstrated the greatest 
activity against the ATCC P. aeruginosa reference strain derived conditioned media 
when compared to the chronic-wound isolated P. aeruginosa cultures. Results 
showed that following 24 hours incubation, the foam dressing containing 
polyphosphate was more active at reducing caseinolytic zones from the high biofilm-
forming P. aeruginosa isolate derived proteases than the Collagen/ORC dressing. 
The foam dressing containing polyphosphate  was also significantly better at 
reducing proteolytic activity than the TLC-NOSF dressing after 3 hours of 
incubation with the conditioned media from the high biofilm-forming isolate 
(P<0.05). SDS-PAGE analysis was conducted to identify the major proteases 
produced by P. aeruginosa isolates in vitro (see figure 9). 
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Figure 8: Percentage decrease in caseinolytic zone of milk-casein agar when incubated with each dressing and protease-
rich conditioned media of an ATCC type strain and 2 chronic wound-isolated P. aeruginosa. Milk-casein agar plates were 
incubated (n=3) for 0, 1,3, 6 and 24 hours. I1: P. aeruginosa Wound strain 1 (low biofilm potential); I2:  P. aeruginosa 
Wound strain 2 (high biofilm potential). 'Polyphosphate' refers to the foam dressing containing polyphosphate. Data is 
presented as mean ± SEM. 
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Figure 9: Example SDS-PAGE showing the major protein bands produced by P. aeruginosa chronic equine wound isolates at 4 
hours (Lanes 2 & 3), 8 hours (Lanes 4 & 5), 12 hours (Lanes 6 & 7) and 24 hours (Lanes 8 & 9) after MHB inoculation. Lane 1: 
Protein markers; Lanes 2, 4, 6 & 8: Low biofilm forming isolate; Lanes 3, 5, 7, & 9: High biofilm forming isolate. The second bands 
from the top of the gel may represent the 33kDa protein, mature elastase whereas the top bands seen on the gel may represent the 
51kDa proelastase or the 53kDa preproenzyme of elastase (McIver, Kessler & Ohman, 1991). However, for confirmation further 
protein analysis would be required. 
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5.4.3 Dressing Incubation with Live P. aeruginosa Cultures 
 
Each of the dressings were tested for their potential ability in sequestering the 
proteases secreted into the media of a number of live P. aeruginosa cultures. Results 
showed that after 24 hours incubation the foam dressing containing polyphosphate 
reduced the caseinolytic zones of milk-casein agar plates inoculated with each of the 
clinical P. aeruginosa isolates when compared with the test plates with no dressing 
and compared to each of the other dressings (see figure 10).  
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Figure 10: Caseinolytic zone measurements (average of 2 measurements) (n=3) of milk-casein agar plates inoculated with P. aeruginosa 
live cultures, overlaid with each of the 4 dressings. Plates were incubated for 24 hours and 48 hours and measurements made at each time 
point. ATCC: P. aeruginosa reference strain; I1: P. aeruginosa Wound strain 1 (low biofilm potential); I2:  P. aeruginosa Wound strain 2 
(high biofilm potential). 'Polyphosphate' refers to the foam dressing containing polyphosphate. Data is presented as mean ± SEM. 
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5.4.4 Dressing incubations with a combination of purified MMP-2 and P. 
aeruginosa conditioned media 
 
Each of the dressings were tested for their potential ability in sequestering the 
proteases of P. aeruginosa conditioned media in combination incubations with 
purified MMP-2 (see figures 11 and 12). Results showed that the foam dressing 
containing polyphosphate reduced the activity of both MMP-2 and the P. aeruginosa 
derived protease steadily over a 6 hour period. However, following further 
incubation, the activity of the bacterial derived protease increased. This also 
occurred in the other dressing incubations, apart from the Collagen/ORC dressing 
which maintained its activity over the 24 hour period. The foam dressing containing 
polyphosphate performed better than the standard foam dressing throughout the 
incubation period.  
 
Results from the zymography analysis revealed that the dressings had an immediate 
action in terms of sequestration of the active MMP-2 enzyme when in combination 
with P. aeruginosa derived protease. Similarly, the levels of P. aeruginosa protease 
activity decreased rapidly throughout the incubation period for all dressings tested. 
However, when incubated with the standard foam dressing the activity of P. 
aeruginosa-derived protease increased after 3 hours before reaching an activity that 
was over 80% of the control after 24 hours incubation. This also occurred when 
samples were incubated with both the foam dressing containing polyphosphate and 
the TLC-NOSF dressing but only after a 6 hour incubation period. The reason for 
this increase is not known, but may suggest that the dressings are only able to alter 
the activity of these enzymes for a limited period. The Collagen/ORC dressing was 
effectively able to reduce the activities of both MMP-2 and P. aeruginosa derived 
protease following 0 (1 minute), 3, 6 and 24 hours incubation when tested in this In 
vitro model.
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Figure 11: Action of each dressing against the activity of MMP2. Dressings were incubated with MMP2 
(n=3) for 0, 3, 6 and 24 hours. 
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Figure 12: Action of each dressing against the activity of P. aeruginosa-derived protease. Dressings were 
incubated with bacterial protease (n=3) for 0, 3, 6 and 24 hours. 
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5.5 Discussion  
 
It has been consistently reported that elevated levels of proteases, particularly the 
metalloproteases MMP-2 and MMP-9 are present in chronic wound fluids in a range 
of mammalian models (Cullen et al, 2002; Lund et al, 1999; Cochrane, 1997). It is 
likely that the sequestration of these harmful levels of MMPs within the wound bed 
could enhance healing and encourage matrix reformation. While it may not be 
possible, and would not be necessary, to completely remove MMPs from the wound 
environment or to completely inhibit their action, their activity may be contained 
sufficiently. 
 
 A number of dressings have been developed with the aim to retain MMPs within the 
wound bed or to sequester protease activity, including silver dressings (Walker, 
Bowler & Cochrane, 2007), collagen-containing dressings which act as an alternative 
substrate for MMPs (Cullen et al, 2002) and dressings which act to absorb and retain 
proteases within the matrix of the dressing whilst immobilising bacteria (Walker et 
al, 2003). While collagen is useful in wound healing as a mechanical scaffold to 
promote fibroblast migration (Hart et al, 2002) and can enhance the metabolic 
activity of newly formed granulation tissue, regenerated cellulose is able to 
effectively reduce levels of proteases. Another type of dressing incorporates a 
compound aimed at improving wound closure primarily through MMP inhibition, 
namely nano-oligosaccharide factor or NOSF. Polyphosphates have been used for 
their ability to chelate alginate, a product of biofilm forming bacteria. Molecularly 
dehydrated polyphosphates have been added to wound dressings to reduce the 
alginate present in infected wounds and they have proved more successful than 
organic surfactants in terms of their toxicity to the skin. Indeed, polyphosphates have 
been shown to be more effective at chelating and solubilising alginate than other 
commercially available chelating agents including EDTA, malonic acid and acetic 
acid. Furthermore, these other chelating agents require stabilisation of pH to ensure 
cytoprotection, which is not always possible during wound management.  
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Ribeiro et al (2009) described a chitosan hydrogel dressing which incorporated 
polyphosphate as an anticoagulant along with silver as an antibacterial agent. While 
many research studies have focussed on the anticoagulant properties of 
polyphosphates in wound dressings, the potential of this substance in protease 
sequestration is emerging. Since polyphosphates are negatively charged, they 
associate with and bind cations, including zinc ions and so prove useful in the 
sequestration of metalloproteinases. Furthermore, polyphosphate has also been 
shown to have antibacterial properties, although this has been insufficiently studied 
experimentally.  
 
In the present study, it has been demonstrated that a foam dressing containing 
polyphosphate was able to sequester both MMP-2 and MMP-9 in their active and 
latent states as visualised using gelatin zymography. The results from this study also 
showed that the Collagen/ORC dressing effectively inhibited the activity of both 
MMP-9 and MMP-2, corresponding well to published data on the efficacy of this 
dressing (Cullen et al, 2002b). The Collagen/ORC dressing functions to actively 
bind and inactivate  proteases involved in wound healing including MMPs, plasmin 
and neutrophil elastase (Cullen et al, 2002b). As in other studies, this dressing 
sustained its activity throughout the 48 hour test period. This coincides with the 
dressing change time period recommended for this type of dressing (Cullen et al, 
2002b). The collagen component of this dressing acts as an alternative substrate, 
binding the proteases and thus inactivating them. The Collagen/ORC active agent is 
negatively charged, and is able to physically bind positively charged molecules 
including metal ions important for MMP structure and stability.  
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The current study represents significant data relating to the efficacy of a foam 
dressing containing polyphosphate in the sequestration of MMPs -2 and -9: the 
dressing was effectively able to reduce MMP-2 and MMP-9 activity throughout the 
48 hour test period, with optimal activity observed after 6 hours of incubation with 
these enzymes. Furthermore, the foam dressing containing polyphosphate out-
performed the standard foam dressing and the TLC-NOSF dressings in terms of 
reducing the levels of active MMP-2 and -9 over the entire incubation period and 
until 24 hours incubation, respectively. Future studies should aim to assess the 
capacity of the foam dressing containing polyphosphate to sequester other important 
proteases involved in wound healing, including neutrophil elastase and also any 
effect of this dressing on the levels of relevant protease inhibitors. 
 
The foam dressing containing polyphosphate also demonstrated potential in the 
inactivation of P. aeruginosa derived proteases, both alone and in combination with 
MMP-2. Moreover, the foam dressing containing polyphosphate was more effective 
in the inhibition of proteases derived from a P. aeruginosa chronic wound-derived 
isolate with high biofilm-forming capacity when compared to a type strain and a low 
biofilm forming isolate. This may be important in relation to chronic wounds in 
which high levels of bacterial bioburden exist, particularly in the biofilm state. There 
is very little evidence in the literature to suggest a role of therapeutic wound 
dressings in inhibition of bacterial derived proteases despite evidence suggesting that 
these proteases play a vital pathological role in wound chronicity.  
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Whilst the methods employed in this study for the analysis of protease activity are 
semi-quantitative, the study demonstrates the potential of a novel foam dressing 
containing polyphosphate to inhibit both host MMPs -2 and -9 and also those 
exogenous proteases found within the wound bed. However, after longer incubation 
times the activity of the P.aeruginosa derived proteases increased for all dressing 
incubations apart from the Collagen/ORC dressing. This may be due to the limited 
effectiveness of dressings over extended time periods or may be a result of proteases 
being released back into the surrounding supernatant from the dressing samples. The 
dressings had an immediate action in terms of sequestration of the active MMP-2 
enzyme when in combination with P. aeruginosa derived protease. Whether this is a 
direct synergistic effect of the presence of bacterial protease remains to be 
elucidated. 
 
In future experimentation, fully quantitative methods should be used to confirm the 
levels of specific bacterial derived proteases; substrate assays can be utilised to 
assess specific protease activity. For instance, the elastin Congo red (ECR) assay can 
be used for the detection of P. aeruginosa elastase. Fluorescent substrate assays can 
also be used for quantitative analysis of proteolytic activity. Furthermore, other 
bacterial proteases should be considered in future studies. For example, 
Staphylococcus aureus produces a number of proteases (including the serine 
protease, V8 protease) which are considered important virulence factors within the 
wound milieu. Different combinations of host and bacterial proteases could be used 
to assess the ability of the foam dressing containing polyphosphate to sequester those 
proteases found within the chronic wound. Although the study of the mechanism(s) 
of action of the polyphosphate foam dressing was beyond the scope of the current 
study, the effect seen could relate to the inhibition of biofilm formation through the 
binding of zinc which is also the key pathway in the inhibition of metalloproteinases. 
Furthermore, chelation of Zn
2+ 
specifically prevents biofilm formation by S. 
epidermidis and methicillin-resistant S.aureus (MRSA) (Conrady et al, 2008). 
However, the exact mechanism which allows for both MMP and biofilm derived 
proteases in combination remains to be elucidated. Yet, the therapeutic inhibition of 
zinc molecules within the wound bed may prove useful in inhibiting both biofilm 
formation (Conrady et al, 2008) and in the inactivation of proteases, both bacterial 
and host-derived.  
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Further investigation into the potential of the foam dressing containing 
polyphosphate to sequester proteases should also consider dressing absorption; 
proteases which are free within the dressing once absorbed may still be active and 
thus would be free to migrate back into the wound bed. It is important to investigate 
the mechanism of action of the dressing in terms of reduction of protease activity and 
to address the questions of whether proteases are bound within the dressing and 
whether they are permanently inactivated. In figures 2-5 and figures 11-12, there is 
evidence of protease activity returning over time following incubation of the 
proteases with the test dressing samples. This may be indicative of an initial decrease 
in protease activity due to dressing absorption; in future experimentation it may be 
useful to pre-wet the dressing samples so as to exclude absorption as an influential 
factor. 
 
In terms of transposing the data presented to the human chronic wound, the equine 
model is an ideal model in which to study the naturally occurring human chronic 
wound (Cochrane, 1997; Cochrane, Pain & Knottenbelt, 2003). The pathophysiology 
of the equine chronic wound is very similar to that of the human chronic wound. For 
example, the equine indolent wound is similar in appearance to human venous leg 
ulcers; they produce little granulation tissue and are often inflamed and infected 
(Cochrane, 1997). The equine wounds used to isolate bacteria used in the present 
study were naturally occurring chronic wounds. Furthermore, gelatinase activity in 
equine tissue homogenates show that the major bands of activity in equine 
granulation tissue correspond to human MMP-2 and MMP-9 and  proteolytic bands 
have been shown to be less prominent in normal tissue homogenates compared with 
granulation tissue homogenates (Cochrane, 1997). Whilst no In vitro model can 
mimic the true clinical environment in terms of the levels of proteolytic activity, 
future experimentation could utilise wound fluids collected from acute and chronic 
wounds to test the ability of wound dressings to sequester various proteases. 
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5.6 Conclusion 
 
To conclude, this study has presented evidence to suggest a role for polyphosphate 
when incorporated into a foam wound dressing for the management of chronic 
wounds with elevated protease activity. A foam dressing incorporating 
polyphosphate has been shown to reduce the activity of both host MMPs -2 and -9 
and P. aeruginosa derived proteinases in an in vitro model. 
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6.0 Chapter 6 
 
6.1 General Discussion and Future Direction 
 
The main aims of this study were to investigate whether P. aeruginosa isolates from 
equine wounds display elevated levels of proteolytic activity in vitro and what 
effects changing the growth environment of these isolates, with relevance to the 
chronic wound environment, have in terms of protease production of these isolates. 
This study highlighted a clear variation in the protease expression of isolates derived 
from chronic equine wounds which corresponded well with previous work by 
Schmidtchen, Wolff & Hansson (2001). Furthermore, the reference, non-wound 
ATCC P. aeruginosa strain used in all experiments generally demonstrated lower 
overall protease secretion and lower elastase secretion in all culture conditions. 
These results collectively highlight the need for caution when interpreting results 
from reference strains and from bacterial isolates obtained from varied sources. 
 
Following the work of Morihara (1964), which characterised P. aeruginosa 
proteases, many studies have focussed upon the pathogenic nature of P. aeruginosa 
isolates from various infection sites in terms of protease secretions. It has long been 
known that the pH of the wound bed is an important factor in the healing process, 
with different pH ranges required for different phases of healing. Oxygen tension 
also has an impact on healing and can cause alterations in patterns of bacterial 
pathogenicity and colonisation (Hunt et al, 1975; Sabra, Kim & Zeng, 2002; Sabra, 
Lünsdorf & Zeng, 2003). In order to investigate the effects of the culture 
environment of P. aeruginosa wound isolates on protease secretion into the 
surrounding environment, studies were conducted using in vitro culture models as 
described in Chapter 2. The study highlighted both the variation in protease activity 
between P. aeruginosa isolates and the variation in the response of isolates to 
changes in initial culture pH in terms of protease activity in the spent culture 
medium. 
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The study also revealed that protease production from the clinical isolates and the 
ATCC reference strain generally increased over the culture period, with caseinolytic 
and elastolytic activities generally maximal by the exponential phase of growth. This 
pattern of proteolytic activity was also maintained when the pH of the culture 
medium and oxygen availability was adjusted. It would be interesting to develop this 
study further by using repeated cultures from the same wounds over a period of time 
to assess the proteolytic profiles of P. aeruginosa isolates over the course of the 
wound healing process.  
 
Given that P. aeruginosa virulence factor production, including protease production, 
is influenced by the nutritional complexity of the growth environment, particularly 
the presence or absence of metal ions (Twining, Davis & Hyndiuk, 1986; Olson & 
Ohman, 1992; Wagner et al, 2003), in future experiments alteration to the growth 
medium could be made in order to increase assay sensitivity since higher amounts of 
both alkaline protease and elastase are produced when such components are added to 
the growth medium (Twining, Davis & Hyndiuk, 1986). Indeed, a recent study has 
highlighted the significance of nitrogen and carbon sources as well as the pH, 
incubation temperature and incubation time in the production of bacterial proteases 
in vitro (Olajuyigbe, 2013). Furthermore, concentrated conditioned growth media 
could be used in assays used to detect proteolytic activity (Kadurugamuwa & 
Beveridge, 1995).  
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Production of virulence factors can be influenced by oxidative stress, as shown by 
recent evidence that virulence factor production, including rhamnolipid, elastase and 
alkaline protease, is affected by the aeration surface when cultured in shaken flasks 
(Pacheco et al, 2012). This work, along with work by Kronemberger et al (2008) 
who demonstrated an elevated production of proteases in cultures with a higher level 
of dissolved oxygen, ties in with the results from the present study whereby 
anaerobic P. aeruginosa cultures generally produced a lower total yield of proteases. 
However, when levels of protease activity were considered in terms of bacterial 
density, anaerobic cultures produced a higher level of proteolytic activity. Given the 
reports of increased protease activity under microaerobic conditions (Sabra, Kim & 
Zeng, 2002) the culture of P. aeruginosa isolates under varied oxygen tensions 
incorporating microaerobic conditions may reveal further differences in proteolytic 
activity in these changing environments.  
 
In terms of the clinical in vivo environment, the use of multi-species bacterial 
cultures to reflect the microbial diversity of the chronic wound milieu could be 
utilised to further consider the synergistic effects of introducing multiple bacterial 
species on overall protease activity. The effects of commonly isolated wound 
bacteria, yeasts and fungi grown in mono-culture and in combination cultures can be 
used to establish which proteases are produced throughout the various growth 
phases. A recent study by Vandecandelaere et al (2014) generated some interesting 
data relating to the effect of protease production by Staphylococcus epidermidis on 
Staphylococcus aureus biofilms. They found that treating S.aureus biofilms with the 
protease-rich supernatant of S.epidermidis caused a decrease in the biomass of the 
biofilm, which was found to be mainly due to the actions of serine proteases causing 
a thinner biofilm with almost no ECM. The relationship between different bacterial 
species within a clinical biofilm and the implications on protease levels within a 
multi-species biofilm would be a basis for future research to more closely reflect the 
clinical situation.  
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Further investigation into possible differences in protease expression by P. 
aeruginosa isolates obtained from acute and chronic wounds could be conducted, 
relating such data to the clinical outcome of the wound. Dressings obtained from 
acute and chronic wounds can also be utilised to detect the presence and abundance 
of both host and bacterial proteases as the wounds progress. To more closely mimic 
a chronically infected wound and to investigate the effects that bacterial proteases 
have on tissue damage, a model such as the one used in the recent study by Harrison 
et al (2014) would be a useful tool for the assessment of the ways in which the 
wound environment, including during polymicrobial infection, influences protease 
levels. 
 
It has been demonstrated that P. aeruginosa secretes some of its exoproducts within 
membrane vesicles during normal growth (Kadurugamuwa & Beveridge, 1995). 
These vesicles 'bleb-off' into the culture medium and it is proposed that they act as a 
mechanism by which P. aeruginosa secretes virulence factors, including proteases, 
into the surrounding environment (Kadurugamuwa & Beveridge, 1995). Indeed, 
more recent data has identified LasA protease as one of many extracellular proteins 
identified from P.aeruginosa outer membrane vesicles (Choi et al, 2011). 
Pseudomonas metalloproteases, elastase and alkaline protease have also been 
identified as outer membrane vesicle proteins in cultures challenged with the 
antibiotic ciprofloxacin (Maredia et al, 2012). Furthermore, these vesicles have been 
found to increase following exposure to gentamicin, a surface-active aminoglycoside 
antibiotic (Kadurugamuwa & Beveridge, 1995). In future studies, the presence of 
membrane vesicles in the supernatant of P. aeruginosa cultures should be 
considered; in culture supernatants a proportion of the proteolytic activity may be 
missed due to retained proteases within the membrane vesicles and thus the use of 
high-speed centrifugation to distinguish between membrane vesicle protease content 
and soluble proteases would allow for a more thorough evaluation of the proteolytic 
activity that is available to act upon the host tissues (Kadurugamuwa & Beveridge, 
1995). In addition, in terms of the clinical situation, where antibiotics are 
administered the increase in membrane vesicles and their content should be 
appreciated. Enzymatically active elastase was not found in these membrane vesicles 
in the aforementioned study by Kadurugamuwa & Beveridge (1995); elastase is 
produced in an inactive form and the proenzyme only becomes active as it crosses 
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the outer membrane (Kadurugamuwa & Beveridge, 1995). Since the proenzyme 
entrapped within the membrane vesicle would not cross the outer membrane it would 
remain inactive (Kadurugamuwa & Beveridge, 1995). Thus, assays such as those 
used in the present study would not detect these enzymes unless they were activated. 
Given that bacteria produce outer membrane vesicles in response to stress factors 
(Maredia et al, 2012; Kuehn & Kesty, 2005), it would seem plausible to further 
investigate the effects of the wound environment on vesicle production. In addition, 
the abundance of proteases within the supernatant of biofilm cultures could have 
been underestimated due to entrapment of these enzymes within the alginate matrix. 
Therefore, further studies should explore the proteolytic content of the biofilm 
matrix as well as within the culture supernatant. 
 
Given recent evidence that suggests a role of the type II secretion system, which is 
involved in the production of proteases, in the type III secretion pathway (Golovkine 
et al, 2014) it would also be interesting to investigate the impact of an active type II 
secretion system on other virulence factor production and the synergistic effect of 
these virulence factors on wound healing. 
 
The present study demonstrated the variability in the BFP of P. aeruginosa isolates 
from chronic equine wounds; whilst most isolates were able to form biofilms to 
some extent, some isolates were unable to produce robust biofilms, as demonstrated 
via the crystal violet assay. Whilst it was not possible to make definitive conclusions 
with regards to a possible relationship between BFP and protease production in the 
present study, in future work the use of more P. aeruginosa isolates with varying 
BFPs should be used to investigate the effects of biofilm formation on the production 
of P. aeruginosa proteases. Previous studies have reported that the sessile or biofilm 
mode of growth and the mucoid phenotype affects bacterial proteolytic activity 
(Evans, Brown & Gilbert, 1994; Ohman & Chakrabarty, 1982; Mathee et al, 1999; 
Mohr et al, 1990). For instance, Mohr et al (1990) explored possible coregulation at 
the transcriptional level of LasB (encoding elastase) and algD (encoding alginate) 
and found that LasB and algD genes showed inverse levels of promoter activity. 
Henderson et al (2014) also found that P.aeruginosa growing in a thick mucus with 
biofilm physiology secreted proteases caused cleavage of mucin macromolecules 
and that proteases can cleave antigenically exposed regions of mucins in CF 
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secretions. Comparatively, Yu et al (2014) found that LasB elastase has a role to 
play in P.aeruginosa biofilm formation; a LasB deletion mutant displayed decreased 
bacterial attachment, microcolony formation and ECM linkage which was also 
associated with a decreased biosynthesis of rhamnolipids. In chapter 3 an in vitro 
biofilm culture model was described; the glass microscope slide biofilm model was 
used to assess the effect of the biofilm mode of P. aeruginosa growth on the 
production of proteases. The present study highlighted a clear difference between P. 
aeruginosa isolates from equine wounds in terms of both growth rate and protease 
production within developing biofilms in vitro but there was generally a low level of 
protease activity in these cultures. However, when compared in terms of biomass the 
biofilm cultures were actually producing higher protease levels relative to biomass 
than the planktonic cultures. Given the these findings, along with the current 
literature, it may be reasonable to suggest that proteases secreted during the early 
stages of biofilm formation aid in their development. Further characterisation of the 
P.aeruginosa isolates used in this study in terms of alginate production along with 
the development of biofilm models of varying maturity would further support the 
evidence suggestive of a relationship between protease activity and the biofilm mode 
of growth and the clinical implications this may have in terms of wound healing. 
 
Given the evidence that heterogeneity exists among clinical P. aeruginosa isolates in 
terms of biofilm formation (Lee et al, 2005), it is likely that differences also exist in 
terms of the proteolytic activity of biofilms formed from different P. aeruginosa 
isolates obtained various chronic and acute wounds throughout their development. 
The present study, to some extent, corroborated this hypothesis in terms of general 
proteolytic activity of early developing biofilms in vitro, however further 
investigation is needed to fully characterise the proteolytic profiles of P. aeruginosa 
wound isolates during growth within mature biofilms. Microarray analysis would 
also allow investigation into the virulence genes which are up or down-regulated 
when bacteria are grown within the biofilm state (Jesaitis et al, 2003). Genomic 
characterisation of the isolates used in this study would give a much clearer 
understanding of the reasons for the elevated protease production of some isolates 
compared with others.  
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The aim of Chapter 4 was to investigate the effects of cell-free conditioned media 
from P. aeruginosa chronic wound isolates and purified P. aeruginosa elastase on 
the viability and growth of equine dermal fibroblasts. Given the limited evidence 
when this study was initiated suggestive of an effect of P. aeruginosa proteases in 
cutaneous wound healing with respect to the regulation of host proteases within the 
wound milieu, this study also aimed to further investigate the potential actions of P. 
aeruginosa exoproducts, including purified P. aeruginosa elastase, on host 
fibroblasts MMP and TIMP expression. Whilst there was a limitation of cell donors, 
clear trends in the inhibition of fibroblast growth and diminished fibroblast viability 
were observed with increasing concentrations of total protein concentration of P. 
aeruginosa conditioned media and purified P. aeruginosa elastase. These results 
corroborated previous findings by Schmidtchen et al (2003) who demonstrated that 
LasB from ulcer-derived P. aeruginosa inhibited fibroblast growth. Whilst it was not 
possible to analyse the results of the qRT-PCR data statistically due to a limitation in 
cell donors, each of the MMPs and TIMPs of interest were up-regulated relative to 
GapDH. It was also noted that fibroblasts derived from different donors and those 
from either granulation tissue or normal skin responded to treatment with P. 
aeruginosa conditioned media and purified P. aeruginosa elastase in different ways.  
 
In order to fully characterise the effects of P. aeruginosa exoproducts on cell 
viability, assays such as the MTT assay (a colorimetric assay using a tetrazoilum 
dye) for cell activity and the caspase-3 assay for apoptosis can be utilised. The 
propidium iodide assay could also be used to assess any effects of the P. aeruginosa 
exoproducts on necrosis of dermal fibroblasts. Additionally, immunocytochemistry 
techniques can be employed to further investigate the effects of P. aeruginosa 
conditioned media and elastase on cultured fibroblasts including potential effects on 
cell surface components and ECM (Azghani, Kondepudi & Johnson, 1992).  
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Schmidtchen and colleagues (2003) demonstrated that P. aeruginosa growth and 
elastase production was similar when isolates were grown in bacterial growth 
medium, wound fluid and in the presence of human skin. Significant degradation of 
wound fluid components was noted in wound fluids incubated with elastase-
producing P. aeruginosa and similar findings were observed when the P. aeruginosa 
isolates were cultured with human skin biopsies. In future work, it would be 
interesting to use ex vivo culture models with metabolic labelling of equine 
fibroblasts in the presence of live P. aeruginosa cultures, P. aeruginosa conditioned 
media and purified elastase to establish the effects of P. aeruginosa proteases on 
components of wound fluids derived from both acute and chronic equine wounds and 
how changes in the growth environment of P. aeruginosa isolates affects such 
degradation of wound fluid components. Fluorescence microscopy can also be 
employed as an advanced method to investigate further the effects of P. aeruginosa 
proteases on fibroblast morphology. 
 
The immunohistochemistry images presented in Chapter 4 confirm the presence of 
bacterial clusters within equine wound tissue both at the outer edges of the wound 
area and within tissue sections taken from the middle of the wound, indicating that 
bacteria are disseminated throughout the wound bed. Furthermore, bacterial staining 
occurred in union with moderate staining of MMP-2, -3 and -13, with dark staining 
around immune cells which seems to link evidence of infection, inflammation and 
protease expression throughout the tissue. It may prove useful to further investigate 
the localisation of MMP/TIMP expression throughout larger granulation tissue and 
normal skin sections upon culture with P. aeruginosa elastase and other exoproducts 
using an in vitro organ culture model. Live P. aeruginosa cultures, incorporating 
specific elastase-producing and elastase-deficient strains, used in equine dermal 
fibroblast infection models would help to further establish the effects of P. 
aeruginosa secretions on fibroblast viability, growth and MMP/TIMP mRNA 
expression in a culture model which more closely reflects the in vivo environment. 
Given that P. aeruginosa proteases are regulated at different levels, including gene 
transcription, translation and pro-enzyme activation (Dong et al, 2000) zymographic 
analysis of concentrated fibroblast culture supernatants would help to establish at 
which level bacterial proteases enhance host fibroblast proteolytic activity.  
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In Chapter 5 the potential MMP modulating capacity of a novel foam wound 
dressing containing polyphosphate was investigated using an in vitro model. It has 
been previously shown that unbound polyphosphate can help to maintain a robust 
ECM and promote wound healing via the inhibition of proteases in a concentration 
dependent manner (Richardson et al, 2009). The present study examined the ability 
of a foam wound dressing containing polyphosphate to sequester MMPs -2 and -9 in 
vitro in comparison with 3 commercially available wound dressings. Using gelatin 
zymography, it was observed that the foam wound dressing containing 
polyphosphate was able to effectively sequester both active and latent forms of 
MMP-2 and MMP-9 throughout a 48 hour test period, with optimal activity of the 
dressing observed after 6 hours of incubation with the enzymes. Furthermore, this 
dressing proved effective in the minimisation of P. aeruginosa derived proteases; the 
polyphosphate-containing foam dressing was able to reduce protease levels of P. 
aeruginosa conditioned media obtained from chronic wound P. aeruginosa isolates 
with both high a low BFP. This study, therefore, demonstrates the potential of a 
polyphosphate foam dressing to inhibit both host proteases and exogenous proteases 
found within the wound bed.  
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Certainly, the data presented in this in vitro study should be interpreted as 
preliminary findings and future work should aim to corroborate these findings and to 
further characterise the mechanisms by which bacterial derived proteases affect the 
wound healing process in vivo. Nonetheless, the data presented in this study has 
highlighted a clear variation in the proteolytic profiles of P. aeruginosa isolates 
obtained from various equine chronic wounds. Furthermore, alterations in the growth 
environment of these isolates has demonstrated that both initial pH and oxygen 
availability, which are known to be important factors which affect the wound healing 
process, along with the growth mode of the bacteria (i.e. the planktonic versus the 
biofilm mode of growth) affects protease production by different P. aeruginosa 
isolates in different ways. It is important, therefore, in future studies to appreciate 
that there exists some deviation in the virulence of P. aeruginosa isolates derived 
from different host environments and in particular that the proteolytic activity of type 
strains varies from clinical isolates. The study has also demonstrated the potential 
effects of P. aeruginosa exoproducts on host fibroblast viability, growth and 
MMP/TIMP expression. The ways in which proteolytic activities can be manipulated 
within the wound milieu have been explored, and a novel foam dressing which 
incorporates polyphosphate has proven to be effective in its ability to sequester not 
only equine MMPs but also P. aeruginosa derived proteases. 
 
Conclusions 
 
Whilst there were a number of limitations with this study, inherent in all in vitro 
investigations, plus a limited number of bacterial isolates and tissue donors the study 
has clearly highlighted a variation in the proteolytic profiles of P.aeruginosa equine 
wound isolates and the detrimental effect that these proteases can have on host 
fibroblasts viability. Changes in the culture environment of these isolates, which 
represent the changes observed during wound healing, have been shown to have an 
effect on the proteolytic productivity of these isolates. Different isolates responded to 
these environmental changes in different ways in terms of proteolytic activity. The 
study has also demonstrated the ability of a novel foam dressing incorporating 
polyphosphate to sequester both host and bacterial proteases in an in vitro model. 
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